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REFERENCES SUMMARY The  aim  of  the  work  described  in  this  thesis  was  to 
identify  genetic  loci  of  herpes  simplex  virus  type  2  (HSV-2) 
with  functions  needed  to  initiate,  maintain  or  reactivate 
virus  from  the  latent  infection.  The  experimental  system 
adopted  involved  mouse  footpad  inoculation  and  3  months 
later  explantation  of  dorsal  root  ganglia  and  footpads,  and 
used  13  of  the  temperature  sensitive  (ts)  mutants  derived 
from  the  HG52  strain  of  HSV-2.  The  phenomenon  of  "latency" 
was  investigated  in  five  different  strains  of  mice  in  order 
to  provide  information  about  the  possible  involvement  of 
host  genetic  factors  in  modulating  HSV  latent  infection. 
The  mouse  core  temperature  (38.5°C)  is  non  permissive  for 
growth  of  the  is  mutants  and  therefore  synthesis  of 
infectious  virus  is  inhibited  by  virtue  of  the  is  lesions. 
The  results  indicate  that  is  mutants  were  recoverable  at 
different  frequencies  from  the  latent  state  in  dorsal  root 
ganglia.  The  mutants  is  3,  is  5  and  is  9  were  only 
recovered  on  one  occasion  each  (1/80,1/59,1/66) 
respectively.  This  finding  implies  that  these  mutants  are 
impaired  in  functions  that  affect  latency.  The  precise 
nature  of  this  impairment  needs  further  detailed 
examination.  A  number  of  intracerebral  inoculations  were 
also  carried  out.  No  virus  was  recovered  from  the  brain  of 
mice  6  weeks  after  intracerebral  inoculation  with  either 
is  3,  is  5  or  is  9. 
None  of  the  13  is  mutants  reactivated  from  the  ganglia 
as  efficiently  as  the  wt  virus.  Differences  in  the  capacity 
of  the  various  is  mutants  to  be  recovered  from  the  latent 
state  support  the  notion  that  latency  is  under  the  genetic 
control  of  several  viral  genetic  loci.  Mouse  strains  were 
found  to  differ  in  the  frequency  with  which  these  viruses could  be  recovered  from  the  latent  state,  e.  g.  "BALB/c", 
"BIOZZI"  and  "A"  strains  giving  more  frequent  recovery  than 
"C57BL/6-J"  or  "PIRBRIGHT":  evidence  for  the  involvement  of 
host  genetically  determined  factors  in  modulating  latency. 
In  addition  no  correlation  was  observed  between  the 
susceptibility  of  mice  to  acute  infection  and  latency;  this 
is  another  interesting  aspect  of  the  system  which  needs 
further  investigation. 
The  mutant  viruses  as  well  as  the  wt  were  reproducibly 
recovered  from  the  footpad  tissues  of  latently  infected 
mice,  and  differences  in  the  recoverability  of  the  is 
mutants  from  the  footpads  were  also  observed:  for  example 
is  5  (0/59)  and  is  11  (0/58)  have  never  been  recovered  from 
the  footpad  whereas  is  3,  is  4  and  is  10  were  recovered  more 
often  from  the  footpad  than  other  mutants  and  wt  viruses. 
This  makes  is  5  is  a  specially  notable  mutant,  having  been 
recovered  from  latency  on  one  occasion  only. 
The  following  lines  of  evidencepoints  toward  the 
possibility  that  HSV  can  establish  latent  infection  in  the 
footpad  and  therefore  in  cells  other  than  neurones:  1)  the 
inability  to  detect  virus  in  footpad  tissue  homogenised 
immediately  after  explantation;  2)  the  difference  in  the 
time  of  virus  reactivation  from  the  dorsal  root  ganglia  and 
from  the  footpad  (generally  viruses  take  longer  to 
reactivate  from  the  footpad);  3)  the  fact  that  some  is 
mutants  were  recovered  from  the  ganglia  but  not  from  the 
footpad,  and  others  from  the  footpad  but  very  rarely  from 
the  ganglia.  However,  the  possibility  that  the  virus  is 
merely  persistent  in  the  footpad  can  not  yet  finally  be 
excluded.  Experiments  are  underway  to  elucidate  this  point. 
HSV-2  was  successfully  reactivated  from  dissociated dorsal  root  ganglia  in  culture;  viral  antigen  first  appeared 
in  neurones  and  only  subsequently  did  reactivated  virus 
spread  to  non  neuronal  ganglionic  cells.  Recovery  of  virus 
from  dissociated  ganglia  clearly  shows  that  anatomical 
integrity  is  not  required  for  reactivation  and  furthermore 
allows  the  system  to  be  examined  in  a  qualitative  and 
quantitative  way. 
The  recovered  viruses  were  always  found  to  have  retained 
their  is  genotype.  The  identity  of  recovered  viruses 
(HSV-2)  has  been  confirmed  by  comparing  their  restriction 
enzyme  profiles  to  that  of  the  originally  inoculated 
viruses.  Apart  from  one  instance,  no  change  in  restriction 
sites  was  observed,  however,  shifts  in  the  mobility  of 
certain  restriction  enzyme  fragments  were  noticed.  In  one 
isolate  of  is  3,  a  HindIIl  site  is  missing  between  the  1  and 
m  fragments. 
Virus  was  never  recovered  from  the  footpad  of  the  non 
inoculated  side.  Virus  was  not  recovered  from  the  left 
dorsal  root  ganglia  except  for  one  instance  where  wt  virus 
was  recovered  from  the  left  sided  ganglia  and  from  the 
spinal  cord  tissue  explanted  from  a  mouse  showing  paralysis 
5  months  after  inoculation.  In  many  cases  virus  could  be 
recovered  from  ganglia  not  associated  with  the  inoculated 
dermatome.  These  findings  simply  suggest  the  spread  of  the 
virus  within  the  nervous  tissue  of  inoculated  mice  and  also 
indicate  that  latent  infection  can  also  be  established 
within  the  spinal  cord. 
The  work  described  here  analyses  the  effect  on  latency 
of  13  HSV-2  is  mutants  and  also  demonstrates  the  important 
modulating  influence  of  the  host  genetic  makeup.  The  state 
of  the  viral  genome  during  latency  has  yet  to  be  elucidated. Further  investigation  of  the  latency  capacity  (both  in  vivo 
and  in  vitro)  of  deletion  mutants,  is  mutants  in  other  genes 
and  recombinants  should  allow  precise  identification  of  the 
regions  of  the  viral  genome  involved  in  latent  infection. INTRODUCTION 1 
Herpesviruses 
Herpesviruses  are  very  widespread  in  occurrence  and 
have  been  isolated  from  humans  and  from  many  other  species 
(Nahmias,  1972).  Many  have  a  very  narrow  host  range  but-in 
other  cases  this  may  vary  considerably  both  in  nature  and  in 
the  laboratory.  Herpesviruses  occur  in  both  warm-  and 
cold-blooded  vertebrates  and  in  invertebrates.  In  addition, 
herpesviruses  have  also  been  reported  in  fungus  (Kazoma  and 
Schonstein,  1972). 
In  the  earliest  writings,  the  word  "herpes"  has  been 
used  to  describe  a  variety  of  clinical  conditions.  In 
recent  years,  herpesviruses  have  been  associated  with  a 
number  of  diseases  and  some  members  of  herpesviruses  have 
been  reported  to  induce  neoplasia  in  their  natural  host 
and/or  in  experimental  animals.  In  cell  culture,  some 
herpesviruses  have  been  shown  to  be  able  to  transform  cells 
into  continuous  cell  lines  which  may  produce  invasive 
tumours  in  appropriate  experimental  hosts  (reviewed  by  Rapp 
and  McCarthy,  1978). 
The  site  of  primary  infection  with  herpesviruses 
varies  and  the  viruses  may  remain  latent  in  their  host  for 
the  life  time  of  the  host;  the  actual  cells  harbouring 
latent  virus  may  vary  depending  on  the  virus  type. 
A  common  characteristic  among  herpesviruses  is  that, 
i.  the  size  of  the  virion  is  120-150  nm  in  diameter  and  they 
possess  a  linear  molecule  of  double  stranded  DNA  genome  with 
an  average  molecular  weight  80-150  x  106  daltons,  ii.  their 
capsid  is  icosahedral  and  composed  of  ('162)  hexagonal  and 
pentagonal  capsomereunits,  iii.  they  are  ether  sensitive 
enveloped  viruses. 
At  least  five  distinct  human  herpesviruses  exist: 2 
Human  herpesvirus  1  is  Herpes  simplex  virus  type  1  (HSV-1) 
Human  herpesvirus  2  is  Herpes  simplex  virus  type  2  (HSV-2) 
Human  herpesvirus  3  is  Varicella  zoster  virus  (VZV) 
Human  herpesvirus  4  is  Epstein-Barr  virus  (EBV) 
Human  herpesvirus  5  is  Cytomegalovirus  (HCMV) 
This  Thesis  deals  mainly  with  herpes  simplex  virus, 
particularly  HSV-2.  However,  whenever  it  is  relevant,  other 
human  herpes  viruses  are  also  discussed. 
Although  the  clinical  syndromes  associated  with  the 
infection  by  HSV  type  1  and  type  2  have  long  been  known,  it 
is  only  recently  that  the  importance  of  studying  these 
viruses  in  detail  has  been  appreciated  for  the  following 
reasons:  a,  Herpes  simplex  virus  has  been  isolated  from 
different  pathological  lesions  (conjunctivitis, 
keratoconjunctivitis,  mouth  ulcers,  stomatitis,  urogenital 
tract  infection  and  fever  blisters).  In  addition  some  cases 
of  aseptic  meningitis  have  been  attributed  to  herpes 
infection,  b,  Herpes  simplex  virus  has  become  a  major  cause 
of  venereal  infections,  c:  the  severity  of  lesions  and 
syndromes  they  induce  has  become  recognised  as  life 
threatening  to  the  newborn  and  to  immunologically 
compromised  hosts  (Rawls,  1973),  d,  it  is  thought  that  HSV 
is  aetiologically  linked  to  urogenital  cancer  particularly 
carcinoma  of  the  cervix,  (Roizman  and  Frenkel,  1976),  e,  the 
virus  has  the  ability  to  induce  latent  infection  and  remain 
within  the  body  for  the  life  of  the  individual,  f,  up  to  now 
and  despite  all  efforts,  there  is  no  real  prospect  for 
eradication  of  these  viruses;  however,  several  antiviral 
compounds  particularly  acyclovir  (ACV)  have  been  shown  to 
possess  substantial  antiviral  activity  in  limiting  virus 
replication,  but  at  present  none  seem  to  affect  the 3 
established  latent  infection  (Blyth  et  al.,  1979;  Field  et 
al.,  1979)  g,  the  development  of  various  molecular 
techniques  has  made  the  manipulation  of  these  viruses  much 
easier. 
The  two  types  of  herpes  simplex  virus  (HSV-1  and 
HSV-2)  are  related,  with  great  similarities  in  their 
molecular  and  biological  properties,  yet  there  is  a 
significant  genetic  divergence  and  the  two  types  can  be 
distinguished  by  a  variety  of  immunological  tests  including 
neutralization  and  by  the  differences  in  the  molecular 
weight  of  virus  induced  polypeptides  (Killington  et  al., 
1977)  and  on  the  basis  of  the  pattern  of  their  DNA 
restriction  endonuclease  fragments  (Hayward  et  al.,  1975; 
Skare  et  al.,  1975;  Lonsdale,  1979).  There  is  approximately 
a  50%  homology  of  genetic  relatedness  between  the  two 
serotypes  (Kieff  et  al.,  1972;  Ludwig  et  al.,  1972) 
Herpes  Simplex  Virus  (Structure  and  Components) 
The  virion 
The  major  structural  features  of  HSV  are  1,  Core;  2, 
Capsid;  3,  Tegument  and  4,  Envelope.  A  diagrammatic 
illustration  of  the  virion  is  shown  in  Figure  (1).  The 
virion  diameter  ranges  between  120-180  nm.  The  virion 
diameter,  however,  is  considerably  affected  by  the  diameter 
of  the  nucleocapsid  and  by  the  volume  of  the  tegument  as 
well  as  by  discontinuities  in  the  virion  envelope  (intact 
virion  has  smaller  diameter  than  the  disrupted  particles). 
In  sectioned  virion  preparations,  the  core  appears  as 
electron  opaque,  and  although  the  precise  configuration  of 
the  DNA  in  the  core  is  not  known,  it  has  been  shown  that  the 
DNA  occupies  a  toroidal  compartment  in  the  core  and  that  a 
"spindle"  of  electron-dense  material  probably  of FIGURE  1 
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5.  tegument 
6.  envelope 
7.  spikes 
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proteinaceous  nature,  extends  through  the  whole  of  the 
toroid  (Furlong  et  al.,  1972).  It  has  also  been  shown  that 
HSV-1  capsids  which  contain  DNA  differ  from  those  lacking 
cores  with  respect  to  certain  virion  polypeptides  (VP), 
where  VP22a  appears  to  be  on  the  surface  of  the  capsid  while 
VP21  is  a  possible  core  protein  (Gibson  and  Roizman,  1972). 
The  polyamine,  spermine  may  also  represent  a  core  component 
packaged  within  the  capsid  (Gibson  and  Roizman,  1971). 
The  average  diameter  of  HSV  capsids  is  approximately 
100  nm.  It  encloses  the  core  and  is  composed  of  smaller 
units,  the  capsomers.  The  total  number  of  the  latter  is  162 
arranged  as  an  icosahedral  structure.  Electron  microscopy 
reveals  two  groups  of  capsomers,  hexomeric  and  pentameric 
(Wildy  et  al.,  1960).  The  nucleocapsid  protein  appears  to 
be  in  the  space  between  the  capsid  and  the  core.  It  is 
thought  that  the  nucleocapsid  protein  may  interact  with  the 
core  and  maintain  its  central  position  within  the  capsid 
(Roizman  and  Furlong,  1974). 
The  material  located  between  the  capsid  and  the 
envelope  is  defined  as  the  tegument  (Roizman  and  Furlong, 
1974).  In  thin  sections  of  virions  or  budding  particles, 
the  electron-dense  tegument  has  no  distinctive  features, 
however,  in  negatively  stained  preparations,  tegument  can 
have  a  fibrous  structure  (Wildy  et  al.,  1960;  Morgan  et  al., 
1968;  Schwartz  and  Roizman,  1969).  The  tegument  seems  to  be 
present  in  most  virions,  but  the  amount  seen  in  the  electron 
microscope  can  vary  from  virion  to  virion,  even  in  the  same 
cell.  The  overall  quantity  of  tegument  appears  to  be 
controlled  at  least  in  part  by  the  virus  (McCombs  et  al., 
1971).  Proteins  present  in  de-enveloped  virions  but  not  in 
nucleocapsids  containing  DNA  have  been  assigned  to  the 5 
tegument.  Among  such  proteins  is  the  VP22  (36,000  MW)  which 
is  thought  to  be  formed  by  cleavage  of  precursor  tegument 
polypeptide,  VP22a  (Gibson  and  Roizman,  1972,1974). 
The  envelope  is  the  virion  outermost  structure.  It  is 
composed  of  lipid  bilayer  and  associated  proteins.  It 
contains  spike-like  projections  (Fig.  l)  on  its  surface 
(Wildy  et  al.,  1960).  All  the  virion  glycoproteins  are 
thought  to  be  restricted  to  the  envelope  and  possibly  the 
tegument  (Roizman  and  Furlong,  1974).  The  polyamine 
spermidine  is  also  associated  with  the  envelope  (Gibson  and 
Roizman,  1971). 
The  Genome 
The  first  direct  chemical  evidence  indicating  that  HSV 
genome  contains  DNA  was  described  by  Ben-Porat  and  Kaplan 
(1962)  and  Russell  (1962).  Further  studies,  had  shown  that 
HSV  DNA  within  virions  is  a  single  (double-stranded)  linear 
molecule  (Russell  and  Crawford,  1963,1964;  Becker  et  al., 
1968;  Frenkel  and  Roizman,  1971;  Furlong  et  al.,  1972; 
Graham  et  al.,  1972)  and  that  the  intact  HSV  DNA  molecule 
strands  as  well  as  the  native  duplex  molecule  are  infectious 
(Sheldrick  et  al.,  1973).  The  size  (molecular  weight)  of 
the  HSV  genome  has  been  the  subject  of  much  controversy  and 
various  methods  used  to  determine  the  molecular  weight  have 
given  values  ranging  between  51x106  daltons  (D)  to  110x106 
(Russell  and  Crawford,  1963,1964;  Becker  et  al.,  1968; 
Wilkie,  1973;  Grafstrom  et  al.,  1974;  Wagner  et  al.,  1974; 
Clements  et  al.,  1976;  Wilkie,  1976;  Cortini  and  Wilkie, 
1978).  The  general  agreement,  however,  is  that  HSV  genome 
is  close  to  100x106  D  in  MW. 
it  is  worth  mentioning  here  that  most  of  the  above 
values  were  determined  using  HSV  type  1,  however,  it  has 6 
been  reported  (Kieff  et  al.,  1971)  that  the  DNAs  of  HSV-1 
and  HSV-2  could  not  be  differentiated  with  respect  to  size 
when  cosedimented  on  neutral  sucrose  gradient-.  Moreover, 
Cortini  and  Wilkie  (1978)  found  that  the  molecular  weight  of 
various  regions  which  constitute  the  HSV-2  genome  are  very 
similar  to  the  corresponding  molecular  weight  in  HSV-1 
genome.  The  buoyant  density  of  HSV-1  and  HSV-2  DNAs  were 
estimated  to  range  from  1.725-1.727  g/cm3  (HSV-1)  and  from 
1.727-1729  g/cm3  for  HSV-2  (Goodheart  et  al.,  1968;  Kieff  et 
al.,  1971;  Graham  et  al.,  1972;  Halliburton,  1972). 
Subsequently  the  base  (guanine  and  cytosine)  composition  of 
the  two  subtypes  were  calculated  and  found  to  be  67  G+C 
moles  %  for  HSV-1  and  69  G+C  moles  %  for  HSV-2.  Some  other 
methods  were  also  used  to  determine  the  base  composition  of 
HSV-1  and  HSV-2  DNAs  such  as  nucleotide  analysis  (Ben-Porat 
and  Kaplan,  1962;  Graham  et  al.,  1972),  melting  temperature 
analysis  "Tm"  (Kieff  et  al.,  1971).  In  addition,  Russell 
and  Crawford  (1963)  described  the  use  of  ultraviolet 
absorption  measurement. 
Fragmentation 
A  significant  property  of  HSV  DNAs  is  their 
fragmentation  upon  denaturation  with  alkali  (Kieff  et  al., 
1971;  Frenkel  and  Roizman,  1972;  Wilkie,  1973;  Biswal  et 
al.,  1974).  Kieff  and  co-workers  (1971)  have  reported  that 
sedimentation  of  alkaline-denatured  DNA  from  purified  virus 
on  alkaline  sucrose  density  gradient  consistently  yielded 
several  bands  of  single  stranded  HSV  DNA  ranging  from 
fragments  of  7x106  D  to  intact  strands  of  48x106  D  in 
molecular  weight.  Similar  results  were  reported  by  Frenkel 
and  Roizman  (1972)  and  in  addition  they  also  reported  that 
of  the  seven  bands  sedimented  on  an  alkaline  sucrose  density 7 
gradient,  only  one  band  is  an  intact  strand  and  the  others 
are  fragments  with  smaller  sizes  than  the  unit  length. 
Possible  explanations  for  this  fragmentation  property  of  HSV 
DNAs,  are  the  presence  of  ribonuclectides  (Hirsch  and  Vonka, 
1974;  Biswal  et  al.,  1974),  however,  this  has  been  largely 
confined  to  newly  synthesized  DNA  as  it  seems  probable  that 
RNA  stretches  which  arise  in  the  replication  are  removed 
only  gradually  during  maturation  (Hirsch  and  Vonka,  1974). 
The  other  explanation  is  the  presence  of  single-strand  nicks 
or  gaps  (Wadsworth  et  al.,  1976;  Hyman  et  al.,  1976;  Ecker 
and  Hyman,  1981).  The  role  of  these  gaps  or  nicks  within 
the  DNA  is  unknown  although  some  of  the  ribonucleotides  may 
serve  as  primers  in  DNA  synthesis.  Their  position  in  the 
DNA  is  subject  to  controversy  and  it  has  been  concluded  that 
the  fragments  are  non  random  in  size  and  originate  at  unique 
positions  from  single  breaks,  of  intact  strands  (Frenkel  and 
Roizman,  1972).  On  the  other  hand,  it  has  been  proposed  on 
the  basis  of  the  heterogenous  sedimentation  and 
electrophoretic  pattern  observed  that  the  single-strand 
interruptions  are  randomly  located  on  the  genome  (Wilkie, 
1973;  Wilkie  et  al.,  1974;  Hyman  et  al.,  1977;  Ecker  and 
Hyman,  1981).  Moreover,  the  intact  strands  were  not  unique 
(Wilkie,  1973)  and  in  vitro  pretreatment  of  the  DNA  with 
repair  enzymes  (DNA  polymerase.  and  DNA  ligase)  would  prevent 
the  alkali  fragmentation  (Hyman  et  al.,  1977). 
Arrangement  of  the  Genome 
Electron  microscope  studies  have  shown  that  most  of 
the  DNA  molecules  have  one  or  two  distinct  ends  indicating 
the  linear  nature  of  the  herpes  simplex  DNA  genome  (Becker 
et  al.,  1968).  Sheldrick  and  Berthelot  (1974)  described 
three  structurally  distinct  molecules  of  HSV  genome,  namely, 8 
a  linear  form  "L",  and  two  circular  forms  Cl  and  C2 
(Fig.  2a).  The  number  of  the  L  forms  in  a  given  preparation 
rarely  exceeded  10-20%  and  more  than  50%  of  the  -L- 
molecules  had  a  highly  folded  region  or  "bush"  at  one  end. 
The  length  of  these  structural  features  (bushes)  was 
estimated  to  account  for  20%  of  the  total  length  of  the  -L- 
molecules. 
The  Cl  molecules  comprise  more  than  70%  of  the  total. 
It  is  a  single-stranded  circle  with  a  bush,  and  as  in  the 
L-form,  the  bush  represents  approximately  20%  of  the  total 
contour  length,  however,  all  Cl  molecules  possess  a  bush. 
The  C2  molecules  are  present  as  less  than  10%  of  the  total 
number  of  the  molecules  and  consist  of  two  single  stranded 
circles,  one  short  (SC)  and  one  long  (LC)  in  circumference, 
joined  by  an  extensive  and  highly  homologous  duplex  region 
(D).  It  has  been  shown  that  it  is  possible  to  convert  Cl 
molecule  to  L-form  by  heating  the  DNA  in  50%  formamide  to  a 
temperature  above  700C  (the  temperature  at  which  complete 
strand  separation  of  native  DNA  occurs),  however,  heating 
the  DNA  to  and  below  70°C  will  lead  to  the  conversion  of  the 
Cl  molecule  to  the  C2  form.  This  thermal  conversion  of  Cl 
to  C2,  probably  involves  a  rearrangement  of  the  bush  in  Cl 
to  the  "stalk"  (SC+D)  in  C2.  Since  C2  molecules  arose  from 
linear  precursors,  these  must  be  present  somewhere  in  the 
DNA  strand  -  two  inverted  repetitions  one  to  generate  SC  and 
the  second  to  generate  LC  (Sheldrick  and  Berthelot,  1974). 
The  finding  that  the  DNA  strand  ends  were  located  near  the 
middle  of  the  duplex  region  D,  had  suggested  that  the  two 
inverted  repeats  were  adjacent  to  each  other  and  of  equal 
length  with  one  half  of  each  repeat  located  at  the  interior 
and  the  other  half  at  the  end  of  the  intact  strand.  The FIGURE  2 
SCHEMATIC  ILLUSTRATION  OF: 
a)  C2  molecule 
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duplex  region  D,  had  no  obvious  topological  features  under 
the  electron  microscope  (spreading  condition  of  50% 
formamide  at  20°C)  and  contained  mainly  non-reiterated  base 
sequences. 
It  has  been  observed  that  native  RSV-1  DNA  formed 
duplex  circles  at  low  frequency  after  digestion  with  \ 
exonucleases  or  exonuclease  III,  which  initiate  sequential 
digestion  at  the  5'  and  3'  termini  respectively  of  duplex 
DNA  (Graftstrom  et  al.,  1974,1975;  Sheldrick  and  Berthelot, 
1974;  Wadsworth  et  al.,  1976;  Kindler  and  Hyman,  1979). 
This  indicates  the  presence  of  terminally  redundant  base 
sequences.  Therefore,  the  HSV-1  genome  (Fig.  2b)  consists  of 
a  short  and  a  long  unique  sequence  (US  and  UL)  flanked  by 
terminal  and  internal  inverted  repeat  sequences  (TRS/IRS) 
and  (TRL/IRL)  respectively.  The  sequence  which  is  directly 
repeated  at  the  genome  termini  (and  inversely  repeated  at 
the  joint)  is  named  as  the  "a"  sequence,  while  the  remaining 
sequences  within  the  TRL/IRL  and  TRS/IRS  are  known  as  the 
"b"  and  "c"  sequences  respectively.  Other  studies  on 
self-annealed  intact  single  strands  and  on  partially 
denatured  molecules  of  herpes  simplex  virus  1  DNA,  confirmed 
the  above  arrangement  of  HSV  genome  (Wadsworth  et  al., 
1975). 
Isomeric  Arrangement  of  HSV  DNA 
It  has  been  proposed  (Sheldrick  and  Berthelot,  1974) 
that  since  the  terminal  regions  are  inverted  internally,  an 
intramolecular  recombination  between  the  ends  of  the 
molecule  and  their  repeat  might  readily  occur.  The  result 
of  such  recombination  will  be  the  inversion  of  the  entire 
unique  regions  (L  or  S)  relative  to  each  other.  A  high 
frequency  of  occurrence  for  such  recombination  events, 10 
distributed  randomly  between  the  two  sets  of  repeats  will 
generate  equal  amounts  of  the  four  genome  arrangements  which 
result  from  possible  combinations  of  inversions  of  the  two 
unique  regions  (Hayward  et  al.,  1975;  Delius  and  Clements, 
1976).  The  four  possible  genomic  arrangements  (Fig.  3a)  are 
designated  P  (prototype),  IS  and  IL  (inversion  of  S  component 
and  L  component  respectively)  and  ISL,  inversion  of  both  S 
and  L  components;  (Roizman  et  al.,  1978;  Hayward  et  al., 
1975b).  The  genome  structure  and  isomerisation  patterns 
were  found  to  be  similar  in  HSV-1  and  HSV-2  DNA  (Clements  et 
al.,  1976;  Cortini  and  Wilkie,  1978). 
Variability  in  HSV  DNA 
Nucleic  acid  hybridization  studies  and  heteroduplex 
thermal  stability  analysis  had  demonstrated  that  HSV-1  and 
HSV-2  share  47-50%  of  their  sequence  (Kieff  et  al.,  1972; 
Sugino  and  Kingsbury,  1976).  In  addition,  analysis  of 
intertypic  recombinants  showed  that  most  of  the  recombinants 
can  multiply  and  the  genes  of  HSV-1  and  HSV-2,  essential  for 
replication  of  the  virus,  are  grossly  colinear  (Morse  et 
al.,  1978;  Marsden  et  al.,  1978).  However,  restriction 
endonuclease  digests  of  HSV-1  and  HSV-2  DNA  revealed  that 
the  two  serotypes  differ  in  most  of  their  cleavage  sites 
(Hayward  et  al.,  1975;  Skare  et  al.,  1975;  Clements  et  al., 
1976;  Wilkie,  1976;  Skare  and  Summers,  1971;  Wilkie  et  al., 
1977;  Cortini  and  Wilkie,  1978;  Locker  and  Frenkel,  1979). 
Moreover,  intratypic  strain  variations  in  the  restriction 
endonuclease  digest  patterns  of  both  HSV-1  and  HSV-2  DNA 
have  also  been  observed  (Hayward  et  al.,  1975;  Skare  et  al., 
1975;  Buchman  et  al.,  1978;  Lonsdale,  1979;  Lonsdale  et  al., 
1980).  The  major  differences  seen  were  in  the  form  of  i, 
absence  of  restriction  sites  leading  to  the  fusion  of  two FIGURE  3a 
THE  FOUR  GENOME  ISOMERS  OF  HSV-1 
Cleavage  of  the  prototype  molecule  (P)  with 
endonuclease  enzyme  Hsu-1  (which  cleaves  DNA  outside  the 
inverted  repeats)  yields  three  fragments  of  interest:  two 
terminal  fragments  (one  on  either  side)  H&G  and  one 
junction  fragment  DM.  When  S  is  inverted,  that  portion  of 
the  junction  fragment  (DM)  which  belongs  to  S  component  now 
becomes  a  new  terminal  fragment  of  the  IS  arrangement  -M-, 
whereas  the  terminal  fragment  of  the  P  molecule  (G)  is  now 
fused  with  the  right  end  of  the  L  component  forming  a  new 
junction  fragment  DG.  Hence,  when  all  four  genome  isomers 
are  cleaved  four  distinct  terminal  fragments  are  present  (G, 
M,  D,  H)  each  of  0.5  molar  ratio  and  four  distinct  junction 
fragments  (DM,  DG,  HM,  HG)  each  of  0.25  molar  ratio. 
P  prototype  isomeric  arrangement 
IS  inversion  of  S  component 
IL  inversion  of  L  component 
ISL  inversion  of  both  S  and  L  components 
FIGURE  3b 
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segments  or  gain  of  a  new  site  leading  to  loss  of  a  fragment 
compensated  by  gain  of  two  smaller  fragments,  ii,  gain  or 
loss  of  small  portions  of  fragments.  This  variability  is 
reflected  by  intertypic  variations  in  structural 
polypeptides  (Heine  et  al.,  1974;  Cassie  et  al.,  1975; 
Pereira  et  al.,  1976). 
Virion  Polypeptides 
Studies  of  the  virion  polypeptides  have  been  published 
primarily  for  HSV-1,  while  similar  investigations  of  HSV-2 
polypeptides  have  not  been  published  in  detail.  However, 
the  number  of  polypeptides  found  in  purified  preparations  of 
both  viruses  were  approximately  the  same  (Cassai  et  al., 
1975).  Based  on  the  data  reported  by  Spear  and  Roizman 
(1972)  and  by  others  (Heine  et  al.,  1974,  Powell  and  Watson, 
1975;  Cassai  et  al.,,  1975;  Strand  and  Aurelian,  1976)  HSV 
virions  contain  from  approximately  15-33  structural 
polypeptides,  which  can  be  divided  into  three  groups:  the 
first  group  has  at  least  six  polypeptides  present  in 
nucleocapsids  prior  to  envelopment.  The  second  group 
comprises  the  glycosylated  polypeptides  most  or  all  of  which 
are  present  in  the  envelope  of  the  virion.  The  third  group 
contains  the  remainder  of  polypeptides  and  most  of  which  are 
probably  constitutents  of  the  tegument. 
Gibson  and  Roizman  (1972)  described  three  types  of 
nucleocapsids;  Nucleocapsid  A  and  B  can  be  isolated  from  the 
nuclei  of  infected  cells  and  nucleocapsid  C  can  be  produced 
by  stripping  virions  of  their  envelope.  Nucleocapsid  A  (DNA 
deficient  or  empty  capsid)  contains  four  polypeptides  (VP5, 
VP19C,  VP23  and  VP24),  while  nucleocapsid  B  which  contains 
viral  DNA,  has  two  additional  polypeptides  (VP21  and  VP22a). 
It  has  been  shown  that  both  A  and  B  capsids  have  another 12 
major  protein  component  with  a  molecular  weight 
approximately  12,000  (Heilman  et  al.,  1979).  The  C  capsids 
were  found  to  contain  all  of  the  B  capsid  protein  (except 
Vp22a),  in  addition  it  also  contains  several  proteins 
present  in  the  virion,  i.  e.  proteins  1-3.  It  has  been 
concluded  that  most  of  the  virion  glycoproteins  are  membrane 
associated  and  are  in  an  exposed  position  at  the  surface  of 
the  virion  (Olshevsky  and  Becker,  1972;  Roizman-and  Furlong, 
1974).  In  support  of  the  latter  conclusion,  is  the  finding 
that  antibodies  directed  against  glycoproteins  (with 
molecular  weights  of  100,000-130,000  or  against  glycoprotein 
gD  (VP17)  have  neutralising  activity  (Powell  et  al.,  1974; 
Cohen  et  al.,  1978).  Very  little  is  known  about  the 
organisation  of  the  tegument  polypeptides  and  it  has  been 
considered  that  proteins  external  to  the  capsid  and  not  in 
the  envelope  are  in  the  tegument,  and  this  would  include 
proteins  1-4,6,6.5,20  and  22  (Roizman  and  Furlong,  1974). 
Variability  in  the  antigenicity  and  electrophoretic 
mobility  of  the  virion  polypeptides 
and  HSV-2  has  been  observed  (Cassai 
al.,  1976).  Serological  tests  have 
in  virion  glycoproteins  (Killington 
DNA  Binding  Proteins 
Preliminary  evidence  for  the 
among  isolates  of  HSV-1 
et  al.,  1975;  Pereira  et 
proved  the  variability 
et  al.,  1978). 
presence  of  a  virus 
specified  DNA  binding  protein  was  provided  by  Bayliss  et  al. 
(1975)  and  Kudler  and  Hyman  (1979).  It  was  found  that 
non-deproteinised  viral  DNA  isolated  from  HSV-1  infected 
cells  was  unable  to  circularise  following  exonuclease  III 
treatment,  and  that  the  DNA  was  more  sensitive  to  digestion 
by  a  3'  than  by  5'  exonuclease  suggesting  that  the  proteins 
are  more  strongly  associated  with  one  strand  than  the  other. 13 
Restriction  endonuclease  cleavage  profiles  of  highly 
purified  but  not  specifically  deproteinised  DNA  were  found 
to  be  different  from  the  published  pattern  (Hyman  et  al., 
1979).  More  evidence  for  DNA  binding  proteins  was  reported 
by  Hayman  (1980)  where  it  has  been  shown  that  polyacrylamide 
gel  electrophoresis  of  purified  HSV  DNA  (treated  with  1251 
labelled  Bolton-Hunter  reagent  which  bound  to  free  amine 
group  of  protein  but  does  not  affect  DNA)  revealed  four 
bands  of  protein.  Electron  microscopic  studies  using 
dinitro  fluorobenzene/antibody  complex  allowed  the 
visualisation  of  the  protein  at  four  sites  on  HSV  DNA,  i.  e. 
near  the  ends  and  within  the  inverted  terminal  repeats  on 
the  DNA  (Wu  et  al.,  1979).  The  exact  functions  of  the 
DNA-bound  proteins  are  unknown,  however,  a  rolling-circle 
mechanism  has  been  proposed  for  HSV  DNA  replication  which 
may  utilise  such  proteins  in  intermediate  structure 
stabilisation  (Jacob  et  al.,  1979).  Recently,  Powell  and 
colleagues  (1981)  purified  major  HSV-2  DNA  binding  protein 
(ICSP  11/12)  and  showed  that  antisera  prepared  against  the 
purified  binding  proteins  inhibits  (in  vitro)  virus  DNA 
synthesis  whereas  antisera  reactive  with  other  virus 
proteins  do  not  exert  such  effect,  suggesting  the 
involvement  of  ICSP  11/12  in  DNA  replication.  In  addition, 
these  proteins  were  also  found  to  cause  the  denaturation  of 
the  DNA  helix  at  40°C.  More  details,  about  the  involvement 
of  the  DNA  binding  protein  in  the  mechanism  of  DNA  synthesis 
have  been  reported  by  Littler  et  al.  (1983),  as  it  has  been 
shown  that  HSV-2  is  mutants  defective  in  DNA  binding  protein 
(mutation  mapped  to  the  area  of  the  genome  known  to  code  for 
these  properties)  were  also  defective  in  replication  of 
virus  DNA  and  that  induction  of  both  DNA  polymerase  and 14 
alkaline  exonuclease  were  also  affected  by  the  is  lesion  in 
the  DNA  binding  protein.  Therefore,  it  has  been  suggested 
that  it  is  likely  that  inhibition  of  DNA  synthesis  is  due  to 
an  effect  brought  about  by  the  lesion  on  the  stability  of 
the  DNA  replication  complex.  However,  it  is  not  known  how 
relevant  these  (in  vitro  defined)  properties  are  to  the  in 
vivo  course  of  viral  infection. 
Polyamines 
Following  detergent  treatment,  the  polyamine 
spermidine  is  removed  in  parallel  with  the  envelope 
constitutents,  suggesting  that  this  polyamine  is  associated 
with  the  envelope  or  the  tegument,  however,  on  the  other 
hand  such  treatment  (non-ionic  detergent  and  urea)  left  the 
amount  of  spermine  unchanged,  indicating  that  spermine  is 
restricted  to  the  nucleocapsid  (Gibson  and  Roizman,  1971). 
The  presence  of  the  polyamines  has  been  confirmed  by 
McCormick  (1978).  It  is  thought  that  the  function  of  the 
spermine  is  to  neutralise  DNA-phosphate  and  may  play  a  role 
in  condensation  of  viral  DNA. 
Lipids 
Chemical  analysis  (Asher  et  al.,  1969;  Ben-Porat  and 
Kaplan,  1971)  revealed  the  presence  of  lipids  in  HSV 
virions.  It  has  been  shown  that  the  infectivity  of  the 
mature  virion  is  destroyed  by  phospholipase  C,  suggesting 
that  the  lipids  are  essential  for  infectivity  and  contained 
in  the  envelope  (Spring  and  Roizman,  1968).  Very  little  is 
known  about  the  factors  that  might  influence  the  lipid 
composition  of  HSV  virions. 
Replication  Cycle 
Cell  Penetration 
The  finding  that  specific  infectivity  of  naked 15 
nucleocapsids  is  much  lower  than  that  of  intact  virions 
(Spring  and  Roizman,  1968;  Rubenstein  et  al.,  1972)  clearly 
indicated  that  the  virion  envelope  plays  a  major  role  in 
entry  of  the  virion  into  the  host  cell.  This  has  been 
confirmed,  as  is  mutations  of  an  envelope  constitituent 
results  in  the  production  of  enveloped  particles  that  can 
not  penetrate  into  cells  (Sarmiento  et  al.,  1979).  Since 
virion  glycoproteins  are  exposed  on  the  surface  of  the 
envelope  (Olshevsky  and  Becker,  1972;  Roizman  and  Furlong, 
1974),  it  is  highly  likely  that  they  play  a  role  in  viral 
adsorption  to,  and/or  penetration  of  the  host  cell. 
However,  the  possible  participation  of  glycoprotein  C  (gC) 
in  viral  adsorption  has  been  ruled  out,  as  a  gC  deficient 
virion  can  still  be  infectious  (Keller  et  al.,  1970; 
Manservigi  et  al.,  1977).  Similarly,  virions  lacking  gB  can 
bind  to  cells  -  although  they  can  not  initiate  infection  - 
an  indication  that  gB  is  required  for  penetration  but  not 
for  adsorption  (Sarmiento  et  al.,  1979).  It  has  been 
hypothesized  that  gB  function  is  to  promote  fusion  between 
the  virion  envelope  and  the  cell  surface  membrane.  This  has 
been  supported  by  the  above  observation  (Sarmiento  et  al., 
1979)  and  by  the  finding  that  gB  plays  an  essential  role  in 
the  promotion  of  HSV-induced  cell  fusion  (Manservigi  et  al., 
1979).  Glycoprotein  D  (gD)  has  been  shown  to  be  HSV-1  type 
specific  envelope  component  which  is  involved  in  the 
attachment  of  the  virion  to  the  host  cell  plasma  envelope 
(Vahlne  et  al.,  1979).  The  mode  of  viral  entry  into  the 
host  cells  is  thought  to  take  place  either  by  i, 
phagocytosis,  where  the  attachment  of  the  virion  to  the  host 
cell  surface  triggers  their  phagocytosis,  which  is  followed 
by  partial  disruption  of  the  virus  and  release  of  the  DNA 16 
(Dales  and  Silverberg,  1969)  or  ii,  after  the  adsorption  of 
the  virus  to  the  host-cell  surface,  the  virion  envelope 
fuses  with  the  cell  surface  membrane,  releasing  the 
nucleocapsid  into  the  cytoplasm  (Morgan  et  al.,  1968). 
However,  the  presence  of  virus  receptors  in  cell-surface 
membranes  and  the  identification  of  a  virus  envelope 
glycoprotein,  that  plays  an  essential  role  in  cell  fusion 
(Manservigi  et  al.,  1977)  appears  to  favour  the  second 
hypothesis  of  viral  entry  to  the  host  cell. 
Following  removal  of  the  envelope  and  entry  of  the 
virus,  the  virus  particles  appear  to  be  uncoated  by  existing 
cellular  enzymes  and  the  naked  viral  DNA  to  be  gradually 
transported  into  the  nuclei  (Hochberg  and  Becker,  1968).  It 
has  been  observed  that  infectious  DNA  of  HSV  forms  a  complex 
with  host  nuclear  protein,  while  the  newly  synthesised  viral 
DNA  does  not  possess  such  a  property.  Moreover,  since  this 
complex  can  be  formed  in  the  presence  of  inhibitors  of  RNA 
and  protein  synthesis,  it  is  possible  that  it  may  be 
involved  in  the  immediate  early  functions  of  the  HSV  genome 
(Rice  et  al.,  1976). 
Viral  and  Cellular  DNA  Synthesis  in  Herpes  Virus  Infected 
Cells 
Cellular  DNA 
Infection  of  cells  with  herpes  simplex  virus  results 
in  cessation  of  host  cell  DNA  and  protein  synthesis,  and  a 
marked  reduction  in  host  cell  RNA  synthesis  (Ben-Porat  and 
Kaplan,  1973).  The  mechanism  that  switches  off  the 
synthesis  of  these  macromolecules  is  unknown.  However,  it 
is  probably  mediated  by  a  virus-specific  protein  bound  to 
cellular  DNA,  in  the  case  of  pseudorabies  virus  infected 
cells  (Ben-Porat  and  Kaplan,  1965).  Similarly,  in  HSV-2 17 
infected  cells  a  virion  structural  component  has  been 
suggested  to  switch  off  the  synthesis  of  cellular  DNA 
(Fenwick  and  Walker,  1978).  Halliburton  and  Timbury  (1976) 
have  reported  that  two  of  the  HSV-2  is  mutants  (ts  9  and 
is  11)  were  not  able  to  switch  off  host  DNA  synthesis  at  the 
non-permissive  temperature  (38°C).  It  appears  likely  that 
these  mutants  are  deficient  in  synthesis  of,  or  lacking  of, 
this  virus  specific  protein(s).  In  a  recent  report, 
Notarianni  and  Preston  (1982)  provided  information  that 
infection  of  chick  embryo  fibrolasts  with  HSV-1  is  K  mutant 
stimulates  the  specific  set  of  cellular  genes  which  encode 
"stress"  or  "heat  shock"  proteins.,  The  function  of  the 
stress  proteins  is  unknown,  though  it  has  been  shown  that 
the  protein  is  being  induced  in  viral  infected  cells  where 
there  is  an  overproduction  of  viral  IE  polypeptides. 
Viral  DNA 
Viral  DNA  synthesis  takes  place  in  the  nucleus. 
Evidence  for  that  was  provided  by  Munk  and  Sauer  (1964); 
Kaplan  and  Ben-Porat  (1964);  Roizman  (1969),  and  it  has  been 
shown  that  in  cells  fractionated  immediately  after  a5 
minute  pulse  labelling  with  3H-thymidine,  labelled  DNA  was 
found  in  the  nuclear  fraction.  In  Hep-2  cells  infected  with 
HSV-1  at  31°C,  viral  DNA  synthesis  started  3  hours 
post-infection  (PI),  peaking  at  4-6  hours  and  was  virtually 
over  by  12  hours  PI  (Roizman,  1969).  While  in  HSV-2 
infected  BHK21  cells  at  37°C,  viral  DNA  synthesis  was 
initiated  around  2  hours  (PI)  and  continued  at  a  rapidly 
increasing  rate  for  a  further  8  hours  (Munk  and  Sauer,  1964; 
Wilkie,  1973).  Only  a  small  fraction  of  parental  viral  DNA 
(HSV-1)  entered  the  replicative  pool  (Jacob  and  Roizman, 
1977),  this  might  be  because  most  of  parental  molecules  are 18 
not  uncoated  (Leinbach  and  Summers,  1980).  It  appears  that 
HSV-2  DNA  synthesis  in  BHK  cells  (at  31°C)  is  somewhat 
slower,  starting  at  3-5  hours  PI,  reaching  a  peak  at  9-11 
hours  post-infection  (Rixon,  1977). 
RNA  Synthesis  in  Herpes  Virus  Infected  Cells 
Cellular  RNA 
As  previously  noted,  infection  of  cells  with  herpes 
simplex  virus  leads  to  an  overall  decline  in  cellular  RNA 
synthesis  (Roizman  et  al.,  1965;  Hay  et  al.,  1966;  Ben-Porat 
and  Kaplan,  1973).  By  cell  fractionation  and  labelling  at 
longer  intervals,  Wagner  and  Roizman  (1969)  were  able  to 
demonstrate  that  nuclear  precursor  rRNA  (45S)  synthesis 
decreases  and  its  processing  to  28S  and  18S  does  not  take 
place.  Moreover,  a  reduction  in  the  rate  of  synthesis  of 
cellular  messenger  RNA  (mRNA)  and  of  transfer  RNA  (tRNA)  in 
herpes  virus  infected  cells,  has  also  been  reported  (Bell  et 
al.,  1971;  Rakusanova  et  al.,  1972). 
Viral  RNA 
The  existence  of  virus  specified  ribonucleic  acid  in 
HSV  infected  cells  has  been  established  (Hay  et  al.,  1966; 
Flanagan,  1967).  It  has  been  found  that  viral  RNA  is  made 
in  the  nucleus  and  has  a  sedimentation  coefficient  of  50S  or 
more  and  therefore,  can  be  distinguished  from  the  45S 
cellular  precursor  rRNA  (Wagner  and  Roizman,  1969).  Viral 
RNA  smaller  (16S-20S)  than  that  found  in  the  nucleus  (50S) 
has  been  detected  in  the  cytoplasm  associated  with 
polysomes.  It  is  suggested  that  this  small  RNA  is  generated 
by  the  cleavage  of  large  precursor  RNA  molecules  (Wagner  and 
Roizman,  1969a).  Herpes  simplex  virus  mRNA  has  been  found 
to  possess  3'-polyadenylated  (poly  A)  tails  (Bachenheimer 
and  Roizman,  1972)  and  the  5'  termini  are  modified,  being 19 
capped  with  a  methylated  guanine  residue  joined  to  the  RNA 
through  5'-5'  pyrophosphate  linkage.  Moreover,  studies  on 
the  methylation  pattern  of  viral  mRNA  revealed  the  existence 
of  5'-terminal  and  internal,  methylated  nucleotides 
(Bartkoski  and  Roizman,  1976).  It  seems  that  the  5'  capped 
ends  of  viral  mRNA  are  essential  for  efficient  in  vitro 
translation  (Jacquemont  and  Huppert,  1977),  as  it  has  been 
found  that  inhibition  of  viral  RNA  methylation  particularly 
of  the  5'-cap,  by  5'  S-isobutyl-adenosine  (a  structural 
analogue  of  5-adenosyl  homocystein)  prevents  the  replication 
of  HSV-1  by  inhibiting  protein  synthesis. 
It  has  been  suggested  that  host  cell  RNA  polymerase 
activity  is  responsible  for  HSV-1  immediate  early  RNA 
synthesis  in  the  infected  cell  (Alwine  et  al.,  1974).  This 
enzyme  activity  has  not  been  found  as  a  virion  component 
implying  that  initial  transcription  utilises  a  pre-existing 
cell  coded  RNA  polymerase.  The  fact  that  purified  herpes 
virus  DNA  is  infectious  (Graham  et  al.,  1973)  supports  the 
above  observation.  Studies  using  oc  -amanitin  (an  inhibitor 
of  cellular  RNA  polymerase  II  activity),  revealed  that  viral 
transcription  is  blocked  at  all  stages  in  infection  and 
suggesting  that  this  particular  host  enzyme  is  required  for 
the  replication  of  HSV  (Alwine  et  al.,  1974;  Preston  and 
Newtown,  1976;  Costanz  et  al.,  1977).  Furthermore,  it  has 
been  shown  that  HSV  replication  can  occur  in  x  -amanitin- 
resistant  cells  lines  but  not  in  a  -amanitin-sensitive  cell 
lines,  in  the  presence  of  the  inhibitors  (Ben-Porat  and 
Becker,  1977). 
Regulation  of  Viral  Transcription 
Using  inhibitors  of  DNA  and  protein  synthesis  to  study 
regulation  of  viral  genome  transcription,  three  classes  of 20 
viral  RNA  have  been  described.  The  immediate  early  (IE)  or 
a;  Early  (E)  or  p  and  the  Late  orV  .  The  synthesis  of  IE 
RNA  takes  place  directly  after  infection  and  before  the 
commencement  of  virus  protein  synthesis.  The  synthesis  of 
this  class  of  RNA  takes  place  even  in  the  presence  of  the 
protein  synthesis  inhibitor  cycloheximide.  Early 
transcription  takes  place  prior  to  viral  DNA  synthesis  but 
after  the  start  of  protein  synthesis,  while  late  M 
transcription  is  dependent  on  prior  viral  DNA  synthesis 
(Wagner  et  al.,  1972;  Frenkel  et  al.,  1973;  Clements  et  al., 
1977;  Jones  and  Roizman,  1979;  Holland  et  al.,  1980;  Mackern 
and  Roizman,  1981). 
Splicing  of  Viral  mRNA 
In  addition  to  3'  polyadenylation  and  5'  capping  and 
methylation  of  viral  mRNA  (Bachenheimer  and  Roizman,  1972; 
Bartkoski  and  Roizman,  1976),  a  third  post-translational 
modification  of  the  viral  mRNA  i.  e.  "splicing"  has  been 
detected.  Three  instances  of  splicing  in  HSV  mRNA  have  been 
detected.  These  are  "IE"  RNAs  4  (which  maps  across  the 
US/IRS  junction);  Immediate  early  RNAs  5  (which  maps  across 
the  US/TRS  junction)  and  the  major  late  2.7  kb  mRNA  (which 
maps  on  the  HindIIl  1  restriction  fragment  in  UL  region) 
(Frink  et  al.,  1981;  Watson  et  al.,  1981;  Rixon  and 
Clements,  1982).  The  roles  of  the  spliced  RNA  segments  are 
subject  to  speculation  and  they  could  be  involved,  as  in 
adenovirus  infected  cells,  in  the  selection  of  certain  viral 
RNA  sequences  for  transport  to  cell  cytoplasm  or  could  be 
responsible  for  the  preferential  translation  of  viral  mRNA 
during  the  late  stage  of  infection  (Berget  et  al.,  1977). 
Protein  Synthesis  in  Herpesvirus  Infected  Cells 
The  effect  of  infection  of  cells  with  herpesviruses  or 21 
the  overall  rate  of  protein  synthesis  varies  with  the 
different  virus-cell  systems  (i.  e.  infecting  virus, 
multiplicity  of  infection,  type  of  cells  and  their 
physiological  state).  The  rate  of  protein  synthesis  in  HSV 
infected  cells  undergoes  an  initial  reduction,  then  an 
increase  between  3-6  hours  post-infection,  and  then  followed 
by  an  irreversable  decline  (Roizman  et  al.,  1965).  These 
changes  in  the  kinetics  of'synthesis  correspond  to 
quantitative  changes  in  cytoplasmic  polyribosomes  (Sydiskis 
and  Roizman,  1967,1968;  Silverstein  and  Engelhardt,  1979). 
Cellular  Proteins 
Four  criteria  have  been  used  to  demonstrate  the 
synthesis  (inhibition)  of  cell-specific  protein  in  cells 
infected  with  herpesviruses.  First  is  the  immune 
precipitation  where  isotopically  labelled  protein  (cellular 
or  viral)  is  precipitated  by  specific  immunoglobulin 
(W-globulin).  The  result  of  such  experiments  indicated  an 
increase  in  the  amount  of  radioactivity  in  protein 
precipitated  by  viral  specific  w_globulin  and  a  decrease  in 
radioactivity  of  protein  precipitated  by  cell  specific 
u-globulin  (Hamada  and  Kaplan,  1965).  Second  is  the 
disaggregation  of  cellular  polysomes  (170S)  after  infection 
and  their  reconstitution  as  (220S-270S)  viral  induced 
polysomes  (Sydiskis  and  Roizman,  1967).  Third  is  the  ratio 
of  various  amino  acids  to  each  other  in  viral  and  cellular 
proteins.  Uninfected  cells  have  much  higher  ratios  of 
lysine  to  leucine  than  those  of  the  infected  cells  (Kaplan 
et  al.,  1970).  Fourth,  electrophoretic  profiles  of  viral 
and  cellular  protein.  The  electrophoretic  profiles  in 
SDS-PAGE  of  protein  synthesized  by  HSV-infected  cells  differ 
greatly  from  those  synthesized  by  control  uninfected  cells 22 
(Spear  and  Roizman,  1968).  Host  protein  synthesis  is 
rapidly  suppressed  after  infection  with  herpes  simplex  virus 
(Powell  and  Courtney,  1975).  It  has  been  suggested  that 
this  suppression  is  mediated  by  both  a  virion  component  and 
a  virus  encoded  function  which  is  expressed  early  in 
infection  (Sydiskis  and  Roizman,  1967;  Marsden  et  al.,  1976; 
Fenwick  and  Walker,  1978;  Fenwick  and  Clark,  1981). 
Viral  Proteins 
HSV  infected  cells  synthesise  a  relatively  large 
number  of  viral  proteins  in  amounts  sufficient  to  give 
distinct  peaks  in  polyacrylamide  gels.  The'number  of  HSV 
induced  polypeptide  species  identified  by  using  one 
dimensional  polyacrylamide  gel  electrophoresis  (SDS-PAGE)is 
about  50  (Honess  and  Roizman,  1973;  Marsden  et  al.,  1976; 
Bookout  and  Levy,  1980).  However,  a  much  larger  number  of 
viral  polypeptides  (230)  has  been  detected  by 
two-dimensional  gel  electrophoresis  (Haarr  and  Marsden, 
1981)  and  some  of  these  polypeptide  species  are  related  by 
post-translational  modification  events. 
The  synthesis  of  HSV  proteins  takes  place  in  the 
cytoplasm  and  many  of  those  made  late  in  infection  migrate 
to  the  nucleus  (Spear  and  Roizman,  1968)  where  they  assemble 
into  nucleocapsids  and  then  into  mature  virions.  The 
factor(s)  responsible  for  the  migration  of  viral  proteins  to 
the  nucleus  are  not  clearly  understood.  Based  on  the  time 
of  maximum  synthetic  rate  and  dependence  on  prior  viral 
protein  or  DNA  synthesis,  HSV  specific  polypeptides  have 
been  classed  into  3  groups,  corresponding  to  the  three 
transcriptional  phases,  i.  e.  a.  (IE),  p  (E)  and  V  (L);  Thea 
or  immediate  early  polypeptide  group  are  those  synthesised 
immediately  after  removal  of  the  cycloheximide  (that  has 23 
been  present  from  the  start  of  infection);  Their  highest 
rate  of  synthesis  is  between  3  and  4  hours  PI  and  their 
synthesis  requires  no  prior  infected  cell  protein  synthesis 
(Honess  and  Roizman,  1974;  Powell  and  Courtney,  1975).  The 
oC-polypeptide  group  consists  largely  of  non-structural 
species. 
Synthesis  of  "Early"  or  p  polypeptides  requires  the 
presence  of  functional  w-  polypeptides,  in  addition  to  new 
RNA  synthesis  (Honess  and  Roizman,  1974).  Their  rate  of 
synthesis  peaking  between  5  hours  and  7  hours  PI;  Functional 
p  -polypeptides  shut-off  residual  host  synthesis  as  well  as 
the  synthesis  of  immediate  early  proteins.  They  are  also 
required  for  regulating  the'synthesis  of  new  viral  RNA 
coding  for  the  next  groups  the  "Late"  or  if  polypeptides. 
The  p  group  of  polypeptides  consist  of  both  minor  structural 
and  non-structural  species.  Viral  DNA  polymerase  (Honess 
and  Roizman,  1975;  Powell  and  Purifoy,  1977),  thymidine 
kinase  (Garfinkle  and  McAuslan,  1974;  Leiden  et  al.,  1976) 
are  p  polypeptides. 
The  late  or  V  group  consist  of  major  structural 
polypeptides.  However,  a  number  of  the  polypeptides  in  this 
group  appear  tobe  non-structural  (Morse  et  al.,  1978). 
Synthesis  of  V  polypeptides  occurs  at  increasing  rate  until 
12  hours  PI  and  also  requires  the  presence  of  functional 
polypeptides  belonging  to  a  and  (3  groups  (lioness  and 
Roizman,  1974). 
It  has  been  concluded  (Marsden  et  al.,  1976)  that  the 
regulation  of  protein  synthesis  in  HSV  infected  cells,  is 
more  complicated  than  the  scheme  of  cascade  regulation 
(od,  p  'v  )  proposed  by  Honess  and  Roizman  (1974)..  In  support 
of  the  early  conclusion  is  the  identification  of  9  classes 24 
of  virus-induced  polypeptides  which  were  dependent  upon  the 
DNA  phenotype  of  the  is  mutants  (Marsden  et  al.,  1976). 
Moreover,  2  classes  of  ß  polypeptides  have  been  identified 
in  HSV-2  infected  cells  (Pereira  et  al.,  1977),  while  HSV-1 
induced  polypeptides  have  been  classified  into  six  distinct 
classes  of  which  one  can  be  subdivided  on  the  basis  of 
kinetics  and  sensitivity  to  arabinosyladenine  (a  DNA 
synthesis  inhibitor)  which  can  exhibit  a  variety  of  enzymes 
(Pedersen  et  al.,  1981). 
The  polypeptide  species  synthesised  in  HSV-1  and  HSV-2 
infected  cells,  show  an  extensive  correspondence  to  each 
other.  However,  there  are  slight  differences  in  the 
apparent  molecular  weight  and  hence  in  their  mobility  in  the 
polyacrylamide  gels  (Killington  et  al.,  1977).  Through  the 
analysis  of  the  viral  polypeptides  and  of  the  restriction 
endonuclease  fragment  profiles  of  HSV-1  x  HSV-2  intertypic 
recombinants,  the  map  locations  of  individual  polypeptides 
have  been  determined  (Marsden  et  al.,  1978;  Morse  et  al., 
1978;  Preston  et  al.,  1978;  Marsden  et  al.,  1982).  The 
results  of  such  analysis  reveals  that  genes  coding  for  all 
classes  of  polypeptides  map  in  both  the  L  and  S  regions  of 
the  genome.  The  map  positions  of  the  polypeptides  is  well 
correlated  with  the  map  position  of  corresponding  mRNAs. 
Moreover,  the  sizes  of  in  vitro  translation  products 
correlate  with  the  sizes  of  corresponding  in  vivo  products 
(Easton  and  Clements,  1980). 
Modification  in  Herpesvirus  Induced  Proteins 
The  mobilities  (in  polyacrylamide  gel  electrophoresis) 
of  the  in  vitro  translated  HSV-1  and  HSV-2  polypeptides 
differ  slightly  from  their  putative  polypeptides  translated 
in  vivo  (Preston,  1977),  suggesting  a  post-translational 25 
modification  of  viral  proteins.  At  least  three  kinds  of 
post-translational  modification  may  alter  the  mobility  of 
virus  polypeptides:  i,  rapid  post-translational  cleavage, 
ii,  slow  post-translational  cleavage  (determined  by 
intracellular  translocation  or  occurring  during  assembly  of 
the  virion),  iii,  conjugation  or  addition  of  prosthetic 
groups  (e.  g.  glycosylation,  phosphorylation,  acetylation, 
sulphation,  methylation).  Such  modification  may  be  required 
for  normal  function  of  enzymes  or  other  non-structural 
proteins.  Preliminary  evidence  (Honess  and  Roizman,  1973) 
had  indicated  that  HSV-1  (F)  infected  cell  polypeptides  do 
not  undergo  rapid  post-translational  cleavage  similar  to- 
that  seen  in  poliovirus  infected  cells,  while  slow 
post-translational  changes  in  the  mobility  of  at  least  two 
polypeptides  were  noticed.  However,  rapid 
post-translational  processing  of  some  of  the  HSV-1  and  HSV-2 
specified  polypeptides  has  been  observed  (Morse  et  al., 
1978).  Moreover,  experiments  involving  the  use  of 
chymotrypsin  inhibitor  tosyl-phenylalanyl-chloromethyl 
ketone  (TPCK)  revealed  that  at  least  14  HSV-1  polypeptides 
are  subjected  to  rapid  post-translational  modification  (H.  S. 
Marsden,  personal  communication). 
Phosphorylation  of  viral  specified  polypeptides  has 
also  been  reported  (Marsden  et  al.,  1978;  Bookout  and  Levy, 
1980)  and  of  the  22  phosphorylated  HSV-1  polypeptides,  nine 
were  found  to  be  major  species.  It  is  possible  that 
phosphorylation  may  mediate  activity  of  regulatory  proteins 
in  HSV  infected  cells,  since  certain  of  these  proteins, 
including  Vmv  175,  are  phosphorylated.  Wilcox  et  al.  (1980) 
have  demonstrated  that  the  affinity  of  proteins  for  DNA  is 
affected  by  their  phosphorylation. 26 
Glycosylated  HSV-1  proteins  are  found  in  the  virion 
envelope  and  also  in  the  plasma  membrane  (Marsden  et  al., 
1976;  Spear,  1976).  Four  major  antigenically  distinct 
glycoproteins  have  been  identified,  namely  gA/gB,  gC,  gD  and 
gE  (Spear,  1976;  Roizman  et  al.,  1977;  Baucke  and  Spear, 
1979). 
Glycoprotein  A  and  gB  share  antigenic  determinants  and 
it  has  been  proposed  (Eberle  and  Courtney,  1980)  that  gA  is 
an  intermediate  in  the  gB  glycosylation.  There  is  evidence 
that  all  glycoproteins  mentioned  above  are  sulphated  with 
the  glycoprotein  E  being  the  major  sulphated  species  (Hope 
et  al.,  1982).  Recently,  a  number  of  minor  glycoproteins 
and  a  new  major  glycoprotein  (designated  gY)  have  been  found 
in  HFL  cells  infected  with  HSV-1  (Palfreyman  et  al.,  1982). 
At  present  six  types  of  HSV-2  glycoproteins  have  been 
described  (Marsden  et  al.,  1978;  Ruyechan  et  al.,  1979) 
gA/gB,  gC,  gD,  gE,  gF  and  92K  glycoprotein.  However,  it  is 
not  clear  whether  the  gC  glycoprotein  which  had  been  mapped 
in  UL  region,  is  in  fact  the  92K  protein  described  by 
Marsden  et  al.  (1983). 
DNA  Replication 
Different  molecular  structures  of  HSV-1  DNA  have  been 
isolated  from  infected  cell  nuclei.  Most  of  these  forms 
were  indicative  of  replicative  intermediates.  The 
topological  features  of  these  structures  as  seen  under 
electron  microscope  are  presented  in  Fig.  4  after  Jacob  and 
Roizman  (1977).  Some  of  the  above  molecules,  namely  the 
rapidly  sedimenting  molecules  which  may  correspond  to  those 
large  tangled  masses  and  molecules  with  single  stranded 
regions,  have  been  confirmed  to  be  precursors  of  mature  unit 
length  of  HSV-DNA  (Hirsch  et  al.,  1976;  Shlomai  et  al., FIGURE  4 
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1976;  Jacob  and  Roizman,  1977). 
Restriction  endonuclease  analysis  of  DNA  concatemers 
generated  during  HSV  DNA  replication  (Jacob  et  al.,  1979) 
show  that  the  concatemeric  DNA  molecules  are  aligned  in 
"head-to-tail"  orientation.  On  the  basis  of  the  above 
observations,  a  rolling  circle  mechanism  for  the  replication 
of  HSV  DNA  (i.  e.  continuous  synthesis  of  one  strand  and 
discontinous  synthesis  of  the  other  strand)  have  been 
proposed  by  Jacob  et  al.  (1979).  Similar  "head-to-tail" 
concatemeric  arrangements  were  observed  in  PsRV  DNA 
(Ben-Porat  and  Rixon,  1979)  which  is  now  thought  to  have 
only  one  main  origin  of  replication  (near-or  at  the  end  of 
the  inverted  repeats  of  the  molecule)  from  which  replication 
proceeds  undirectionally.  The  observation  that  PsRV  DNA  is 
largely  found  in  cirdular  forms  during  the  first  round  of 
replication  supports  the  rolling  circle  mechanism  of 
replication  (Ben-Porat  and  Veach,  1980). 
The  origins  of  replication  on  HSV-1  DNA  have  been 
located  both  at  terminal  and  internal  sites  (Shlomai  et  al., 
1976;  Hirsch  et  al.,  1977;  Spaete  and  Frenkel,  1982;  Stow, 
1982).  It  has  also  been  shown  that  purified  monomeric 
repeat  units,  corresponding  to  map  units  0.94-1.00  could 
replicate  to  generate  defective  multimers  using  only  a 
helper  virus  trans  function  (Vlazny  and  Frenkel,  1981).  The 
ac  sequence  of  HSV  genome,  seems  to  contain  the  recognition 
site  for  cleavage  to  unit  length  molecules  generated  by 
rolling  circle  mechanism  (Jacob  et  al.,  1979),  and  for  the 
encapsidation  of  the  mature  product  (Vlazny  et  al.,  1982). 
More  recently,  it  has  been  found  that  the  signals  required 
for  the  encapsidation  of  HSV-1  DNA  reside  within  the  'a' 
sequence  (Stow  et  al.,  1983). 28 
Virion  Assembly  and  Release  from  the  Cell 
The  mechanism  of  HSV  maturation  is  not  well  understood 
but  there  is  evidence  that  the  assembly  of  herpesvirus 
nucleocapsids  takes  place  in  the  nucleus  of  the  infected 
cells,  as  it  has  been  shown  by  EM  studies  that  empty  capsids 
tend  to  accumulate  in  nuclei  prior  to  the  appearance  of 
capsids  with  dense  cores  (Watson  et  al.,  1964;  Nii  et  al., 
1968).  Experiments  designed  to  study  the  assembly  of  viral 
proteins  and  DNA  into  mature  virions  revealed  that  capsid 
proteins,  synthesized  in  the  cytoplasm  are  transported  to 
the  nucleus  where  they  are  assembled  into  the  characteristic 
capsid  (Olshevsky  et  al.,  1967;  Spear  and  Roizman,  1968). 
Few,  biochemical  studies  of  nucleocapsid  assembly  have 
been  reported,  and  studies  using  is  mutants  of  HSV-1  and 
HSV-2  have  been  carried  out  (Schaffer  et  al.,  1974;  Cabral 
and  Schaffer,  1976;  Atkinston  et  al.,  1978;  Dargan  and 
Subak-Sharpe,  1983).  The  primary  site  of  nucleocapsid 
envelopment  is  the  inner  nuclear  membrance  (Morgan  et  al., 
1959).  However,  it  has  been  proposed  that  nucleocapsids  of 
HSV-2  may  acquire  their  envelopes  by  de  novo  deposition 
within  the  nucleus,  instead  of  by  budding  through  the  inner 
nuclear  membrane  (Atkinson  et  al.,  1978). 
Release  of  herpesvirus  can  take  place  either  by 
budding  (reverse  pinocytosis)  through  the  cytoplasmic 
membrane  (Morgan  et  al.,  1959)  or  by  transportation  through 
pores  which  connect  the  endoplasmic  reticulum  directly  with 
the  extracellular  fluid  (Schwartz  and  Roizman,  1969a). 
Moreover,  virus  transmission  from  cell  to  cell  may  take 
place  due  to  fusion  of  neighbouring  cell  membranes  resulting 
in  formation  of  synctyia  (Brown  et  al.,  1973;  Timbury  et 
al.,  1974). HSV-2  TEMPERATURE  SENSITIVE  MUTANTS 29 
HSV-2  Temperature  Sensitive  Mutants 
In  this  section,  the  temperature  sensitive  (ts) 
mutants  derived  from  HSV-2  (wt)  strain  HG52  will  be 
discussed.  It  must  be  noted  that  is  mutants  derived  from 
HSV-1  and  from  other  strains  (186)  of  HSV-2  have  also  been 
isolated  and  described  (Schaffer  et  al.,  1971,1974;  Brown 
et  al.,  1973;  Manservigi,  1974;  Esparza  et  al.,  1974). 
Using  the  mutagen,  5-bromodeoxyuridine  (BUdR)  at  a 
concentration  of  5  ug/ml,  Timbury  (1971)  isolated  33 
independent  temperature  sensitive  mutants  from  the  HG52 
strain  of  HSV-2;  and  on  the  basis  of  complementation  tests 
(infectious  center  assay)  the  mutants  were  assigned  into  10 
different  complementation  groups.  Later  another  three 
complementation  groups  of  is  mutants  were  added  and 
described  bringing  the  total  number  of  complementation 
groups  to  13  (Halliburton  and  Timbury,  1976).  The  mutants 
were  designated  as  is  1  to  is  13  and  found  to  grow  well  at 
the  permissive  temperature  (PT)  31°C  (the  temperature  at 
which  they  were  first  isolated),  but  no  growth  was  noticed 
at  the  non-permissive  temperature  (NPT)  38°C  (Halliburton 
and  Timbury,  1973,1976).  Limited  cpe  (cell  rounding), 
however,  has  been  observed  in  cells  infected  with  the 
mutants  (except  is  9  and  is  11)  at  38°C.  Further,  all  the 
mutants  absorbed  to  cells  just  as  well  as  38°C  as  at  31°C. 
Electron  microscopic  studies  of  cells  infected  with 
the  mutants  at  the  NPT,  revealed  that  all  the  13  is  mutants 
were  unable  to  produce  complete  electron  dense 
nucleocapsids.  On  the  contrary,  all  other  types  of  capsids 
(empty,  partial,  dense,  enveloped)  were  observed  in  cells 
infected  with  the  ts+  (wt)  virus  at  380C  (Atkinson  et  al., 
1978).  On  the  basis  of  the  type  of  capsid  (if  any) 30 
produced,  is  mutants  were  classified  into  three  classes:  I. 
those  producing  no  capsid  structures  (ts  2,7,9,10  and 
is  12),  II.  those  producing  empty  and  partial-cored  capsid 
(ts  1,6  and  is  13),  and  III.  those  producing  empty,  partial 
and  dense-cored  capsid  (ts  3,4,5  and  is  11).  In  addition, 
an  array  of  microtubules  -a  characteristic  feature  of  HSV-2 
infection  -  were  observed  in  the  nucleus  and  to  a  lesser 
extent  in  the  cytoplasm  of  cells  infected  with  the  mutants 
except  those  infected  with  is  6  or  is  12.  Although-HSV-2  is 
mutants  had  exhibited  a  variety  of  defects  in  morphogenesis, 
these  defects  could  not  be  correlated  completely  with  the 
DNA  phenotype  as  both  DNA  positive  and  DNA  negative  mutants 
showed  these  defects  at  380C  (Atkinson  et  al.,  1978). 
However,  there  is  generally  a  tendency  for  DNA-negative 
mutants  to  show  more  defects  than  DNA  positive"mutants  in 
both  morphogenesis  and  polypeptide  synthesis.  Support  for 
this  conclusion  comes  from  unpublished  observations 
(H.  S.  Marsden)  which  indicate  that  DNA  negative  mutants  show 
multiple  defects  in  synthesis  of  polypeptides  at  38°C,  while 
DNA  positive  mutants  have  polypeptide  profiles  similar  to 
that  of  the  wt  virus,  except  is  3  and  is  12  which  also 
possess  multiple  defects  (Table  1).  However,  Halliburton 
and  Timbury  (1973,1976)  have  shown  that  DNA  synthesis  in 
is  12  and  also  in  is  13  (both  mutants  considered  DNA 
positive)  was  remarkably  reduced  to  an  extent  of  90%  less 
than  the  wt.  In  the  study  reported  by  Timbury  and  Calder 
(1976),  a  third  marker  (syncytial  plaque  morphology  or  syn) 
was  introduced  into  some  of  the  is  mutants  by  backcrossing 
the  is  mutants  to  a  syncytial  but  not  temperature  sensitive 
mutant  of  wild  type  virus.  This  was  used  to  order  the  is 
mutations  and  the  results  showed  that  is  mutants  of  HSV-2 TABLE  1 
SYNTHESIS  OF  POLYPEPTIDES  AT  38°C 
RELATIVE  TO  THE  AMOUNT  SYNTHESIZED 
AT  31°C  (H.  MARSDEN,  UNPUBLISHED  DATA) 
MUTANTS 
POLYPEPTIDES 
91012368211171345 
182 
157 
146  ID 
138  ID 
134/132 
127 
118 
66/65  ID 
50  ID  ID 
42.5 
41.5 
39.5 
38/37.8 
29.5 
1  T, 
ID  ID  ID 
Viral  DNA 
synthesis 
+  +  + 
No.  Polypeptide  49  affected  9  9  7 
A 
7 
- 
6  5  4  1  2  1  1  0 
Polypeptide  produced  in  significantly  reduced  amounts. 
Polypeptide  produced  in  normal  amounts. 
Polypeptide  synthesis  stimulated.  *  MW  reduced 
1 
Polypeptide  not  detected.  ID,  Insufficient  data. 31 
recombine  and  many  do  so  with  relatively  high  frequency. 
It  is  noteworthy  that  the  L  unique  region  comprises 
about  70%  of  the  total  DNA,  thus  there  is  a  strong 
probability  that  most  of  the  mutants  isolated  would  lie 
within  the  L  region  (Timbury  and  Calder,  1976).  Experiments 
with  intratypic  and  intertypic  marker  rescue  analysis 
confirmed  the  above  assumption  and  indicated  that  the 
physical  map  (Chartrand  et  al.,  1981)  correlates  very  well 
with  the  genetic  map  (Timbury  and  Calder,  1976)  except  for 
is  12  which  possess  two  separate  is  mutations  (Fig.  5a  and 
b).  Ts  13,  in  addition  to  is  12,  is  also  known  to  be  a 
double  mutant  with  one  lethal  mutation  (at  0.64-0.70 
fractional  length)  affecting  the  thermal  stability  of  the 
virion  and  a  second  non-lethal  is  mutation  (at  0.12-0.21 
fractional  length)  in  the  viral  (DNase  activity)  exonuclease 
gene  (Moss  et  al.,  1979).  All  other  is  mutants  of  the  HG52 
strain  show  variable  activity  to  induce  this  nuclease 
activity  (Table  2)  under  the  restrictive  conditions  (Moss  et 
al.,  1979;  Moss,  1982). 
Studies  with  DNA  polymerase  activity  of  the  mutants 
under  low  salt  conditions  (30  mM-KC1)  and  high  salt 
conditions  (100  mMkcl)  at  the  permissive  and  non-permissive 
temperature  revealed  that  both  DNA-positive  and  DNA-negative 
mutants  are  able  to  induce  DNA  polymerase  activity  in  BHK 
cells  at  31°C;  and  all  DNA-positive  mutants  do  so  at  the  NPT 
(38°C)  (Hay  et  al.,  1976).  Moreover,  while  is  6  and  is  9 
(DNA-negative  mutants)  failed  to  induce  this  activity  at  the 
NPT,  '  is  11  (DNA-negative)  induced  only  a  small  amount  of  DNA 
polymerase  at  the  same  temperature.  On  the  contrary,  is  1 
induced  more  DNA  polymerase  than  the  wt  at  both 
temperatures.  The  results  suggested  that  at  least  three FIGURE  5 
a)  physical  map  for  some  of  the  is  mutants  of 
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functions  (ts  6,  is  9  and  is  11)  were  required  for 
regulation  and  full  expression  of  this  enzymatic  activity. 
In  the  same  study,  Hay  et  al.  (1976),  assay  for  viral 
pyrimidine  deoxyribonucleoside  kinase  activity  (TK)  showed 
that  mutants  is  1  to  is  10  are  capable  of  producing  this 
activity  at  both  permissive  and  non-permissive  temperatures. 
However,  the  actual  amounts  of  the  enzyme  produced  were  not 
reported. 
It  has  been  reported  that  HSV  type  2  virus, 
inactivated  by  UV  radiation,  had  the  ability  to  transform 
hamster  embryo  cells  in  vitro,  and  that  these  transformed 
cells  were  oncogenic  upon  inoculation  into  hamsters  (Duff 
and  Rapp,  1973).  Utilizing  the  fact  that  in  is  mutants, 
infectious  virus  synthesis  is  inhibited  at  38°C  by  virtue  of 
the  is  lesion  while  the  remaining  viral  gene  activities 
remain  unimpaired,  Macnab  (1974)  successfully  induced 
transformation  of  rat  embryo  cells  with  is  mutants  (without 
UV  radiation)  of  HSV-2  at  the  NPT.  The  result  of  this  study 
revealed  that  is  1  and  is  7  (DNA-negative)  and  is  3,  is  4 
and  is  5  (DNA-positive)  are  transformation  positive,  while 
all  other  mutants  were  not  able  to  induce  cell 
transformation  (Macnab,  1974).  Attempts  to  demonstrate 
infectious  virus  in  the  transformed  cell  line  gave  negative 
results,  but  HSV  specific  antigens  were  demonstrated  by 
indirect  immunofluorescence.  Recently,  it  has  been  shown 
that  HSV-l  can  be  rescued  from  a  rat  tumour  (induced  by  a 
HSV  transformed  cell  line)  by  injecting  the  tumour  with 
intertypic  virus  HSV-21  is  1  (Park  and  Macnab,  1983). 
Furthermore,  two  of  the  transformed  cell  lines,  namely  REl 
and  RE7  (ts  1  and  is  7  transformed  rat  embryo  cell  lines 
respectively)  and  HSV-2  strain  333  proved  to  be  tumourigenic 33 
after  injection  (S.  C.  )  into  highly  immunosuppressed  inbred 
rats  (Macnab,  1979).  A  summary  of  HSV-2  is  mutant 
characteristics  are  listed  in  Table  2. TABLE  2 
PROPERTIES  OF  HSV-2  (HG52)  TEMPERATURE  SENSITIVE  MUTANTS 
310C  310C  380C  380C  380C  380C  380C  520C  380C  380C  380C  380C  380C 
Virus  Log  Max.  v.  Max.  v.  CPE  Viral  (Switch  Effect  on  Thermo-  DNase  DNA  Thymidine  Transforma-  Polypeptide 
phase  yield  yield  DNA  off)  Cel-  histone  stability  activity  polyme-  kinase  tion  of  rat  profile 
(hr)  (hr)  (hr)  synth.  lular  DNA  synth.  (nuc)  rase  (DP)  (TK)  cells 
synth. 
tsl  18-24  c  -  e  NI  Stable  +@  +  +  Defect 
ts2  18-24  c  -  ve  NI  Labile  +  +  -  Defect 
ts3  18-24  c  +  e  50%  redu  Labile  +  +  +  Defect 
ts4  18-24  c  +*  e  NI  Labile  +  +  +  wt 
ts5  18-24  c  +  e  50%  redu  Stable  +  +  + 
- 
wt 
Defect  ts6  18-24  3c 
-  ve  50%  redu  Labile 
0 
-  + 
+  Defect  ts7  18-24  $4  c  -  e  NI  Stable  r  +  + 
Defect  ts8  18-24  to  c  -  e  50%  redu  Stable  +  +  - 
-  Defect  ts9  18-24  0-  -  f  unaffected  Stable  -  + 
-  Defect  tsl0  18-24  Zc  -  ve  50%  redu  Labile  +  + 
Defect  tsll  24  c  -  f  NI  Stables  +  NI  - 
-  Defect  tsl2  24  c  (+)  ve  NI  Labile"  +  NI 
wt  ts13  24  c  (+)  ve  NI  Labile"  nuc-  +  NI  - 
wt  wt  2-3  11  6  ++  +  e  50%  redu  Stable  nuc+  +  +  + 
c  cytopathic  effect  comparable  to  wt  was  observed  (but  virus  yield 
decreased  by  time  due  to  heat  inactivati  on) 
*  reduced  DNA  synthesis  (10-20%  le  ss  than  the  wt) 
(+)  DNA  synthesis  reduced  (90%  less  than  the  wt) 
e  efficient  ) 
ve  very  efficient  )  to  switch  off  host  cell-DNA  synthesis 
f  fails  ) 
NI  no  information 
thermostability  was  checked  at  3  90C  and  not  at  520C 
@  enzyme  induced  in  amount  greater  than  the  wt  at  both  temperature 
(31°C  and  38°C) 
±  enzyme  produced  in  a  very  little  amount 
Halliburton  and  Timbury,  1973,1976 
Macnab,  1974 
Hay  et  al.,  1976 
H.  S.  Marsden  (unpublished  data) 
Mose  et  al.,  1979 
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Terminology  and  Definition 
The  terminology  of  viral  infection  continues  to  be 
controversial,  though  it  is  generally  agreed  that  viral 
infections  are  of  two  main  types:  I.  Acute  infection,  as  a 
result  of  virus  interaction  with  permissive  cells.  Normally 
this  type  of  infection  is  productive  and  leads  to  cell  death 
which  is  reflected  in  the  individual  host  as  an  overt 
infection  which  is  usually  cleared  by  effective  immune 
response.  II.  Prolonged  infection,  where  a  degree  of 
equilibrium  is  established  between  the  virus  and  the 
infected  host.  Three  subtypes  of  such  infection  can  be 
distinguished.  First,  after  infection  the  virus  is  retained 
within  the  host  but  in  a  non-detectable  form,  (i.  e.  by  using 
present  techniques)  and  shedding  of  the  virus  to  the  outside 
occurs  sporadically,  e.  g.  as  a  result  of  reactivation  of  HSV 
or  VZV  in  dorsal  root  ganglia  (DRG).  This  type  of  infection 
is  referred  to  as  "latent  infection"  and  the  phenomenon  is 
known  as  latency.  The  second  type  of  infection  is  where  the 
virus  persists,  replicates  and  continues  to  be  shed  often 
throughout  the  life  of  an  individual  host  in  the  presence  of 
an  immune  response  e.  g.  adenovirus  in  human  tonsils.  Third, 
a  typical  infection  often  in  the  presence  of  a  defective 
immune  response  when  prolonged  continuous  virus  growth  takes 
place,  in  for  example  Hepatitis  B  carrier,  SSPE.  Some  other 
terms  have  alternatively  been  used  for  the  purpose  of  the 
definition  of  the  above  types  of  infection  (Smith  and 
Ritchie,  1980),  for  example  the  term  "inapparent  infection" 
has  been  used  to  describe  the  whole  area  of  infections  which 
give  us  no  overt  sign  of  their  presence.  The  term 
'subclinical'  can  be  used  as  an  alternative,  particularly  in 
human  medicine.  According  to  this  scheme  of  terminology, 35 
latent  infection  is  an  inapparent  infection,  whereas  "occult 
virus"  is  used  to  describe  the  case  where  virus  particles 
can  not  be  detected  and  in  which  the  actual  state  of  the 
virus  can  not  as  yet  be  ascertained.  However,  the  simplest 
definition  of  latency  is  whereby  an  organism  is  infected 
with  a  virus  but  yet  shows  no  apparent  disease  or  sign  of 
infection.  The  phenomenon,  latency,  is  widespread  among  the 
herpesviruses  group.  Based  on  the  behaviour  of  viruses  in 
their  natural  hosts,  Wildy  and  co-workers  (1982)  constructed 
a  list  of  herpes  viruses  that  show  classical  latency 
(Table  3).  One  criterion  that  has  to  be  satisfied  before  a 
virus  is  acceptable  on  the  list  is  evidence  that  it  can 
remain  latent  in  dorsal  root  ganglia  (the  anatomical  site 
and  relation  to  other  organs  of  these  ganglia  is  shown  in 
Figure  6  and  7)  and  can  be  reactivated. 
In  this  chapter,  the  available  data  concerning  HSV 
latency  will  be  reviewed,  while  the  latent  infection  by 
other  herpsviruses  will  be  discussed  later. 
Latent  HSV  Infection  in  the  Natural  Host 
Almost  from  the  time  of  their  discovery,  herpes 
viruses  have  been  known  to  cause  latent  infection,  and  even 
before  the  causative  agent  for  herpetic  fever  blisters  was 
identified  as  a  virus,  its  ability  to  establish  latent 
infection  was  postulated  (Goodpasture,  1929).  Recurrent 
herpes  is  produced  by  both  types  (HSV-1  and  HSV-2)  of  virus. 
Moreover,  patients  may  be  infected  with  both  types  and  have 
recurrences  caused  by  either  or  both  viruses  (Wheeler, 
1975).  The  site  of  recurrence  appears  to  be  determined  by 
the  location  of  the  primary  infection  (Chang,  1971).  The 
primary  exposure  of  individuals  to  herpes  simplex  virus 
usually  occurs  early  in  life.  Most  of  these  infections  are TABLE  3 
HERPES  VIRUSES  AS  CANDIDATES  FOR  CLASSICAL  LATENCY 
Virus  Melnick's  %G+C  Typical  primary  infectiona 
group 
Local  or  Pulmonary 
widespread  involvement 
B  virus  A  75  L- 
(Herpesvirus 
simiae) 
Pseudorabies  A  73  L-W  + 
virus  (Aujeszky's 
disease  virus) 
Spider  monkey  A  71  L-W  + 
herpes  virus 
+  Infectious  bovine  A  71  W15 
rhinotracheitis 
virus 
Squirrel  monkey  A  67  L? 
herpes  virusd 
(Herpesvirus 
tamarinus) 
Herpes  simplex  A  68  L- 
virus  2 
Herpes  simplex  A  66  L- 
virus  1 
Bovine  mammilit  sA  64  L-W  - 
virus 
Equine  abortion  A  56  L-W  + 
virus 
SA8  A  L? 
Varicella-zoster  B  46  W+ 
virus 
Feline  rhinotra-  B  46  W+ 
cheitis  virus 
Canine  herpesvirus  B  33  L+ 
A  Viruses  have  a  wide  host  range  tissue  culture  and  are  not  greatly 
cell  associated 
B  Viruses  have  narrow  host  range  and  tend  to  remain  cell  associated 
a  In  the  natural  host,  immunocompetent,  non-neonate 
b  Genital  infection  is  markedly  localized 
c  Not  to  be  confused  with  Herpesvirus  ateles 
d  Not  to  be  confused  with  Herpesvirus  saimiri TABLE  3  (continued) 
Natural  Other  Recurrence  or  Reactivation 
host  experimental  recrudescence  from  nervous 
hosts  tissue 
Rhesus  ++ 
(Man)rabbit  usually 
guinea-pigs,  lethal 
other  simians 
Swine  ++ 
Rabbits,  calves  usually 
mice  and  many  lethal 
other  species 
Ateles  +? 
Guinea-pigs,  usually 
marmosets,  lethal 
rabbits 
Cattle  +  -? 
Rabbits, 
cotton  tail 
rabbits 
Squirrel  +? 
monkey  Mice,  rabbits  ++ 
Man  Mice,  ++ 
rabbits,  ++ 
Man  guinea-pigs  ++ 
Cattle  +  -? 
Mice,  rabbits 
Horses  +  -? 
Hamsters,  mice 
Vervet  +?  + 
Rabbit 
++  Man  Nonee 
Cats  ++ 
Dogs  +- 
e  D-herpes  virus  of 
varicella-zoster) 
+?  probably 
-?  tried  but  not  yet 
L  localized 
W  widespread 
patas  monkey  (serologically  related  to 
successful FIGURE  6 
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subclinical  and  the  principal  clinical  manifestation  is 
gingivostomatitis  (Scott  et  al.,  1941).  The  incidence  of 
primary  infection  with  herpes  simplex  virus  type  2  increases 
with  increasing  sexual  activity  and  a  significant  proportion 
of  the  adult  population  have  antibodies  to  this  strain  of 
herpes  simplex  virus  (Rawls  et  al.,  1973;  Nahmias  et  al., 
1974).  Recurrent  herpes  simplex  has  been  recognised  for 
centuries,  and  the  early  evidence  which  suggests  that  herpes 
simplex  virus  might  remain  latent  within  nervous  system 
tissues  and  specifically  within  the  trigeminal  (TG)  or  other 
sensory  ganglia  of  humans,  was  provided  by  a  variety  of 
clinical  observations.  These  were:  many  patients  can 
predict  the  appearance  of  vesicles  because  of  a  sensation  of 
numbness,  tingling  or  pain  in  the  area  12-48  hours  before 
the  appearance  of  the  eruption  in  the  skin  (Behrman  and 
Knight,  1954;  Layzer  and  Conant,  1974).  In  addition  some 
factors  are  well  known  to  have  the  ability  to  provoke 
recurrent  herpes  infections  such  as  stress,  allergic 
reactions,  menstruation,  fever,  exposure  to  sunlight,  trauma 
and  sexual  activities  (Warren  et  al.,  1940;  Chang,  1971; 
Nahmias  and  Roizman,  1973a,  b,  c;  Segal  et  al.,  1974). 
Other  evidence  which  also  suggests  the  involvement  of  the 
nervous  system  particularly  the  trigeminal  ganglia,  in 
provocation  of  herpes  simplex  virus  lesions,  is  provided  by 
the  observation  that  90%  of  patients  subjected  to  trigeminal 
rhizotomy  develop  herpetic  lesions  on  their  lips  or  mouth 
(Ellison  et  al.,  1959).  In  fact,  some  years  earlier,  Carton 
(1953)  showed  that  herpes  lesions  occur  after  section  of  the 
trigeminal  nerve  proximal  to  the  ganglion,  while  section  of 
the  nerve  distal  to  the  ganglion  will  not  lead  to  the 
development  of  such  lesions.  In  fact,  section  of  the  nerve 37 
distal  to  the  ganglion  or  damaging  the  nerve  by  injection  of 
alcohol  may  prevent  herpes  on  the  face.  Moreover,  herpes 
usually  occurs  only  in  the  area  innervated  by  the  maxillary 
and  mandibular  branches  of  the  trigeminal  nerve  and  not  the 
ophthalmic  branches  (Fig.  8).  However,  asymptomatic 
shedding  of  HSV  in  the  tears  has  been  observed  presumably 
after  reactivation  of  virus  in  the  trigeminal  ganglion 
(Klein,  1982).  Furthermore,  it  has  been  suggested  that 
latent  HSV-1  may  not  be  located  only  in  neurones  associated 
with  the  site  of  primary  infection,  which,  in  the  majority 
of  cases  is  the  oral  cavity  and  the  perioral  area  - 
innerveted  by  the  maxillary  and  mandibular  branches  (Klein, 
1976).  Recovery  of  herpes  simplex  virus  from  explanted 
human  trigeminal  ganglia  (Barringer  and  Swoveland,  1973)  has 
confirmed  the  belief  that  virus  resides  in  the  human 
trigeminal  nerve  ganglion  during  clinically  inactive  herpes. 
In  addition  to  the  surgical  manipulation  of  the 
trigeminal  structures,  other  factors  such  as  fever  and 
sunburn  (light)  have  been  used  to  precipitate  recurrent 
herpes  in  man.  Fever  was  produced  by  using  diathermy, 
infrared  bulbs,  blankets  and  hot  water  baths  (Warren  et  al., 
1940;  Keddie  et  al.,  1941).  About  75%  of  fever  treated 
patients  developed  herpes,  and  herpetic  eruptions  usually 
appeared  within  24-48  hours  after  the  induction  of  fever. 
The  results  suggest  that  almost  everyone  who  has  been 
infected  with  herpes  virus  can  be  made  to  develop  recurrent 
herpes  if  the  stimulus  is  strong  enough.  Evidence  for  the 
latter  conclusion  came  from  the  observation  that  if  the 
initial  fever  was  between  390C  and  39.50C  about  55%  of 
patients  develop  herpes,  while  increasing  the  initial  fever 
to  40.8°C-41°C  will  result  in  herpes  development  in  about FIGURE  8 
DIAGRAM  ILLUSTRATING  THE  THREE  BRANCHES  OF 
HUMAN  TRIGEMINAL  GANGLION  (TG) 
a)  lateral  view 
b)  superior  view 
1.  ophthalmic  branch 
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86%  of  the  total  patients  (Keddie  et  al.,  1941).  Using 
sunburn  to  induce  recurrent  herpes  (in  patients  known  to 
have  had  herpetic  infection)  Wheeler  (1975)  suggested  the 
administration  of  8  minimal  erythema  doses  of  ultraviolet  to 
a  3-inch  diameter  circle  centered  over  a  healed  recurrent 
site.  Herpes  was  precipitated  in  the  three  patients  in  four 
of  nine  attempts  giving  4.5  to  8  minimal  erythema  doses  of 
U.  V.  light.  These  and  other  reactivation  inducing  agents 
will  be  discussed  later. 
The  data  reported  by  Spruance  et  al.  (1977)  confirmed 
the  previous  observation  about  the  short  lived  nature  of 
lesions  in  recurrent  herpes  simplex  labialis.  The  data 
showed  that  two  thirds  of  the  80  patients  studied,  had 
prodromal  symptoms  which  generally  lasted  a  few  hours  only 
and  that  pain  was  experienced  early,  gradually  reducing. 
Moreover,  the  progression  "erythema  ->  papule  ->  vesicle  -> 
ulcer  ->  healing"  was  usual  and  most  lesions  progressed  from 
the  vesicle  to  the  ulcer  stage  within  48  hours;  virus  was 
isolated  from  60%  of  patients  with  papules  and  from  all 
patients  with  vesicles.  No  virus  was  isolated  during  the 
prodromal  or  erythematous  stage,  though  virus  was  retrieved 
by  cocultivation  in  3/6  attempts.  However,  Daniels  et  al. 
(1975)  were  able  to  isolate  virus,  on  several  occasions,  up 
to  three  weeks  from  recurrent  lesions  persisting  in  two 
immunocompromised  patients.  Infectious  virus  was  frequently 
in  the  form  of  immune  complexes. 
Three  main  hypotheses  concerning  the  location  of  the 
virus  during  the  latent  stage  of  infection  have  been 
described  (Pain,  1964;  Chang,  1971;  Nahmias  and  Roizman, 
1973a,  b,  c).  The  first  hypothesis  postulates  that  a 
chronic  infection  of  the  mucous  membranes  and  glandular 39 
appendages  of  the  eye,  mouth  or  genitalia  is  established  and 
serves  as  a  source  of  virus  for  clinically  evident 
recurrences.  Supporting  this  theory  is  the  observation  that 
virus  is  present  in  tears,  saliva  and  genital  secretions  and 
can  be  isolated  from  time  to  time  in  the  absence  of  clinical 
disease  (Buddingh  et  al.,  1953).  Such  virus  can  produce 
lesions  in  the  cornea,  lip,  vulva  and  penile  skin.  However, 
this  does  not  explain  how  virus  from  mucocutaneous  areas  can 
repeatedly  produce  recurrent  lesions  at  distant  sites  e.  g. 
on  the  buttocks,  hands  or  lower  legs.  Moreover, 
asymptomatic  shedding  of  virus  in  tears  has  been  observed 
after  microneurosurgical  decompression  of  the  trigeminal 
ganglion  nerve  root  (Pazin  et  al.,  1978).  The  second  theory 
is  that  virus  is  present  in  some  latent,  incomplete  or 
site  of 
inactive,  form  at  the/recurrence  ,  i.  e.  the  skin  and 
mucous  membrane.  The  third  theory,  says  that  virus  is 
present  in  some  latent,  incomplete  or  inactive,  form  in 
nerve  tissue  at  a  point  distant  from  the  recurrent  site 
(e.  g.  sensory  ganglia)  which  innervates  the  recurrent  site. 
It  is  the  latter  two  theories  that  attracted  the  attention 
of  many  workers  and  they  will  be  discussed  in  detail  later. 
However,  it  is  relevant  to  discuss  them  from  the  natural 
host's  point  of  view,  in  the  following  paragraph. 
Human  Skin  Tissue  as  a  Site  of  Latent  Infection 
It  seems  to  be  reasonable`to  consider  that  latent  HSV 
resides  in  the  skin  during  the  interval  between  recurrences. 
According  to  one  point  of  view,  the  site  of  latent  infection 
is  the  skin  or  the  mucous  membranes  where  the  primary 
infection  occurred  (Kauffman  et  al.,  1967;  Sabin,  1975). 
This  idea  is  supported  by  the  following  facts:  first,  HSV 
has  been  isolated  from  the  saliva  and  lachrymal  secretions 40 
of  healthy  carriers  (Buddingh  et  al.,  1953;  Kauffman  et  al., 
1968;  Douglas  et  al.,  1970).  Second,  10%  of  non  pregnant 
women  with  a  history  of  recurrent  herpes  presented  evidence 
of  asymptomatic  HSV  shedding  (Adam  et  al.,  1979),  while  70% 
of  mothers  delivering  HSV  infected  newborns  shed  virus 
asymptomatically  (Whitley  et  al.,  1980).  In  addition, 
experimental  reinoculation  of  the  virus  into  human  skin 
induces  a  new  recurrence  at  the  site  (Blank  and  Haines, 
1973).  Furthermore,  herpes  simplex  virus  type  2  has  been 
isolated  from  the  buffy  coat  of  two  adults  with  meningitis 
(Craig  and  Nahmias,  1973).  However,  the  idea  that  the  skin 
is  the  site  of  latent  infection  has  generally  been  hampered 
by  the  failure  to  demonstrate  the  presence  of  the  virus 
(either  by  isolation  from  homogenized  tissues  or  by  organ 
culture)  in  the  skin  during  the  quiescent  stage  (Findlay  and 
MacCallum,  1940;  Rustigian  et  al.,  1966;  Wohlenberg  et  al., 
1976). 
Early  studies  in  man  (Stadler  and  Zurukzoglu,  1936) 
had  shown  that  it  was  not  possible  to  transfer  a  recurrence 
by  switching  skin  grafts  on  the  same  patient,  but  recurrent 
lesions  were  observed  in  skin  adjacent  to  the  donor  site, 
suggesting  that  recurrence  did  not  depend  upon  residence  of 
the  virus  in  the  skin.  However,  this  was  done  in  only  two 
or  three  patients  in  the  1930s  and  it  is  hardly  conclusive 
(Wheeler,  1975). 
The  observation  that  local  ultraviolet  light 
administration  precipitates  recurrent  herpes  (Wheeler,  1975) 
suggested  that  the  virus  may  be  in  the  skin,  but  it  could 
alternatively  be  due  to  light  (or  heat)  serving  to  call  the 
virus  forth  from  a  nerve  ganglion.  However,  as  will  be 
explained  later,  some  evidence  has  accumulated  suggesting 41 
that  latent  infection  can  be  induced  (at  least  in 
experimental  animals)  in  peripheral  tissues  (Scriba,  1977, 
1981;  Hill  et  al.,  1980;  Al-Saadi  et  al.,  1983).  Moreover, 
Hoyt  and  Bilson  (1976)  reported  recurrent  herpes  simplex  in 
patients  with  blow-out  fractures  which  had  severed  the  nerve 
supply  to  the  area  of  skin  involved,  indicating  that  the 
lesions  must  have  arisen  from  virus  already  present  in  the 
skin.  Nevertheless,  the  skin  is  unlikely  to  be  the  most 
important  site  in  view  of  the  substantial  evidence  that 
reappearance  of  herpetic  lesions  is  dependent  on  the 
preservation  of  intact  anterior  roots  of  viable  ganglionic 
cells  (Klein,  1976). 
Neuronal  Tissue  as  the  Site  of  Latent  Infection 
The  concept  that  the  virus  resides  in  the  some  latent 
or  inactive  form  in  nerves  has  been  popular  for  years 
(Cushing,  1904;  Howard,  1905).  Goodpasture  (1929)  was  the 
first  to  hypothesize  the  location  of  HSV  in  ganglionic 
tissue.  This  was  supported  by  the  clinical  observation  that 
herpes  eruptions  regularly  followed  rhizotomy  (Cushing, 
1904;  Carton  and  Kilbourne,  1952;  Carton,  1953).  A  further 
suggestion  that  nervous  tissue  is  involved  in  recurrence  of 
herpes  simplex  virus  lesions  comes  from  the  observation  that 
most  of  the  patients  experienced  burning,  itching  and 
neuralgic  pains  24-48  hours  before  the  appearance  of  lesions 
(Behrman  and  Knight,  1954;  Constantine  et  al.,  1968;  Layzer 
and  Conant,  1974).  However,  while  early  attempts  to  isolate 
the  virus  from  the  ganglion  were  unsuccessful  (Burnet  and 
Lush,  1939;  Ritchter,  1944;  Carton  and  Kilbourne,  1952; 
Ellison  et  al.,  1959),  herpes  simplex  virus  isolation  from 
both  the  semilunar  (Bastian  et  al.,  1972;  Baringer  and 
Swoveland,  1973;  Plummer,  1973;  Rodda  et  al.,  1973)  and 42 
sacral  (Baringer,  1974)  ganglia  was  successfully  achieved 
during  the  past  decade.  Furthermore,  herpes  simplex 
specific  RNA  has  been  detected  in  sensory  ganglia  (Galloway 
et  al.,  1979)  of  patients  with  no  evidence  of  herpes  or 
recurrent  infection,  though  no  attempts  were  reported  to 
recover  the  infectious  virus  and  it  is  not  clear  if  this 
hybridization  was  to  neurones  containing  truly  latent 
virus.  In  addition  to  the  sensory  or  dorsal  root  ganglia 
other  neurological  sites  have  been  speculated  as 
possibilities  for  latent  HSV  infection.  Warren  et  al. 
(1978)  have  demonstrated  (by  isolation)  the  presence  of 
latent  herpes  simplex  virus  in  the  superior  cervical  and 
vagus  ganglia  of  human  beings.  Furthermore,  there  is 
unconfirmed  evidence  for  the  presence  of  herpes  simplex 
virus  in  the  central  nervous  system  (CNS)  of  man,  using  DNA 
hybridization  (Sequera  et  al.,  1979).  Also  there  is  a 
report  of  rescue  of  defective  viruses  from  long  term 
trigeminal  ganglion  cell  cultures  by  superinfection  with  is 
mutants  at  the  non-permissive  temperatures  (Brown  et  al., 
1979).  The  presence  of  HSV  genomes  in  the  CNS  of  man  has 
been  proposed  as  a  possible  precursor  of  encephalitis  or  it 
might  provide  a  stimulus  for  demyelination.  In  general,  it 
has  been  concluded  that  the  sensory  ganglion  is  the 
important  site  in  man  which  harbours  herpes  simplex  virus 
(see  Table  3)  in  classical  latency  (Wildy  et  al.,  1982). 
Latent  HSV  Infection  in  Experimental  Models 
The  different  stages  (initiation  or  establishment, 
maintenance,  reactivation)  of  the  mechanism  of  latent  HSV 
infection  have  been  variably  investigated  both  in  in  vitro 
and  in  vivo  experimental  models.  Among  the  experimental 
animals  which  have  been  used  are  mice  (Stevens  and  Cook, 43 
1971;  Hill  et  al.,  1975;  Harbour  et  al.,  1981;  Al-Saadi  et 
al.,  1983),  rabbits  (Perdrau,  1938;  Good  and  Campbell,  1948; 
Schmidt  and  Rasmussen,  1960;  Nesburn  et  al.,  1967;  Plummer 
et  al.,  1970),  guinea-pigs  (Scriba,  1975;  Donnenberg  et  al., 
1980),  and  tree-shrews  (Campbell,  1966;  Goodman,  1966;  Munk 
et  al.,  1978;  Darai  et  al.,  1978).  The  main  point  to  note 
is  that  some  aspects  of  herpes  pathogenesis,  latency  and 
reactivation  are  reproducible  in  the  animal  models. 
Moreover,  some  of  these  models  provide  a  close  reproduction 
of  the  disease  in  humans:  for  example,  recrudescence  in  mice 
(Hill  et  al.,  1975;  Harbour  et  al.,  1981),  recurrent  genital 
herpes  infection  in  guinea  pigs  (Scriba,  1975)  and  recurrent 
ocular  herpetic  infection  in  rabbits  (Anderson  et  al.,  1961; 
Nesburn  et  al.,  1967).  Beside,  host  strain  differences  (if 
any)  can  be  studied  in  laboratory  animals,  particularly  when 
a  large  variety  of  host  strains  are  available  e.  g.  mice  used 
during  this  study.  However,  since  the  molecular  aspects  of 
HSV  infection  and  latency  are  difficult  to  study  in  vivo, 
investigations  have  examined  the  interaction  between  HSV  and 
some  cells  (both  of  neural  and  non-neural  origin)  in  vitro. 
Moreover,  using  the  latter  system  may  help  to  shed  light  on 
the  mechanism  in  man  and  in  animals.  Nevertheless  it  should 
always  be  kept  in  mind  that  human  and  animal  infections 
involve  additional  complications  due  to  the  activity  of 
their  immune  system. 
In  Vitro  Studies 
Many  and  varied  cell  culture  systems  have  been  used  to 
study  HSV-cell  interaction  resulting  in  long  term  infected 
cell  lines  and  during  the  quiescent  stage  of  infection 
different  terms  (chronic,  prolonged,  persistent  and 
abortive)  have  been  used  to  describe  the  nature  of 44 
infections.  The  goal  of  the  investigations  was  to  establish 
a  reliable  model  system  to  study  HSV  latency  in  vitro. 
Certain  criteria  have  been  suggested  (Levineet  al., 
1980)  for  any  HSV  cell  culture  latency  model:  i,  survival  of 
infected  cells,  ii,  absence  of  infectious  particles  in  the 
surviving  culture,  iii,  retention  of  the  complete  viral 
genome  in  the  surviving  cells,  iv,  ability  to  induce  the 
synthesis  of  infectious  virus  by  some  manipulation  of  the 
culture.  These  criteria,  however,  do  not  take  into  account 
the  fact  that  naturally  occurring  latent  infection  does  not 
require  as  a  prerequisite  a  certain  alteration  in  the  host 
body  temperature,  or  the  presence  of  viral  inhibitors  such 
as  arabinosyl  cytosine  (ara-c)  or  phosphonoacetic  acid  which 
are  used  in  most  of  the  in  vitro  systems;  moreover  the 
criteria  do  not  take  into  consideration  the  nature  of  cells 
harbouring  latent  virus  under  natural  conditions,  i.  e.  the 
non-dividing  neurons  (and  perhaps  other  cells)  that  might  be 
latently  infected  by  viruses  which  have  travelled  from  the 
primary  site  of  entry.  In  addition,  low  levels  of  virus 
replication  or  virus  gene  expression  (i.  e.  persistence) 
should  be  excluded  as  viral  antigens  can  not  normally  be 
detected  in  latently  infected  neurones.  _ 
Some  of  the  in  vitro  HSV  cell  interactions  are  listed 
in  Table  No.  4.  In  reports  where  the  infection  is  described 
as  latent  (O'Neill  et  al.,  1972,1977;  Colberg-Poley  et  al., 
1979,1981;  Wigdahl  et  al.,  1982a,  1983),  supportive 
measures  (i.  e.  antimetabolites,  interferon  and  elevation  of 
the  temperature  of  incubation)  were  essential  in  preventing 
virus  replication.  Moreover,  infectious  virus  was  detected 
within  a  short  period  upon  removal  of  additives  or  upon 
lowering  the  temperature  of  incubation.  Recently,  it  was *NFr 
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possible  to  establish  a  similar  type  of  latent  infection  in 
C13  cells  without  the  presence  of  supportive  measures  (E. 
Notarianni,  personal  communication).  In  another  study 
Wigdahl  et  al.  (1983)  have  claimed  the  establishment  of 
latent  HSV-1  infection  in  neuron  culture,  but  the  presence 
of  infectious  virus  was  detected  within  2-3  days  after 
lowering  the  temperature  of  incubation  and  the  presence  of 
contaminating  fibroblast  and  Schwanncells  in  the  culture  was 
not  excluded.  It  can  be  seen  that  the  conditions  under 
which  the  infection  was  established  are  highly  artificial 
and  in  none  of  these  systems  has  a  true  latent  infection 
been  established  that  can  be  said  to  mimic  the  course  of  the 
infection  in  vivo.  However,  it  is  worth  discussing  HSV  cell 
interaction  in  some  of  these  systems. 
Different  studies  had  shown  that  cells  range  from  non 
permissive,  semi  permissive  to  permissive  for  HSV 
replication  (Schwartz  and  Elizan,  "1973;  Vahlne  and  Slycke, 
1977,1978;  Adler  et  al.,  1978;  Doller  et  al.,  1979;  Lewin 
et  al.,  1980;  Smith  and  Lancz,  1982)  and  that  HSV  can 
persistently  infect  a  variety  of  cells  (Table  No.  4) 
including  neural  and  non  neural  (i.  e.  epithelial,  fibroblast 
and  lymphoid)  cells  of  different  species,  e.  g.  Chinese 
hamster  ovary  cells  (Hampar  and  Copeland,  1965;  Hampar  and 
Burroghs,  1969),  L  cells  (Nii,  1969),  HeLa  cells,  (Szanto, 
1963)  both  in  the  presence  or  absence  of  supportive 
measures.  In  most  of  these  cells,  however,  there  is  lack  of 
evidence  for  retention  of  HSV  genetic  information  in 
cultures  that  are  no  longer  producing  infectious  virus. 
Results  of  these  studies  have  indicated  that 
persistent  HSV  infection  can  be  maintained  for  variable 
often  prolonged  lengths  of  time,  or  as  long  as  the  cultures 46 
were  maintained  under  supraoptimal  temperature  e.  g.  for  128 
days  in  HFF  cells  (O'Neill  et  al.,  1977).  It  was  also  shown 
that  in  these  cells  (B103)  non  permissiveness  is  temperature 
and  multiplicity  dependent  (Lewin  et  al.,  1980).  On  the 
other  hand,  it  has  been  shown  (Rice  et  al.,  1979)  that  in 
contrast  to  human  glioma  (COX)  and  mouse  neuroblastoma  (D2) 
cells,  rat  glioma  (C6)  cells  do  not  support  generalised 
HSV-1  replication  and  a  persistent  infection  of  these  cells 
(i.  e.  C6)  is  established.  In  conclusion,  HSV  replication 
patterns  in  cultured  cells  are  quite  variable  and  no 
generalization  can  be  made  particularly  for  HSV  infection  in 
neural  cells. 
s  in  latency,  the  molecular  basis  of  the  persistent 
infection  is  unclear,  and  the  state  of  the  virus  genome  in 
such  types  of  infections  is  not  understood.  Manipulations 
of  persistently  infected  cell  cultures  (lowering  the 
temperature  or  removal  of  inhibitors)  have  resulted  in 
resumption  of  virus  growth  and  both  released  virus  and  cpe 
were  observed  in  the  treated  culture  (Rice  et  al.,  1979; 
Dawson  et  al.,  1983).  Stimulation  of  HSV-2  production  in 
persistently  infected  cultures  was  also  achieved  by 
superinfecting  cells  with  the  wt  virus  and  is  mutants  of 
human  cytomegalovirus  (Colberg-Poley  et  al.,  1979,1981). 
Similarly,  superinfection  with  HSV-2  is  mutants  stimulated 
HSV-1  genome  in  persistently  infected  cell  culture  (Wigdahl 
et  al.,  1982;  Park  and  Macnab,  1983).  Evidence  in  both  of 
the  superinfection  systems  indicated  that  HCMV  and  HSV-2  DNA 
synthesis  is  not  required  for  activation  of  repressed  HSV 
genomes  suggesting  the  involvement  of  early  genome  functions 
in  the  stimulation  process.  However,  it  is  not  clear 
whether  the  superinfection  mechanism  stimulates  cellular 47 
functions  that  are  required  for  HSV  replication,  or  directly 
stimulates  virus  transcription,  or  alternatively',  provides 
functions  or  products  necessary  for  replication  and  there  is 
no  evidence  to  support  any  of  the  latter  possibilities.  In 
addition,  recombination  between  repressed  HSV-1  and 
inoculated  HSV-2  genomes  has  not  been  totally  excluded 
(Wigdahl  et  al.,  1982). 
It  has  been  reported  that  some  cell  cultures 
persistently  infected  with  HSV  underwent  a  series  of 
"crises"  of  cell  destruction  and  regrowth,  i.  e.  cyclical 
persistent  infection  (Hampar  and  Copeland,  1965;  Nii,  1969; 
Robey  et  al.,  1976;  Szanto  et  al.,  1976;  Rice  et  al.,  1979). 
Several  models  have  been  proposed  to  explain  persistence  and 
cyclical  activity  in  tissue  infected  with  cytopathic  viruses 
(Friedman  and  Ramseur,  1979)  including  i,  defective 
interfering  (DI)  particles,  ii,  involvement  of  the 
interferon  system,  iii,  genetic  changes  of  virus  or  host, 
e.  g.  spontaneously  generated  temperature  sensitive  mutants 
and  iv,  probably  integrated  DNA.  Though  a  proportion  of  the 
Epstein-Barr  virus  DNA  (human  herpes  virus)  was  found  as  an 
integrated  form  (Nonoyama  and  Pagano,  1972;  Tanaka  and 
Nonoyama,  1974)  in  the  Raji  cell  line  and  subsequently  in 
other  EBV  carrying  lines,  there  is  no  evidence  for 
integration  of  the  HSV  genome  in  persistently  infected 
cells.  The  integration  of  EBV-DNA  in  host  cells  will  be 
discussed  later.  The  first  two  possibilities  (DI  particles 
and  interferon)  are  subjects  of  controversy.  The  role  of  DI 
particles  has  not  been  confirmed  and  it  has  been  proposed 
(Roizman,  1965)  that  both  functional  and  defective  subunits 
may  play  a  role  in  the  mechanism  of  HSV  abortive  infection. 
In  addition,  a  low  level  of  HSV  DNA  synthesis  was  observed 48 
in  C6  cells  persistently  infected  with  HSV-l  (Rice  et  al., 
1979)  which  might  preclude  the  formation  of  DI  particles. 
However,  this  has  not  been  confirmed  since  viral  DNA 
synthesis  and  specific  antigens  were  not  detected  in  similar 
cell  cultures  infected  with  HSV-2.  -  On  the  other  hand,  it 
has  been  shown  that  interferon  is  not  involved  (Lancz  and 
Zettlemoyer,  1976;  Smith  and  Lancz,  1982)  or  at  least  not  of 
primary  importance  in  the  establishment  and/or  maintenance 
of  persistent  infection  in  C6  cells  (Dawson  et  al.,  1983). 
Investigations  attempting  to  characterize  a'HSV-cell 
interaction  have  produced  inconsistent  results,  for  example, 
certain  variants  of  glioma  cell  lines  vary  in  their  ability 
to  produce  virus  (Rice  et  al.,  1979).  Moreover  a 
discrepancy  between  the  levels  of  resistance  and  HSV 
production  in  C6  cells  has  been  noticed  in  different  reports 
(Schwartz  and  Elizan,  1973;  Lancz  and  Zettlemoyer,  1976; 
Ando  and  Arai,  1980;  Smith  and  Lancz,  1982;  Dawson  et  al., 
1983).  These  discrepancies  probably  explain  the 
inconsistency  of  terms  used  to  describe  the  infection 
(prolonged,  chronic,  persistent,  abortive  and  others). 
These  observations,  indicate  the  important  role  of  the  virus 
and  host  cell  factors  in  the  mechanism  of  persistent 
infection. 
In  Vivo  Studies 
There  is  general  agreement  on  the  basic  features  of 
HSV  infection.  The  virus  enters  the  host  organism  in  most 
cases  through  the  mucocutaneous  surface  where  the  primary 
infection  occurs  then  there  is  usually  infiltration  of  the 
corresponding  ganglia  by  the  virus.  For  some  individuals, 
the  virus  may  periodically  reactivate  subsequently  with 
recrudescence  or  without  the  development  of  detectable 49 
lesions  at  the  peripheral  site  within  the  infected  dermatome 
(recurrence)  (Wildy  et  al.,  1982).  It  is  convenient  to 
review  the  mechansims  of  latency  in  the  order  of  1st,  acute 
ganglionic  infection;  2nd,  establishment  and  maintenance  of 
latent  infection;  3rd,  reactivation. 
Acute  Ganglionic  Infection 
Evidence  for  the  presence  of  HSV  virus  in  the  spinal 
ganglia  of  mice,  during  the  acute  phase  of  infection,  has 
been  provided  by  Hill  et  al.  (1972)  and  Cook  and  Stevens 
(1973).  Following  peripheral  inoculation  of  mice,  HSV  can 
be  demonstrated  in  spinal  ganglia  within  20-24  hours  p.  i. 
The  amount  of  infectious  virus  that  can  be  detected  in  the 
corresponding  ganglia  increases  for  the  first  4-7  days  p.  i. 
and  then  subsequently  declines.  The  increase  in  the  amount 
of  virus  in  the  ganglia  leads  to  the  assumption  that  a 
productive  neuronal  infection  occurs  during  the  acute  phase 
of  the  infection  (Cook  and  Stevens,  1973).  Supporting  this 
and  the  assumption  that  HSV  travels  centripetally  along  the 
axon,  is  the  observation  of  the  presence  of  virions  in 
neuronal  bodies  and  axons  several  days  after  infection 
(Wildy,  1967;  Hill  et  al.,  1972;  Cook  and  Stevens,  1973; 
Knotts  et  al.,  1974;  Kristensson  et  al.,  1974,1978). 
Moreover,  the  presence  of  viral  mRNA  in  the  ganglia  during 
the  acute  phase  of  infection  has  also  been  demonstrated 
indicating  a  productive  infection  (Puga  et  al.,  1978). 
However,  the  viral  RNA:  DNA  ratio  suggests  that  either  virus 
DNA  replication  was  limited  to  only  a  few  genomes  or  the 
lytic  cycle  was  arrested  during  an  early  stage  of  infection. 
In  addition,  topical  treatment  of  the  inoculation  site  with 
2%  phosphonoacetic  acid  (PAA)  resulted  in  suppression  of 
virus  multiplication  at  the  site  of  inoculation  with 50 
subsequent  drop  of  virus  titre  in  corresponding  ganglia 
(Klein  and  Destefano,  1981).  This  indicated  that  local 
antiviral  treatment  could  reduce  the  viral  titre  in  ganglia 
by  halting  the  continuous  virus  supply  from  the  site  of 
primary  infection.  However,  the  possibility  that  productive 
ganglionic  infection  may  occur  to  a  limited  extent  has  not 
been  totally  excluded.  On  the  other  hand  good  evidence  has 
indicated  that  a  productive  infection  is  not  necessary  for 
the  establishment  of  latent  infection  in  neurones  or 
ganglia.  Using  HSV-1  temperature-sensitive  mutants,  Lofgren 
et  al.  (1977)  showed  that  there  is  no  apparent  relationship 
between  the  capacity  of  the  mutant  to  induce  encephalitis 
and  the  subsequent  establishment  of  latent  infection  in 
brains  of  mice.  Similarly,  McLennan  and  Darby  (1980)  have 
concluded  that  there  is  no  absolute  requirement  for  a 
productive  infection  during  the  establishment  of  latency  in 
the  neurone.  Furthermore,  it  has  been  shown  that  acyclovir 
resistant  (ACVr)  mutants  can  establish  acute  but  not  latent 
infections  in  trigeminal  ganglia  of  mice  (Klein  et  al., 
1980). 
Virus  Pathway  to  the  Nervous  System 
The  intra-axonal  transport  of  herpesvirus  was  proposed 
in  the  early  years  of  this  century  (Goodpasture,  1929). 
Four  alternative  routes  have  been  suggested,  namely,  virus 
travels  within  the  periaxonal  (extracellular)  spaces 
(Payling  Wright,  1953);  virus  travels  by  multiplying  in 
Schwann  cells  in  a  stepping-stone  fashion  along  the  nerve 
fibres  (Johnson,  1964);  virus  travels  through  lymphatics  or 
as  a  viraemia  (Field,  1952).  Evidence  against  the 
possibility  that  the  virus  travels  through  periaxonal  spaces 
or  by  multiplication  in  supporting  (Schwann)  cells,  is 51 
provided  by  the  demonstration  of  virus  first  in  the  ganglia 
and  spinal  cord  and  only  afterwards  in  the  sciatic  nerve 
(Wildy,  1967;  Kristensson  et  al.,  1971;  Cook  and  Stevens, 
1973).  Moreover,  virus  titres  were  consistently  higher  in 
ganglia  than  in  the  sciatic  nerve  (Cook  and  Stevens,  1973; 
Klein,  1982).  In  addition,  viruses  were  almost  never  seen 
to  be  free  in  the  extracellular  space  and  were  only  rarely 
seen  in  supporting  cells.  On  the  contrary,  intact  virions 
were  observed  within  the  axoplasm,  though  it  is  not  possible 
to  be  certain  that  the  particles  observed  are  the  effective 
virions. 
The  failure  to  detect  HSV  virus  in  the  distal  and 
proximal  sections  of  the  sciatic  nerves  (during  the  first  2 
days  p.  i.  )  and  the  fact  that  HSV  is  first  detected  in  the 
ganglia  and  only  afterwards  in  nerves,  suggested  an 
alternative  (haematogenous  or  lymphatic)  route  may  be 
involved  in  the  dissemination  of  virus  to  the  nervous 
system.  Cook  and  Stevens  (1973)  have  tentatively  concluded 
that  since  HSV  infection  progresses  (i.  e.  the  development  of 
lesions  in  the  nervous  system)  despite  the  presence  of 
significant  levels  of  neutralizing  antibody  (passive 
administration  of  anti-viral  sera),  blood  and  lymph  vessels 
are  not  involved  in  the  transport  of  virus  to  ganglia. 
However,  following  the  inoculation  of  the  virus  in  the 
footpad  of  guinea  pigs,  HSV-2  has  been  regularly  found  in 
the  regional  lymph  nodes  by  the  second  day  p.  i.  (Scriba  and 
Tatesber,  1981).  Some  other  studies  (Kristensson  et  al., 
1971;  Knotts  et  al.,  1974;  Renis  et  al.,  1976;  Kristensson 
et  al.,  1978)  also  reported  the  absence  of  herpes  simplex 
virus  in  blood  following  corneal,  footpad,  intravaginal  or 
intraperitoneal  inoculation.  But  HSV  has  been  detected  in 52 
the  blood  of  newborn  and  adult  mice  following  footpad 
(Wildy,  1967;  Lascano  and  Berria,  1980;  Klein,  1982)  or 
intranasal  inoculation  of  newborn  mice  (Kern  et  al.,  1975). 
It  is  not  known  whether  virus  invades  the  nervous  system 
subsequent  to  viraemia  or  whether  viraemia  is  due  to  virus 
spill  over  from  the  peripheral  nervous  tissues.  Direct 
evidence  for  the  possible  involvement  of  the  circulatory 
system  is  the  demonstration  that  HSV-1  selectively 
establishes  latent  infection  in  mouse  neural  tissue, 
particularly  the  sensory  ganglia,  after  intravenous 
inoculation.  This  was  shown  conclusively  when  (tail  vein) 
inoculation  was  immediately  followed  by  tail  amputation  at 
2.5  cm  proximal  to  the  injection  site  (Cook,  and  Stevens, 
1976).  It  is  possible  that  nervous  tissue  may  not  be 
infected  directly  by  virus  in  the  blood  stream,  but 
indirectly  by  virus  travelling  in  the  nerves  associated  with 
vessels  or  other  organs  that  became  first  infected  through 
viraemia. 
Using  the  PAP  method  (peroxidase  antiperoxidase)  to 
trace  viral  antigen,  Lascano  and  Berria  (1980)  reported 
evidence  that  supports  the  mixed  route  for  the  neural 
transport  of  HSV-1  in  newborn  mice.  This  study  suggested 
that  the  neural  transport  of  HSV  depends  on  more  than  one 
mechanism:  a.  cell-to-cell  active  transport  (Schwann  and 
connective  tissue  cells  of  the  sciatic  nerve)  b,  passive 
movement  of  the  virions  along  the  intracellular  spaces 
within  the  neural  structures. 
It  is  obvious  that  much  controversy  persists 
concerning  the  mechanism  of  virus  transport.  Another 
approach  (neurectomy)  has  been  used  to  investigate  the 
possible  structures  involved  in  dissemination  of  virus  to 53 
the  nervous  system.  Wildy  (1967)  showed  that  sciatic  nerve 
sectioning  three  days  before  virus  inoculation,  prevented 
HSV  isolation  from  the  spinal  cord  in  80%  of  mice. 
Moreover,  Kristensson  et  al.  (1971)  reported  that  colchicine 
treatment,  ligature  or  freezing  of  sciatic  nerve  0-4  days 
before  virus  inoculation  into  the  footpad  of  mice  reduced 
the  mortality  rate  to  10%  compared  to  100%  if  the  treatment 
was  carried  out  after  inoculation.  In  neither  of  the  above 
reports  were  attempts  made  to  recover  the  virus  from 
ganglia.  Total  surgical  section  of  the  sciatic  and  femoral 
nerves  completely  prevented  the  establishment  of  latent  HSV 
infection  in  sensory  ganglia  of  guinea-pigs  inoculated  into 
the  footpad  (Scriba,  1981).  Similar  experiments  in  the 
mouse  (Klein,  1982)  revealed  that  establishment  of  acute 
infection  in  spinal  ganglia  was  prevented  by  section  of  both 
femoral  and  sciatic  nerves  in  about  80%  of  mice.  Free 
virus,  however,  was  regularly  demonstrated  on  the  4th  and 
7th  day  after  infection  in  spinal  ganglia  of  mice  in  which 
either  the  sciatic  or  femoral  nerves  were  severed.  Further 
evidence  supporting  the  axonal  transport  hypothesis  has  come 
from  the  in  vitro  study  of  attachment  of  HSV  to  rabbit  and 
rat  astrocytic  glia,  neuronal  perikarya  and  (nerve 
terminals)  synaptosomal  fractions  (Vahlne  et  al.,  1978). 
HSV  preferentially  adsorbs  to  the  synaptosome  fraction 
rather  than  neuronal  perikarya.  However,  it  remains  unclear 
whether  this  difference  in  virus  attachment  was  due  to  the 
presence  of  specific  HSV  receptors  on  the  synaptosomes  or 
merely  reflected  a  high  endocytic  activity  of  the 
synaptosomes. 
Another  observation  is  the  rate  of  HSV  translocation 
from  the  skin  to  the  ganglia  which  has  been  reported  to  be 54 
in  agreement  with  the  rate  of  movement  of  macromolecules  and 
organelles  by  retrograde  axonal  transport  (Cook  and  Stevens, 
1973;  Kristensson  et  al.,  1974,1978). 
In  conclusion,  it  seems  that  axonal  transport  is  the 
most  important  method  of  virus  translocation,  though  the 
virus  may  also  travel  by  other  routes.  Irrespective  of  the 
way  virus  travels  to  the  nervous  system,  the  subsequent 
result  is  almost  always  the  establishment  of  latent 
infection. 
Latent  Phase  of  the  Infection 
Establishment 
After  the  initial  increase,  the  amount  of  detectable 
HSV  in  cell  free  ganglion  homogenates  decreases  gradually; 
within  14  days  p.  i.  virus  can  no  longer  be  detected  in 
homogenates,  but  HSV  can  still  be  recovered  by  explantation 
or  cocultivation  of  ganglia.  At  this  point  the  acute  phase 
is  terminated  and  the  latent  phase  of  the  infection  begins 
(Openshaw  et  al.,  1979a;  Sekizawa  et  al.,  1980;  Klein, 
1982).  The  transition  from  the  'acute'  to  the  'latent' 
phase  of  infection,  coincides  with  the  appearance  of  immune 
responses,  particularly  high  levels  of  antibodies.  It  has 
been  proposed  that  immune  factor(s)  play  a  major  role  in  the 
switch  from  the  acute  to  the  latent  phase  of  infection 
(Openshaw  et  al.,  1979a;  Sekizawa  et  al.,  1980;  Openshaw  et 
al.,  1981),  though  the  mechanism  by  which  these  immune 
responses  could  produce  the  transition  from  the  acute  to  the 
latent  state  of  infection  is  not  clear.  Some  hypothetical 
models  (Openshaw  et  al.,  1981)  have  been  proposed  (Fig.  9): 
1,  The  immune  modulation  model;  this  assumes  that  ganglion 
cells  are  permissive  but  the  immune  response  modulates  the 
infection  at  the  level  of  the  ganglion,  converting  a FIGURE  9a 
IMMUNE  ELIMINATION  MODEL  FOR  ESTABLISHMENT  OF  LATENCY 
There  are  two  populations  of  ganglion  cells,  one 
permissive  and  the  other  non-permissive  for  HSV  replication. 
1.  latent  infection  is  established  in  non-permissive  cells 
while  a  productive  infection  develops  in  permissive 
cells 
2.  immune  response  aids  in  eliminating  the  productively 
infected  cells  leaving  the  latently  infected  cells 
intact 
FIGURE  9b 
NON-PERMISSIVE  MODEL  FOR  LATENCY  AND  REACTIVATION 
1.  ganglion  cells  are  primarly  non-permissive  for  HSV 
replication.  Replication  of  virus  at  the  skin  and/or 
the  ensuing  inflammation,  directly  or  indirectly, 
provides  a  signal  (stimulus)  that  makes  the  ganglion 
cells  permissive  for  HSV 
2.  during  the  course  of  the  natural  infection,  the  host's 
immune  response  shuts  off  this  signal  by  decreasing 
replication  of  the  virus  at  the  epithelial  surface. 
This  puts  ganglion  cells  back  to  the  non-permissive 
state  and  latency  ensues 
3.  reactivation  occurs  when  any  non-viral  stimulant,  e.  g. 
trauma,  provides  a  signal  at  the  epithelial  site 
innervated  by  the  latently  infected  ganglion  cell.  This 
makes  the  non-permissive  ganglion  cell  once  again 
permissive  for  HSV  replication 
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potentially  lytic  infection  into  non-lytic  or  latent 
infection  (i.  e.  the  immune  response  plays  an  active  role  in 
establishing  latency).  2,  The  immune  elimination  model, 
(Fig.  9a)  where  there  are  two  populations  of  ganglion  cells: 
permissive  and  nonpermissive.  A  productive  HSV  infection 
occurs  in  the  permissive  cells  and  a  non  lytic  or  latent 
infection  occurs  in  the  nonpermissive  cells.  The  host 
immune  response  strictly  has  nothing  to  do  with  the 
establishment  of  latency,  but  just  eliminates  only  acutely 
infected  cells.  3,  The  third  model  (Fig.  9b)  assumes,  that 
ganglion  cells  are  ordinarily  nonpermissive  for  HSV 
replication,  however  they  become  permissive  after  receiving 
signals  (induced  by  the  inflammatory  reaction  in  the  skin 
due  to  virus  replication).  The  host  immune  response  then 
turns  off  these  signals  by  decreasing  virus  replication  in 
the  skin,  returning  ganglion  cells  to  the  nonpermissive 
state  hence  latency  is  established.  The  above  three  models, 
rely  solely  on  immune  mechanisms  to  account  for  the 
transition  from  the  acute  to  the  latent  state  of  infection. 
Another  model  has  been  proposed  by  Klein  (1982)  which 
assumes  that  ganglion  cells  are  nonpermissive;  colonization 
of  the  ganglia  is  achieved  by  continuous  virus  supply  from 
the  site  of  primary  infection.  Immune  responses  restrict 
virus  replication  in  mucocutaneous  tissue.  It  is  suggested 
that  the  majority  of  virions  in  neurones  are  inactivated  by 
cellular  enzymes  and  only  a  minority  will  be  in  a  latent 
form  in  cellular  structures  (Fig.  10). 
It  must  be  emphasized,  that  the  above  models  are 
merely  hypothetical  and  there  is  no  hard  evidence  to  support 
them.  Besides,  the  models  do  not  consider  the  possible 
establishment  of  latent  infection  in  tissues  other  than FIGURE  10 
HYPOTHETICAL  MODEL  FOR  THE  TRANSITION  FROM  THE  ACUTE 
TO  THE  LATENT  PHASE  OF  HSV  INFECTION 
a)  virus  replicates  in  the  skin  then  migrates  to  the 
corresponding  ganglion  (neurone) 
b)  development  of  immune  responses,  followed  by 
neutralisation  of  virus  in  the  skin  which  ends  the 
process  of  virus  migration 
c)  virus  is  eliminated  from  the  skin.  Immune  and/or  other 
mechanisms  eliminate  the  majority  of  virus  from 
neurones.  A  few  virions  remain  latent  within  the  cell 
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ganglion  cells. 
Maintenance 
The  factors  involved  in  maintenance  of  HSV  latency 
have  not  been  fully  demonstrated  and  no  settled  conclusions 
have  been  achieved  yet.  Stevens  and  Cook  (1974)  claimed 
that  passive  administration  of  anti-HSV  IgG  prevented 
reactivations;  latently  infected  ganglia  were  less  likely  to 
reactivate  when  implanted  (in  a  Millipore  chamber)  within 
the  peritoneal  cavity  of  immune  mice  than  in  non  immune 
mice.  However,  this  study  did  not  distinguish  between  a 
direct  effect  of  antibody  on  the  reactivation  process  and  a 
reduction  in  the  ability  of  reactivated  virus  to 
subsequently  replicate.  Studies  with  immunised  and  nude 
mice  showed  that  the  immunological  status  of  the  host  is  one 
of  the  factors  that  controls  the  number  of  cells  in  ganglia 
that  become  infected  (Walz  et  al.,  1976).  However,  in  vitro 
studies  (Openshaw  et  al.,  1979;  Wohlenberg  et  al.,  1979) 
revealed  that  neither  antibody  nor  interferon  treatment 
prevented  reactivation.  Furthermore,  Sekizawa  and 
co-workers  (1980)  were  able  to  establish  latent  HSV 
infection  in  mice  passively  immunized  with  rabbit  anti-HSV 
serum  administered  at  various  times  post  infection.  A  few 
months  later,  neutralizing  antibody  was  undetectable  in 
passively  immunized  mice  which  remained  latently  infected 
(i.  e.  ganglionic  homogenates  were  negative  but  ganglionic 
explants  yielded  virus).  Persistence  of  virus  in  the 
absence  of  neutralizing  antibody  suggests  that  once  latency 
is  established,  serum  neutralizing  antibody  does  not  appear 
to  be  required  to  maintain  the  latent  state  (Openshaw  et 
al.,  1981).  However,  a  role  for  non  neutralizing  antibodies 
has  not  been  excluded  (Nash,  1981).  Furthermore,  anti-HSV 57 
antibody  found  in  cerebrospinal  fluid  (CSF)  of  acutely 
infected  mice  was  probably  not  from  the  serum  but  possibly 
produced  locally  (Kastrukoff  et  al.,  1981).  Although  the 
immune  responses  are  thought  to  play  a  role,  some  other 
determining  factors  have  been  suggested  as  being  involved  in 
the  prolonged  maintenance  of  latent  herpes  simplex  virus 
infection  in  sensory  ganglia  (Klein,  1982)  of  infected 
individuals:  - 
i)  The  number  of  latently  infected  neurones  after 
termination  of  the  acute  phase. 
ii)  The  number  of  neurones  involved  during  each 
reactivation  event. 
iii)  The  fate  of  neurones  after  reactivation. 
iv)  The  possibility  of  infecting  new  sets  of  neurones 
after  each  recurrent  episode. 
A  schematic  illustration  of  the  above  possibilities  is 
presented  in  Figure  11. 
An  independent  estimate  of  the  total  number  of  cells 
in  the  mouse  trigeminal  ganglion  is  not  available,  and  the 
ratio  of  nonneuronal  to  neuronal  cells  is  also  unknown. 
However,  the  number  of  neurones  in  the  trigeminal  ganglion 
of  man,  cats  and  rats  range  from  50,000  to  124,000  with  an 
estimated  nonneuronal:  neuronal  ratio  of  10-20  to  1  (Puga  et 
al.,  1978).  Based  on  their  relative  numbers  in  the  above 
species,  the  total  number  of  cells  in  the  mouse  trigeminal 
ganglion  was  estimated  as  about  8x105,  with  an  average  of 
104  to  2x104  neuronal  cells  per  ganglion  (Puga  et  al., 
1978;  Klein,  1982).  If  these  figures  are  correct,  then  the 
estimate  of  the  percentage  of  latently  infected  cells  (by 
infectious  center  assay)  in  mouse  trigeminal  ganglia  as  0.1% 
(10  to  20  neurones)  is  probably  an  underestimate  (Walz  et FIGURE  11 
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al.,  1976),  due  to  possible  loss  of  cells  during  physical 
manipulation  and  also  because  of  the  potentially  low  plating 
efficiency  of  infected  cells.  The  proportion  of  latently 
infected  neurones  in  the  human  has  been  assumed  to  range 
between  0.1  and  10  percent,  i.  e.  150-15,000  latently 
infected  neurones  in  each  trigeminal  ganglion  (Klein,  1982). 
The  number  of  neurones  in  which  reactivation  takes  place 
during  each  recurrent  episode  is  unknown.  However, 
experiments  in  which  ganglia  from  latently  infected  mice 
(with  HSV-1  wt  and  is  mutants)  were  excised  2  weeks  after 
neurosurgery  and  then  reactivated  in  vitro,  have  revealed  a 
signficant  reduction  in  the  total  number  of  resulting  foci 
(McLennan  and  Darby,  1980).  Moreover,  the  virus  produced  on 
culture  of  positive  ganglia  (of  surgically  manipulated  mice) 
was  significantly  less  than  that  generated  in  the  controls. 
This  would  suggest  that  virus  reactivation  occurs  in  most  or 
all  latently  infected  neurones  and  that  the  consequence  of 
reactivation  is  destruction  of  latently  infected  cells 
(neurones).  However,  the  possibility  that  latency 
disappears  (due  to  virus  reactivation)  only  from  those 
ganglia  in  which  few  neurones  have  been  latently  infected 
has  not  been  excluded.  Supporting  this  argument  is  the 
observation  that  virus  can  still  be  detected  in  25% 
(McLennan  and  Darby,  1980)  and  in  32-62%  (Klein,  1982)  of 
ganglia  after  neurectomy.  Furthermore,  since  preliminary 
data  suggest  that  there  is  a  relationship  between  the 
frequency  of  persistent  infections  after  neurectomy  and 
virus  dose  used  in  primary  infection,  it  seems  possible  that 
ganglia  in  which  large  numbers  of  neurones  were  latently 
infected  can  continue  to  shed  virus  even  after  neurectomy. 
It  has  been  proposed  that  the  productive  replication 59 
which  follows  activation  of  latent  virus  in  the  neurones 
leads  to  the  death  of  that  cell.  Supporting  this 
interpretation  is  the  strong  immunofluorescence  observed  in 
ganglion  cells  (neurones)  following  HSV  reactivation 
(McLennan  and  Darby,  1980).  Moreover,  electron  microscopic 
study  revealed  active  virus  synthesis  in  neurones  of 
latently  infected  ganglia  (rabbit  trigeminal  ganglia) 
maintained  in  culture  (Barringer  and  Swoveland,  1974). 
However,  in  man,  on  the  basis  of  clinical  data,  it  is  not 
clear  whether  the  neurone  is  necessarily  destroyed  after  an 
HSV  reactivation  episode  and  whether  the  latent  virus  may 
disappear  from  the  cell  after  reactivation. 
Klein  (1976)  has  proposed  two  mechanisms,  viz, 
"one-way"  transmission  and  the  "round-trip".  In  both 
mechanisms  it  is  assumed  that  the  neurone  is  not  destroyed 
and  reactivation  occurs  in  all  latently  infected  neurones. 
The  "one-way"  trip  proposed  that  the  number  of  latently 
infected  neurones  is  fixed,  and  the  virus  is  reactivated 
from  the  neurone,  travels  to  the  skin.  However,  the 
information  for  renewed  recurrence  is  never  lost  from 
latently  infected  neurones.  The  "round-trip"  proposed  that 
infection  of  a  new  set  of  neurones  is  possible.  After 
reactivation,  some  virions  escape  the  elimination  process  at 
the  neuronal  level,  and  travel  to  the  skin  where  they 
produce  lesions.  Then  virus  synthesized  in  the  skin  will 
migrate  toward  the  neurone  and  re-establish  a  latent 
infection.  Neither  of  these  mechanisms  has  been  proven  or 
rejected;  nevertheless  since  the  reduction  in  frequency  of 
latent  foci  was  seen  in  mice  infected  with  the  most 
pathogenic  HSV-1  strain  (SC16"  virus,  Hill  et  al.,  1975),  it 
would  seem  unlikely  that  latency  is  re-established  by  spread 60 
of  reactivated  virus  within  the  ganglion  (McLennan  and 
Darby,  1980). 
Virus  State  During  Latency 
Two  hypotheses  have  been  proposed  by  Roizman  (1965), 
namely  the  "static-state"  hypothesis  which  proposes  that 
certain  (virogenic)  cells  are  capable  of  sheltering  a 
non-replicating  HSV  or  its  genome  between  recurrent  attacks; 
and  the  "dynamic  state"  hypothesis,  where  latent  virus 
appears  to  be  multiplying  in  a  very  slow  fashion  resulting 
in  a  chronic  subclinical  infection.  Supporting  evidence  to 
the  latter  hypothesis,  is  the  isolation  of  both  HSV-1 
(Buddingh  et  al.,  1953;  Lindgren  et  al.,  1968;  Douglas  and 
Couch,  1970)  and  HSV-2  (Jeansson  and  Molin,  1970;  Centifanto 
et  al.,  1971,1972;  Masukawa  et  al.,  1972)  from  apparently 
healthy  individuals  during  the  quiescent,  stage  of  infection. 
Moreover,  Kaufman  et  al.  (1967,1968)  were  able  to  isolate 
HSV  from  lachrymal  glands  of  rabbits  and  from  tears  of 
humans.  Furthermore,  in  vitro  studies  where  persistent 
infection  has  been  established  in  cell  cultures,  revealed 
cycles  of  cell  destruction  followed  by  periods  of  cellular 
recovery  and  repopulation  (Hampar  and  Burrough,  1969;  Nii, 
1969,1970).  Those  studies  and  those  of  others  (Hampar  and 
Keehn,  1967)  underlined  the  role  of  the  antibody  and  of 
genetically  determined  factors  in  the  maintenance  of  the 
dynamic  state  of  virus-cell  interaction.  On  the  other  hand, 
nonspecific  or  specific  factors  may  be  involved  in 
preventing  the  initiation  and  maintenance  of  virus 
multiplication  (i.  e.  static  state).  It  has  been  suggested 
(Roizman,  1965)  that  virus  infected  cells  may  specifically 
produce  a  substance  (possibly  interferon  or  some  other 
product)  that  inhibits  virus  replication.  It  has  also  been 61 
reported  that  extracts  from  Burkitt's  lymphoma  (Rabson  et 
al.,  1971)  and  from  hamster  cells  transformed  by  HSV-2 
(Doller  and  Duff,  1974)  can  inhibit  the  replication  of 
herpes  simplex  virus.  More  evidence,  supporting  the 
static-state  hypothesis  is  the  demonstration  of  the  presence 
of  infectious  HSV  virus  in  ganglia  of  latently  infected  mice 
and  rabbits,  but  only  after  placing  the  ganglia  in  organ 
culture  (Stevens  and  Cook,  1971,1973).  Furthermore,  in 
vitro  studies  (O'Neill  et  al.,  1972)  where  persistent  HSV-2 
infection  was  established  in  HEL  cells  in  the  presence  of 
ara-c,  revealed  that  some  cells  contained  HSV-2  in  a  non 
infectious  form  during  the  latent  period  (the  period  between 
the  disappearance  and  subsequent  reappearance  of  the  virus). 
However,  infectious  HSV-2  reappeared  several  days  after  the 
removal  of  the  inhibitors.  Hence,  following  the  prevention 
of  synthesis  of  detectable  infectious  virus  (by  the 
inhibitors),  HSV  remains  stable  and  is  not  degraded  by  the 
host  cell  (O'Neill  et  al.,  1972). 
The  form  HSV  assumes  while  in  a  non  replicating  stage 
is  unknown.  However,  the  virus  may  possibly  exist  as  a, 
complete  virion  present  within  a  cell;  b,  incompletely 
assembled  virions;  c,  nucleoprotein;  d,  solely  as  nucleic 
acid;  e,  nucleic  acid  with  limited  transcription  and  gene 
expression.  No  direct  evidence  is  available  favouring  any 
one  of  the  above  possibilities  as  far  as  HSV  is  concerned. 
If  the  virion  really  exists  as  such  and 
ifully  infective 
within  the  cells,  it  should  have  been  detected  by 
homogenisation  experiments  or  by  hybridisation  studies.  If 
one  assumes  that  virus  exists  as  nucleic  acid,  it  would  be 
important  to  find  out  whether  it  exists  in  an  integrated 
state  (covalently  linked  to  the  host  chromosomal  DNA)  or  in 62 
a  nonintegrated  state,  i.  e.  possibly  as  an  episomal  factor 
(Docherty  and  Chopan,  1974).  Strong  evidence  has  been 
provided  for  the  existence  of  the  Epstein-Barr  virus  (EBV) 
genome  within  the  nucleus  of  "virus-free"  malignant  lymphoma 
cells  (Nonoyama  and  Pagano,  1972;  Lindahl  et  al.,  1976). 
But  there  are  important  differences  between  EBV  and  HSV 
induced  infections,  as  the  viruses  interact  with  two 
different  cell  types  (i.  e.  B-lymphocytes  and  neurones) 
within  the  individual  host  and  as  EBV  "latent"  infection  has 
not  been  defined  yet.  Moreover,  it  seems  unnecessary  for 
the  HSV  genome  to  be  integrated  into  the  host  cell  since 
neurones  do  not  divide  (Fenner  et  al.,  1974). 
Reactivation 
At  any  time  following  the  establishment  of  latency, 
virus  may  be  released  spontaneously  or  as  a  result  of 
particular  stimuli  so  that  infectious  virus  can  be 
reisolated  -  this  is  called  reactivation.  Following 
reactivation,  the  released  virus  may  produce  observable 
lesions  (recrudescent  lesions)  in  the  dermatome  relating  to 
the  sensory  ganglion,  or  alternatively  the  virus  travels  to 
the  periphery,  (where  it  probably  multiplies  and  can  be 
isolated)  without  the  development  of  a  noticeable  lesion, 
this  is  called  recurrence  (Wildy  et  al.,  1982).  A  third 
possible  type  of  reactivation  (in  addition  to  the  above)  is 
that  the  virus  reactivates  in  the  ganglion  only  (Fig.  12) 
without  subsequent  shedding  or  lesion  development  (Klein, 
1982).  Spontaneous  reactivation  of  HSV  has  been  reported  in 
the  rabbit  eye  (Nesburn  et  al.,  1967)  and  in  brain  (Perdrau, 
1938). 
Various  physical  and  chemical  methods  have  been  used 
to  induce  reactivation.  Good  and  Campbell  (1948)  were  able FIGURE  12 
LEVELS  AT  WHICH  REACTIVATION  OF 
LATENT  HSV  IN  HUMAN  TRIGEMINAL  GANGLION  CAN  OCCUR 
1.  virus  reactivation  in  the  trigeminal  ganglion  only  (?  ). 
No  virus  shedding  and  no  lesions. 
2.  virus  reactivation  in  ganglion  followed  by  shedding, 
e.  g.  in  tears,  no  lesions. 
3.  virus  reactivation  in  ganglion  and  multiplication  of 
virus  in  the  skin;  recurrent  herpes 63 
to  reactivate  HSV  in  rabbit  brain  (with  subsequent 
development  of  encephalitis)  by  subjecting  the  latently 
infected  rabbits  to  anaphylactic  shock  (by  intravenous 
injection  of  0.2  to  0.6  cc  of  egg  white),  or  by  the 
injection  of  synthetic  adrenaline  (Schmidt  and  Rasmussen, 
1960)  intramuscularly  with  a  total  dosage  of  2.0  mg. 
Electrical  stimulation  of  the  trigeminal  ganglion  has  been 
described  as  inducing  in  vivo  reactivation  of  HSV  in 
rabbits,  where  the  reactivated  virus  can  be  detected  in  the 
tear  film  (Green  et  al.,  1981).  Epinephrine  iontophoresis 
to  the  cornea  has  also  been  used  to  induce  reactivation 
(Hill  et  al.,  1982).  Attempts  to  induce  reactivation  of  HSV 
by  artificially  induced  fever,  or  by  injection  of  cortisone 
(Schmidt  and  Rasmussen,  1960;  Stevens  and  Cook,  1973),  or 
adrenalin,  or  immunosuppressive  agents  (cyclophosphamide), 
or  irradiation  or  implantation  of  tumour  cells  were  not 
successful.  However,  intratracheal  infection  of  the  animal 
with  pneumococci  resulted  in  virus  reactivation  (Stevens  and 
Cook,  1973).  Contrary  to  these  reports,  reactivation  of 
HSV-1  (Sekizawa  et  al.,  1980)  and  HSV-2  Murata  et  al., 
1978)  has  been  successfully  achieved  in  mice  (inoculated  by 
lip  or  by  the  corneal  route)  by  the  use  of  cyclophosphamide. 
Moreover,  reactivation  has  been  precipitated  by  burning  with 
CO2  (Openshaw  et  al.,  1979b),  hair  plucking  (Hurd  and 
Robinson,  1976),  U.  V.  and  X-ray  treatment  (Blyth  et  al., 
1976;  Openshaw  et  al.,  1979b;  Harbour  et  al.,  1983a) 
sellotape  stripping  (Hill  et  al.,  1978),  and  application  of 
xylene,  retinoic  acid,  and  dimethylsulphoxide  (Harbour  et 
al.,  1983a).  Furthermore,  virus  reactivation  has  been 
induced  in  spinal  ganglia  of  mice  after  nerve  sectioning 
(Walz  et  al.,  1974;  Price  and  Schmitz,  1978;  McLennan  and 64 
Darby,  1980;  Klein,  1982).  In  general,  four  types  of 
stimuli  have  been  shown  to  induce  in  vivo  reactivation 
(Table  5);  however,  no  common  path  can  be  recognized  for  the 
listed  stimuli  and  it  is  not  known  whether  these 
reactivation  positive  stimuli  act  directly  on  the  latent 
virus  or  through  a  mediator,  or  whether  they  only  promote 
the  development  of  recurrent  lesions  by  virus  already 
reactivated. 
Two  theories  have  been  proposed  in  an  attempt  to 
explain  the  complexity  of  the  reactivation  process.  The 
first  theory  was  called  the  "Ganglion  Trigger"  theory  by 
Hill  and  Blyth  (1976)  to  distinguish  it  from  their  theory, 
the  "Skin  Trigger"  theory.  The  ganglion  trigger  theory 
(Fig.  13a)  proposed  that  a  stimulus  acts  on  latent  infection 
in  the  ganglion  to  "switch  on"  virus  from  the  latent  state, 
virus  then  travels  down  to  the  peripheral  nerve,  and 
epidermal  cells  are  infected  so  that  a  skin  lesion  develops 
(Cook  and  Stevens,  1973;  Merigan,  1974;  Lehner  et  al., 
1975).  The  theory  is  widely  accepted,  however,  it  does  not 
explain  (at  least  in  man)  the  development  of  a  lesion  a 
relatively  short  time  after  stimulation  or  injury,  or  how 
certain  stimuli  like  exposure  of  surface  skin  to  U.  V.  light 
can  affect  virus  latent  in  the  ganglion.  Moreover, 
reactivation  of  virus  in  ganglia  does  not  automatically 
produce  recurrent  disease  (Hill  and  Blyth,  1976).  On  the 
other  hand,  the  skin  trigger  theory  (Fig.  13b)  assumes  that 
a  reactivating  stimulus  acts  on  virus  in  the  skin  rather 
than  in  the  ganglion.  This  postulates  that  virus  is  often 
produced  in  the  ganglion  and  as  a  result  reaches  the  skin 
cells  via  a  nerve  perhaps  every  few  days,  then  microfoci  of 
infection  develop  which  are  usually  eliminated  by  host .P  W  N 
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defence  mechanisms;  most  of  these  infections  may  be 
abortive.  Changes  in  the  skin  occasionally  allow  these 
microfoci  to  grow  into  visible  lesions  either  by  stimulating 
virus  replication  or  by  temporary  suppression  of  local 
defence  (Hill  and  Blyth,  1976).  The  theory  explains  that 
inducing  agents,  e.  g.  U.  V.  light  and  trauma  do  not  act 
directly  upon  latent  virus  in  the  ganglion,  instead  the 
stimuli  induce  some  physiological  changes  (inflammation)  in 
the  skin  which  provoke  the  development  of  lesions.  Among 
the  local  changes  that  may  be  induced  in  the  skin  after 
exposure  to  U.  V.  light  is  the  release  of  prostaglandin 
(Eaglstein  and  Weinstein,  1975)  particularly  prostaglandin 
E2  (PGE2).  It  has  been  shown  that  HSV  can  be  reactivated  by 
injecting  PGE2  into  the  original  site  (ear  skin)  of 
infection  in  mice.  Moreover  the  effect  of  prostaglandin  was 
similar  to  the  virus  inducing  effect  of  U.  V.  light,  as  the 
virus  appeared  in  the  skin  in  20-30%  of  mice  2-3  days  after 
even  a  single  intradermal  injection  of  PGE2  (Blyth  et  al., 
1976).  Supporting  the  assumption  that  PGE  plays  a  major 
role,  is  the  observation  that  PGE2  and  PGF2  increase  the 
size  of  HSV  plaques  produced  in  Vero  cells;  PGE2  does  not 
enhance  the  growth  of  the  virus  by  increasing  the  amount 
produced  per  cell,  but  by  enabling  the  virus  to  spread  from 
cell  to  cell  more  efficiently  (Harbour  et  al.,  1978). 
Furthermore,  inhibitors  of  prostaglandin  synthesis 
(mefenamic  acid  and  indomethacin)  decrease  plaque  size  and 
inhibit  the  growth  of  virus  inoculated  at  low  multiplicity 
of  infection.  Such  inhibition  can  be  partially  reversed  by 
adding  PGE2.  Recently,  Harbour  and  co-workers  (1983)  have 
shown  that  in  the  absence  of  serum,  -both  PGE2  and  PGF2 
increase  the  adhesion  between  cells  infected  with  HSV-1  and 66 
uninfected  cells.  In  addition,  prostaglandin  treatment  did 
not  induce  polykaryocyte  formation  in  culture  infected  with 
wild  type  virus.  This  observation  supports  the  early 
suggestion  (Harbour  et  al.,  1978)  that  PGs  facilitate 
cell-to-cell  spread  of  virus.  Preliminary  results  indicated 
that  treatment  of  mice  with  indomethacin  decreases  to  a 
great  extent  the  number  of  lesions  induced  by  xylene 
application  (Hill,  1981).  However,  the  skin  trigger  theory 
does  not  explain  the  mechanism  of  action  of  some  inducing 
agents  which  do  not  act  on  the  skin,  e.  g.  stress,  anxiety, 
depression,  menstruation,  fatigue  (Klein,  1982).  A  further 
possibility  is  that  effective  inducers  of  recurrent  disease 
may  produce  changes  both  in  the  skin  and  ganglia  (Fig.  14c). 
Indeed,  using  the  mouse  ear  model  (Fig.  14),  Hill  (1981) 
reported  that  infectious  virus  can  be  found  in  cervical 
ganglia  of  10%  of  latently  infected  mice  1-4  days  after  ear 
stripping  with  sellophane  tape.  Moreover,  increase  in 
uptake  of  3H  thymidine  has  been  noticed  in  cervical  ganglia 
of  normal  mice,  1-2  days  after  ear  stripping  suggesting 
certain  metabolic  changes  in  the  ganglia. 
Neither  the  "ganglion  trigger"  nor  the  "skin  trigger" 
theories  explain  how  the  virus  can  be  reactivated  from 
peripheral  tissue  that  has  no  direct  anatomical  connection 
with  the  dorsal  root  ganglia  (Scriba,  1977).  In  conclusion, 
it  seems  that  recurrence  must  occur  after  reactivation  and 
axonal  transportation  of  the  virus,  and  similarly 
recrudescence  must  follow  recurrence,  though  they  are  not 
necessary  consequences.  Furthermore,  latency  and 
reactivation  in  the  ganglion  seem  to  be  quite  distinct 
phenomena  from  recurrence  or  recrudescence  (Wildy  et  al., 
1982). FIGURE  14 
MOUSE  EAR  MODEL 
I 
Virus  injected  intradermally  in  right  ear. 
Latency  established  in  2nd,  3rd  and  4th  cervical 
ganglia.  Spontaneous  recurrence  of  clinical  disease 
occurs  at  a  rate  of  3.5%. 
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Immunology  of  Latent  HSV  Infection 
The  relationship  of  the  immune  response  to  latent  HSV 
infection  is  not  clearly  defined.  Several  immunological 
agencies  have  been  recognized  to  be  involved  in  the  response 
to  herpes  infection  including:  macrophages  (Zisman  et  al., 
1970;  Morhan  and  Morse,  1979),  cytotoxic  T  cells  (Pfizenmair 
et  al.,  1977;  Sethi  and  Brandis,  1977;  Nash  et  al.,  1980b), 
antibody  dependent  cell  cytotoxicity-ADCC  (Shore  et  al., 
1976),  natural  killer  (NK)  cells  (Ching  and  Lopez,  1979; 
Rager-Zisman  and  Allison,  1980;  Engler  et  al.,  1981), 
delayed  type  hypersensitivity  (Nash  et  al.,  1980a,  1981), 
suppressor  T  and  suppressor  B  cells  (Nash  and  Gell,  1980; 
Engler  et  al.,  1981;  Nash  et  al.,  1981),  interferon  (Gresser 
et  al.,  1976;  Sonnenfeld  and  Merigan,  1979),  antibody  and 
complement  (Burns  et  al.,  1975;  Oldstone  and  Lampert,  1979). 
Humoral  immunity  alone,  has  been  found  of  limited  importance 
both  in  eliminating  acute  infection  at  least  in  nude  mice 
(Openshaw  et  al.,  1979a)  and  in  maintaining  latency 
(Sekizawa  et  al.,  1980).  On  the  other  hand,  cell-mediated 
immunity  (CMI)  has  been  shown  as  an  important  factor  for 
host  protection  against  herpes  infection  (Lodmell  et  al., 
1973;  Oakes,  1975;  Rager-Zisman  and  Allison,  1976)  and  in 
recovery  from  HSV-1  infection  in  mice  (Nagafuga  et  al., 
1979). 
Impaired  CMI  has  been  demonstrated  in  human  patients 
undergoing  recrudescence  (Wilton  et  al.,  1972;  Shillitoe  et 
al.,  1977).  In  support  of  the  importance  of  T  cells  in  the 
maintenance  of  latent  infection  is  the  observation  provided 
by  Kastrukoff  et  al.  (1981).  They  showed  that  in  C3H  mice 
where  CMI  is  acutely  suppressed  (i.  e.  mice  were 
thymectomized  one  month  after  infecting  with  HSV  and  later 68 
irradiated,  then  reconstituted  with  anti-Thy  1.2  hybridoma 
antibody  plus  complement  treated  bone  marrow,  and 
subsequently  given  antilymphocyte  serum)  a  severe  illness 
developed  and  the  virus  was  observed  in  trigeminal  ganglia, 
lip  and  CNS  at  a  time  when  anti  HSV  antibody  was  present. 
Control  (uninfected)  or  chronically  infected  but  sham 
treated  mice  remained  well.  However,  some  mice  in  the 
experimental  group  did  recover,  possibly  due  to  the  action 
of  circulating  antibody. 
Based  on  the  analysis  of  the  results  in  the  mouse  ear 
model  (Nash  and  Gell,  1980;  Nash  et  al.,  1980a,  b,  1981), 
Wildy  and  colleagues  (1982)  have  proposed  that  three  immune 
mechanisms  are  initiated  following  herpes  virus  infection: 
namely  delayed  type  hypersensitivity  (DTH),  cytotoxic  T  cell 
responses  and  neutralizing  antibody.  It  is  believed  (Wildy 
et  al.,  1981)  that  the  three  immune  responses  are  active 
during  the  primary,  recurrence  and  recrudescence  stages  of 
infection,  and  that  T  helper  cells  (Figure  15)  play  a  key 
role  essential  for  the  induction  of  all  three  responses. 
Molecular  Aspects  of  Latent  HSV  Infection 
Neither  the  virus  coded  functions  essential  for 
establishment  and/or  maintenance  of  latent  infection,  nor 
the  mechanisms  that  control  HSV  replication  in  nonpermissive 
cells  are  defined.  The  molecular  events  leading  to 
reactivation  are  totally  unknown. 
Studies  with  is  mutants  of  HSV-l  (Watson  et  al.,  1980; 
Stevens,  1981;  Clements  and  Subak-Sharpe,  1983)  and  of  HSV-2 
(Al-Saadi  et  al.,  1983)  revealed  differences  in  the  capacity 
of  the  mutants  to  establish  latent  infections  in  the  mouse 
brain  and  ganglia.  Comparison  of  latency  phenotype  (i.  e. 
latency  positive  and  latency  negative)  with  the  properties FIGURE  15 
DIAGRAM  ILLUSTRATING  THE  PROPOSED  T-CELL  MECHANISM 
IN  THE  INDUCTION  OF  PROTECTIVE  IMMUNE  RESPONSE  DEFINED  BY 
USING  THE  MOUSE  EAR  MODEL 
Ts,  suppressor  T  cells;  Th,  helper  T  cells;  Tdh, 
delayed  hypersensitivity  T  cells;  Tc,  cytotoxic  T  cells;  pT, 
precursor  T  cells;  mT,  memory  T  cells;  Bs,  suppressor  B 
cells;  B,  activated  B  cells;  pL,  plasma  cells;  MO,  activated 
macrophage;  NK,  natural  killer  cell;  ADCC, 
antibody-dependent  cell  cytotoxicity;  IF,  interferon;  C', 
complement;  VITC,  virus  infected  cell  (neurone  or  epidermal 
skin  cell) 
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of  the  mutants  expressed  under  restrictive  conditions  (Brown 
et  al.,  1973;  Subak-Sharpe  et  al.,  1974;  Marsden  et  al., 
1976;  Stow  et  al.,  1978;  Watson  and  Clements,  1978;  Gerdes 
et  al.,  1979)  led  to  the  following  conclusions:  i,  viral  DNA 
synthesis  (HSV-1  and  HSV-2)  may  be  irrelevant  to  the 
establishment  of  latent  infection,  as  some  DNA+  and  some 
DNA-  mutants  were  equally  able  to  establish  latent 
infection,  while  other  DNA+  and  other  DNA-  mutants  were 
latency  negative  (Watson  et  al.,  1980;  Stevens,  1981; 
Al-Saadi  et  al.,  1983);  ii,  there  is  a  loose  correlation 
between  absence  of  morphologically  identifiable  type  1  viral 
products  in  infected  cells  (neuroblastoma  cells  in  culture; 
neurones  in  brain)  and  the  capacity  to  establish  latent 
infection;  iii,  HSV-genes  essential  to  establish  latent 
infections  are  not  clustered  on  the  physical  and  genetic 
maps  obtained  with  these  mutants;  iv,  and  most  important,  is 
that  one  latency  negative  HSV-1  mutant,  namely  is  K,  has 
been  found  to  involve  the  gene  encoding  the  immediate  early 
polypeptide  Vmw  175  (Preston,  1979)  and  since  other  is 
mutants  (ts  A,  is  I,  is  U,  is  S)  which  are  blocked  beyond 
the  immediate  early  stages  of  the  replication,  are  also 
latency  negative,  it  is  possible  to  conclude  that  at  least 
one  immediate  early  and  one  or  more  later  functioning  virus 
gene  products  are  necessary  for  establishment  and/or 
maintenance  of  the  latent  state  (Watson  et  al.,  1980; 
Stevens,  1981).  Furthermore,  since  is  K  (latency-)  and  is  D 
(latency+  but  in  the  same  gene  as  is  K)  exhibit  little 
leakiness  (i.  e.  replication  in  the  brain)  while  is  I 
(latency-)  and  is  F  (latency+)  are  both  rather  leaky,  it  is 
concluded  that  there  is  no  pattern  relating  latency  to  virus 
replication  (leakiness)  in  mouse  brain.  It  is  important  to 70 
note  that  both  is  I  and  is  K  were  found  to  be  able  to  induce 
latent  infection  in  mice  in  the  dorsal  root  ganglia 
(Clements  and  Subak-Sharpe,  1983)  which  is  in  contrast  to 
the  previous  results  reported  by  Watson  et  al.  (1980). 
However,  different  routes  of  inoculation  and  different  mouse 
strains  were  used  in  each  of  the  studies. 
What  determines  whether  cells  are  permissive  or  non 
permissive  for  HSV  replication  is  not  defined.  However,  it 
is  known  that  replication  of  HSV  in  a  permissive  cell 
requires  the  utilization  of  cellular  enzymes  such  as  RNA 
polymerase  II  for  the  early  transcription  of  viral  DNA 
(Ben-Zeev  and  Becker,  1977).  Other  studies  (Becker,  1981) 
revealed  that  treatment  of  permissive  cells  with  ac-amanitin 
(an  inhibitor  of  RNA  polymerase  II)  or  arginine  depriviation 
(prevention  of  virion  assembly)  leads  to  inhibition  of  the 
synthesis  of  virus  progeny.  Similarly  the  synthesis  of 
defective  interfering  particles  (DI)  may  eventually  block 
the  synthesis  of  infectious  virus  progeny.  It  is  reported 
that  HSV  can  not  replicate  in  cell-cycle  mutants  that  are 
prevented  from  entering  the  S  phase  of  the  cell  cycle 
(Yanagi  et  al.,  1978).  Furthermore,  nonstimulated  T  and  B 
lymphocytes  are  incapable  of  supporting  HSV  replication 
(Kirchner  et  al.,  1977;  Westmoreland,  1978).  In  XC  cells, 
(a  Rous  sarcoma  virus  transformed  rat  cell  line)  HSV 
expresses  only  50%  of  its  genetic  information,  i.  e.  early 
genes  (Padgett  et  al.,  1978)  and  only  viral  thymidine  kinase 
(Docherty  et  al.,  1973;  Garfinkle  and  McAuslan,  1973,1974) 
and  DNA  polymerase  (Becker,  1981)  are  detectable,  whereas 
viral  DNA  synthesis  is  prevented.  However,  none  of  these 
systems  resemble  the  HSV-neurone  cell  interaction. 71 
Virus  and  Host  Factor  in  Latency 
Viruses 
It  is  well  known  that  viruses  differ  in  their 
virulence  for  certain  host  species.  Differences  in  latency 
capacity  between  HSV-l  and  also  between  HSV-2  is  mutants  has 
been  reported  (Zygraich  and  Huygelen,  1973;  Lofgren  et  al., 
1977;  Watson  et  al.,  1980;  Al-Saadi  et  al.,  1983). 
Moreoever,  it  has  been  shown  that  HSV-2  is  mutants  can  be 
recovered  from  the  spleen  (but  not  from  other  tissues)  of 
latently  infected  tree-shrew  (Darai  et  al.,  1980).  It  has 
been  proposed  that  both  highly  virulent  (large  plaque 
producing)  as  well  as  less  virulent  (small  plaque  producing) 
viruses  are  able  to  induce  latent  infection  (Becker,  1981). 
HSV-1  thymidine  kinase  deficient  (TK-)  mutants  which 
multiply  poorly  in  vivo  and  tend  to  be  avirulent,  were  found 
to  induce  latency  in  trigeminal  ganglia  of  mice  (Tenser  and 
Dunstan,  1979;  Field  and  Darby,  1980)  and  guinea  pigs 
(Tenser  et  al.,  1979)  after  corneal  inoculation  but  with 
more  difficulty  (-  106-108  pfu  of  input  virus)  than  the  wt 
viruses  and  their  multiplication  is  often  restricted  in  the 
nervous  system.  In  many  instances,  a  great  difference  is 
noticed  between  the  wt  and  TK-  mutant  latency  capacity 
(Tenser  and  Jones,  1982).  It  is  interesting  that  TK- 
mutants  of  HSV-1  replicate  efficiently  in  actively  growing 
cell  cultures  but  fail  to  replicate  in  non  multiplying  serum 
starved  cells  (Jamieson  et  al.,  1974),  an  observation  which 
suggests  that  HSV  specified  deoxypyrimidine  kinase  activity 
is  essential  for  HSV  replication  under  conditions  where  the 
host  cells  are  not  making  thymidilate.  It  is  likely  that 
cells  initially  invaded  in  natural  infections  by  herpesvirus 
will  have  a  low  level  of  thymidine  metabolism  and  resemble 72 
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resistance  to  primary 
or  reactivated  herpes  virus  infection  has  not  yet  been 
determined.  In  man,  however,  when  the  histocompatibility 
antigen  types  of  260  patients  (who  had  a  clear  history  of 
frequent  circumoral  herpes  infection)  were  compared  with  606 
normal  (control)  subjects,  a  positive  association  between 
the  HLA  antigen  Al  and  the  incidence  of  recrudescent  herpes 
was  observed  (Russell  and  Schlaut,  1977).  A  suggestive 
association  with  antigen  A29  and  B8  was  also  noticed. 
However,  this  association  has  not  been  explained  and  it  is 
not  known  whether  such  individuals  are  susceptible  to 
infection  with  the  virus.  Nevertheless,  the  observation' 
suggests  that  one  factor  that  increases  susceptibility  to 
this  condition  in  man  (recrudesence)  may  be  inherited 
(Russell  and  Schlaut,  1977). 
Other  experimental  studies  (Lopez,  1975)  where  8 
strains  of  HSV-1  were  used,  revealed  that  inbred  strains  of 
mice  differ  in  their  ability  to  resist  infection 
(susceptible  mice  develop  paralysis  and  death)  and  the  mice 
were  categorized  as  resistent  (C57BL/6),  moderately 
susceptible  (BALB/c)  or  very  susceptible  (A/J).  Other 
studies  confirmed  these  differences  (Kirchner  et  al.,  1978). 
It  has  been  concluded  that  these  differences  are  genetically 
determined  and  appear  to  be  mediated  by  natural  killer  cells 
(Lopez,  1980).  Similarly  intraperitoneal  (IP)  inoculation 73 
of  HSV-2  (Mogensen,  1976)  in  a  series  of  inbred  strains  of 
mice  revealed  that  some  strains  of  mice  were  resistent  while 
others  were  susceptible  to  focal  necrotic  hepatitis  caused 
by  the  HSV-2.  Resistance  to  HSV-2  seems  to  be  sex  linked 
(i.  e.  resistance  gene  is  located  on  the  X-chromosome)  and  it 
is  involved  in  macrophage  function  (Mogensen,  1980). 
Spontaneous  recrudescences  (characterized  by  redness  of  the 
ear  and,  occasionally,  vesicles)  have  been  reported  in  mice, 
and  some  mice  had  more  than  one  episode  of  recrudescence 
(Hill,  1975;  Harbour,  1981). 
In  the  guinea  pig  model  described  by  Scriba  (1975)  and 
Donnenberg  and  co-workers  (1980)  recrudescence  was  much  more 
frequent  (occuring  in  45%  to  90%  of  animals)  than  that 
observed  in  mice,  and  HSV-2  was  regularly  isolated  from 
extraneural  sites.  It  is  noteworthy,  that  the  duration  of 
clinical  lesions  in  guinea  pigs  varied  between  2  days  and  4 
weeks  and  recrudescence  occurs  on  average  once  every  6-7 
weeks  (Scriba,  1975).  This  may  explain  the  regular 
isolation  of  the  virus  described  by  Donnenberg  et  al. 
(1980).  In  addition  to  the  mouse  and  guinea  pigs  models, 
recurrence  was  observed  in  rabbits  following  ocular 
inoculation  (Anderson  et  al.,  1961;  Nesburn  et  al.,  1967). 
A  reasonable  conclusion  is  that  both  virus  and  host 
factors  are  involved  in  determination  of  susceptibility  to 
HSV  infection  and  latency. LATENCY  OF  OTHER  HUMAN  HERPES  VIRUSES 74 
Latency  of  Other  Human  Herpesviruses 
In  this  chapter,  the  latency  properties  of  other  human 
herpes  viruses  will  be  discussed.  As  far  as  the  five  human 
herpes  viruses  are  concerned  no  reliable  animal  model  is 
available  to  study  the  latency  characteristics  of 
varicella-zoster,  Epstein-Barr  and  cytomegalo  viruses, 
however,  reported  attempts  for  using  laboratory  animals  in 
the  study  of  such  infection  will  be  discussed. 
Varicella-Zoster  Virus  (VZV) 
Primary  infection  with  VZV  most  frequently  occurs 
early  in  life  (childhood)  and  results  in  an  acute 
generalized  virus  disease  known  as  varicella  or  chicken  pox. 
Later  in  individuals  who  have  had  chicken  pox,  VZV  infection 
may  be  manifested  as  herpes  zoster  (shingles)  with  the 
development  of  cutaneous  lesions.  Evidence  for  the 
involvement  of  the  nervous  system  in  herpes  zoster  infection 
has  been  reported  by  Denny-Brown  and  Adams  (1944)  and 
earlier  by  Head  and  Campbell  (1900),  who  had  studied  autopsy 
material  from  21  cases  with  different  forms  of  herpes 
zoster.  Histopathological  studies  showed  that  the  dorsal 
spinal  ganglion  is  the  site  of  extremely  acute  inflammatory 
changes  that  also  affected  the  posterior,  but  not  the 
anterior,  nerve  root.  Moreover,  marked  secondary 
degenerative  changes  were  also  observed  in  the  fibres  that 
enter  the  posterior  root  ganglion  (i.  e.  peripheral  nerves). 
It  has  been  suggested  that  herpes  zoster  of  skin  represents 
a  reactivation  of  varicella  virus  which  has  remained  latent 
in  ganglia  after  an  earlier  episode  of  varicella  infection 
(Stokes,  1959;  Hope-Simpson,  1965).  In  fact  viral  isolates 
from  patients  with  chicken  pox  and  zoster  were  found  to  be 
antigenically  (Weller  and  Coons,  1954)  and  morphologically 75 
(Esiri  and  Tomlinson,  1972)  identical.  Moreover,  their  DNAs 
have  similar  molecular  weights  and  similar  restriction 
endonuclease  pattern  (Oakes  et  al.,  1977;  Richards  et  al., 
1979).  The  demonstration  of  the  presence  of  virus  in  the 
trigeminal  nerve  and  ganglia  during  active  herpes  zoster 
infection,  by  immunofluorescence  and  electron  microscopy 
(Esiri  and  Tomlinson,  1972),  together  with  virus  isolation 
from  dorsal  root  ganglia  (Bastian  et  al.,  1974;  Shibuta  et 
al.,  1974)  strongly  supports  the  view  that  VZV  remains 
latent  in  the  spinal  ganglia  after  primary  infection.  Later 
and  upon  reactivation,  the  virus  moves  down  the  sensory 
nerve  and  infects  the  skin  where  herpes  vesicles  are 
produced.  Unlike  HSV,  varicella-zoster  virus  has  not  been 
isolated  during  the  quiescent  period  (Esiri  and  Tomlinson, 
1972;  Shibuta  et  al.,  1974),  whether  this  is  because  the 
virus  is  not  there  during  the  latent  phase  or  because  of  the 
strong  cell-associated  nature  of  VZV  (that  makes  the  virus 
more  difficult  to  recover)  is  not  known.  Although,  VZV  is 
regularly  isolated  from  the  skin  lesions  of  herpes  zoster 
(Esiri  and  Tomlinson,  1972;  Bastian  et  al.,  1974;  Shibuta  et 
al.,  1974),  it  is  not  unlikely  that  the  pain  syndrome  of 
herpes  zoster  can  occur  without  subsequent  rash  or  skin 
eruption  (Luby  et  al.,  1977).  A  condition  known  as 
"zoster-sine  herpete",  was  described  by  Lewis  (1958).  The 
latter  observation  implies  that  VZV  reactivation  can  be 
aborted  and  it  is  possible  that  reactivation  is  frequent  but 
suppressed  by  normal  host  defences  (Zaia,  1981).  However, 
the  role  of  the  immune  system  in  the  reactivation  of  herpes 
zoster  remains  unknown.  Nevertheless,  some  observations 
have  been  made  suggesting  the  importance  of  the  immune 
functions,  for  example  zoster  has  been  reported  to  occur  in 76 
the  first  year  of  life  in  certain  children  who  have  been 
exposed  in  utero  to  chicken  pox  (Hope-Simpson,  1965;  David 
and  Williams,  1979),  this  short  latent  period  between  the 
initial  infection  and  viral  reactivation  (compared  to  the 
usual  one  in  the  adult)  may  be  due  to  poor  or  immature  cell 
mediated  immunity  or  due  to  a  decline  in  maternal  antibody 
levels  within  six  months  of  birth  (Gershon  et  al.,  1976). 
However,  the  fact  that  antibody  to  VZV  does  not  prevent  the 
recurrence  of  infection  in  the  form  of  herpes  zoster, 
suggests  that  other  host  defence  mechnisms  are  responsible 
for  the  maintenance  of  virus  latency.  Other  studies  showed 
that  humoral  antibody  and  local  interferon  production 
(possibly  mediated  by  sensitized  lymphocytes)  have  an 
important  role  in  preventing  or  restricting  the 
dissemination  of  an  initially  local  disease  (Mazure  et  al., 
1979;  Stevens  and  Merigan,  1979).  Moreover,  studies  of  73 
patients  undergoing  renal  transplantation,  who  had 
immunosupressive  therapy,  showed  no  relation  between 
surgical  immunusuppression  (splenectomy  and  thymectomy), 
medical  immunosuppressive  therapy  (azathioprine,  prednisone 
and  actinomycin  C)  or  the  side  effects  of  immunsuppression 
(e.  g.  hypogammaglobulinemia  and  leukopenia)  and  the 
development  of  herpes  zoster  in  these  patients  (Rifkind, 
1966).  In  contrast  following  local  X-irradiation  (as  an 
antirejection  measure),  zoster  eruptions  appeared  primarily 
in  the  irradiated  segments.  These  observations  suggest  that 
VZV  may  be  latent  in  many  sensory  ganglia  or  in  other  nearby 
sites  and  can  be  activated  by  local  X-rays  or  by  some  other 
factors  like  leukaemia,  exposure  to  cold  and  pressure 
(Stokes,  1959;  Rifkind,  1966). 
The  information  about  VZV  infection  is  derived  from 77 
clinical  observations  as  there  is  no  suitable  animal  model. 
VZV  like  Epstein-Barr  virus,  is  not  pathogenic  (Darai  et 
al.,  1980a)  even  when  inoculated  intravenously  (IV)  in 
juvenile  or  adult  tree-shrews.  However,  Myers  and 
co-workers  (1980)  reported  successful  infection  of  weanling 
guinea  pigs  with  fetal  guinea  pig  adapted  VZV  (FGP  VZV) 
where  nasopharyngeal  virus  shedding,  viraemia,  and  specific 
humoral  responses  were  noticed  (in  some  animals);  yet  no 
evidence  for  virus  reactivation  was  reported. 
Epstein-Barr  Virus  (EBV) 
Unlike  herpes  simplex  and  varicella  zoster,  there  is 
no  evidence  for  the  involvement  of  the  nerve  cells  as  a 
possible  site  of  latent  infection  with  EBV  or 
cytomegalovirus  (CMV). 
Epstein-Barr  virus  is  the  cause  of  Paul  Bunnell 
positive  (Henle  and  Henle,  1979)  infectious  mononucleosis 
(IM),  however,  the  virus  is  also  been  associated  with  two 
other  diseases  of  man,  namely  Burkitt's  lymphoma  (BL)  and 
nasopharyngeal  carcinoma  (NPC)  reviewed  by  Miller  (1978). 
Primary  infection  with  EB  virus  usually  occurs  in  early 
childhood  (Henle  et  al.,  1968;  Kafuko  et  al.,  1972).  The 
infection  in  the  infant  remains  essentially  silent  (Biggar 
et  al.,  1978)  and  once  infected  a  person  becomes  a  life  long 
carrier,  shedding  virus  periodically  (Smith,  1978). 
Reactivation  of  EBV  is  less  well  documented  partly  due  to 
the  difficulty  in  viral,  detection,  and  moreover  it  appears 
that  EBV  causes  no  symptoms  upon  reactivation  (Strauch  et 
al.,  1974;  Naraqi  et  al.,  1977).  In  one  of  the  studies 
(Strauch  et  al.,  1974),  human  leucocyte  immortalization 
activity  (an  assay  of  EBV  biological  activity)  was  detected 
in  throat  washings  of  three  out  of  twenty  (15%)  healthy, 78 
renal  unit  associated  personnel,  and  in  18%  of  general 
hospital  outpatients  (Chang  et  al.,  1973)  suggesting  that 
asymptomatic  excretion  of  EBV  is  common  among  the  general 
population.  It  has  been  proposed  (Pagano  and  Shaw,  1979) 
that  infection  with  EBV  involves  primary  (epithelial)  and 
secondary  (B-lymphocyte)  cell  types.  The  oropharyngeal 
epithelium  is  thought  to  be  the  site  for  vegetative  virus 
replication  (during  the  course  of  infectious  mononucleosis) 
from  which  the  virus  is  subsequently  excreted  (Lemon  et  al., 
1977),  presumably  reaching  the  tonsils  where  infection  and 
transformation  of  B-lymphocytes  occurs.  The  above  finding 
is  inconsistent  with  early  observations  that  virus  shedding 
can  occasionally  be  localised  in  the  anterior  oropharynx 
(where  lymphoid  tissue  is  scant  but  epithelium  is  abundant) 
rather  than  the  posterior  pharynx  and  tonsillar  areas 
(Neiderman  et  al.,  1976).  Unlike  the  epithelial  cells,  EBV 
replication  in  lymphocytes  is  repressed  and  a  state  of 
latent  infection  induced  (Pagano,  1975). 
Explantation  of  EBV  latently  infected  lymphocytes 
results  in  virus  replication  and  cellular  proliferation 
reviewed  by  Pagano  and  Nedrud  (1981).  Occasionally, 
however,  latent  EBV  genomes  can  persist  in  epithelial  cells. 
Evidence  for  the  latter  fact  has  been  reported  by  Wolf  and 
colleagues  (1973)  who,  by  using  in  situ  hybridization, 
demonstrated  that  the  EB  viral  genome  is  harboured  by 
epithelial  cells  of  nasopharyngeal  carcinoma.  Similarly, 
Huang  and  co-workers  (1974)  reported  the  presence  of  EBV 
associated  nuclear  antigen  (EBNA)  in  nasopharyngeal 
carcinoma  cells.  Furthermore,  EBV  has  been  recovered 
(Morgan  et  al.,  1979)  from  cell  free  material  in  saliva  or 
in  secretions  from  parotid-gland  orifices  or  ducts  (by 79 
cannulation  of  Stensen's  duct). 
While  the  state  of  the  HSV  genome  in  latently  infected 
cells  is  not  yet  understood,  little  is  known  about  the  state 
of  EBV  genome  during  latency.  The  virus  DNA  has  been 
characterized  as  a  linear  molecule  with  a  molecular  weight  ` 
108  (Adams  and  Lindahl,  1975)  and  it  has  been  found  that  in 
a  nonproducer  latently  infected  cell  line  (Raji  cell  line 
which  was  derived  from  a  Burkitt's  lymphoma)  part  of  EBV  DNA 
is  present  as  an  integrated  form,  while  the  majority  of  the 
DNA  occurs  in  free  form  in  the  cell  nuclei  (Nonoyama  and 
Pagano,  1972;  Tanaka  and  Nonoyama,  1974).  This  free  form  of 
viral  DNA,  described  as  EBV  "plasmid"  or  "episome"  (Nonoyama 
and  Pagano,  1972;  Lindahl  et  al.,  1976)  exists  as  a 
supercoiled  molecule  within  latently  infected  cells  (Adams 
and  Lindahl,  1975;  Adams,  1979;  Shaw  et  al.,  1979). 
Further,  EBV  episome  replication  is  associated  with  cellular 
chromosomal  (S-phase)  replication  (Hampar  1974)  and  complete 
copies  of  the  virus  genome  persist  in  replicating  cells 
(Epstein  and  Achong,  1977).  So  it  appears  that  both 
integrated  and  non  integrated  (Fig.  16)  viral  DNA  occurs  in 
the  transformed  cell  lines  (Lindahl,  1976;  Anderson  and 
Lindahl,  1978). 
Activation  of  EBV  DNA  in  non  productive  cell  lines  by 
the  use  of  different  inducing  agents  (phorbol  ester  -  TPA, 
sodium  butyrate,  corticosteroids,  antihuman  IgM  and  low 
temperature)  were  generally  unsuccessful  (Hampar,  1979). 
However,  in  addition  to  the  limited  spontaneous  virus 
production  in  the  virus-producing  P3HR-l  cell  line  (Hinuma 
et  al.,  1967)  the  induction  of  the  latently  infected  cells 
to  express  viral  antigens  and  produce  virus  (within  such 
productive  cell  lines)  was  greatly  been  enhanced  by  using 01  U1M  b'  a 
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these  inducing  agents  (Hampar,  1979).  Moreover,  when 
non-producer  (Raji  cells)  were  treated  with  iododeoxyuridine 
(IUdR)  only  the  early  antigen  (EA)  component  was  detected 
(no  significant  increase  in  EBV  DNA  and  no  virus  particles 
were  observed),  while  similar  treatment  of  somatic  cell 
hybrids,  produced  by  fusion  of  Hela  and  Raji  (D98/Raji), 
resulted  in  synthesis  of  early  antigen,  EBV  DNA  and  virus 
particles  (Glaser  and  Nonoyama,  1974).  On  the  other  hand, 
the  somatic  cell  hybrid  (D98/HR-1),  produced  by  fusion  of 
HR-1  cells  (producer)  to  human  Hela  cell  variant  D98,  was 
shown  to  contain  EBV  DNA  but  the  genome  was  repressed  (i.  e. 
no  detectable  specific  virus  antigens  were  synthesized). 
However,  when  the  hybrid  was  treated  with  IUdR  or  BUdR, 
synthesis  of  EBV  DNA,  EA,  virus  capsid  antigen  (VCA)  and 
virus  particles  were  observed  (Glaser  and  Rapp,  1972;  Glaser 
et  al.,  1973;  Klein  et  al.,  1976).  These  facts  suggest  that 
the  degree  of  induction  of  latent  virus  (in  producer  and  non 
producer  cell)  is  under  the  cellular  control  rather  than  due 
to  differences  in  EBV  genomes  "episomes"  present  in  these 
two  cell  lines. 
Cytomegalovirus  (CMV) 
Cytomegaloviruses  are  a  group  of  viruses  which  in 
addition  to  human  cytomegalovirus  (HCMV),  includes  species 
specific  viruses  of  other  animals  like  the  murine  CMV, 
simian  CMV  and  guinea  pig  CMV.  Though  there  is  structural 
and  biological  similarity,  there  is  lack  of  genetic 
relatedness  between  these  viruses  as  determined  by  nucleic 
acid  hybridization  and  restriction  endonuclease  analysis 
(Huang  and  Pagano,  1974).  Primary  HCMV  infection  is  most 
likely  to  be  asymptomatic  and  the  infection  can  be  acquired 
perinatally  (with  clinical  manifestations  ranging  from 81 
silent  infection  to  severe  cytomegalic  inclusion  disease  and 
intrauterine  death),  or  during  the  childhood  or  adulthood 
period  (Weller,  1971a,  b).  And  it  appears  that  CMV  is 
endemic  in  all  human  societies.  The  virus,  in  addition  to 
being  non-specifically  associated  with  a  variety  of  clinical 
syndromes,  is  now  recognized  as  the  cause  of  certain 
clinical  disorders  (fever,  leukopenia,  thrombocytopenia,  a 
mononucleosis-like  illness,  pneumonitis  and  hepatitis)  early 
after  renal  transplantation,  and  asymptomatic  virus 
excretion  (in  saliva  and  urine)  continued  up  to  2-14  years 
postrenal  transplantation  (Cheesman  et  al.,  1979).  CMV  has 
been  isolated  from  saliva,  urine,  blood  and  human  milk 
(Hayes  et  al.,  1972)  and  faeces  (Cox  and  Hughes,  1974). 
Asymptomatic  excretion  in  the  throat  and  in  urine  is  common 
particularly  in  congenitally  infected  infants  (Reynolds  et 
al.,  1974). 
The  clinical  and  epidemiological  observations  strongly 
support  the  assumption  that  after  primary  infection  HCMV  can 
establish  latent  infection  with  subsequent  recurrence  or 
reactivation  upon  disturbance  of  virus  host  relationship 
(Weller,  1971b).  Experimental  studies  on  the  site  and 
mechanism  of  virus  persistence  and  reactivation  in  man  is 
not  possible.  Nevertheless,  CMV  "inclusions" 
(characteristic  cytomegalic  cells)  have  been  located  in 
epithelial  cells  of  renal  tubules  (Fetterman  et  al.,  1968) 
and  in  salivary  glands  (Huang  and  Pagano,  1977).  Further, 
Diosi  and  co-workers  (1969)  have  reported  the  isolation  of 
CMV  from  explanted  leucocytes  of  healthy  blood  donors.  The 
demonstration  of  CMV  in  human  semen  (Lang  et  al.,  1974) 
raises  the  possible  persistence  of  latent  viral  genomes  in 
spermatozoa. 82 
Since  cytomegaloviruses  are  highly  species  specific, 
studies  of  HCMV  in  laboratory  animals  has  been  limited. 
However,  acute  and  chronic  CMV  infection  of  mice  with  mouse 
salivary  gland  cytomegalovirus  (MCMV)  is  very  similar  to 
that  in  man  (Brodsky  and  Rowe,  1958;  Medearis,  1964).  Thus 
a  murine  model  of  CMV  infection  may  provide  important  and 
relevant  information  about  the  disease  in  man. 
Olding  and  colleagues  (1975)  could  reactivate  and 
reisolate  MCMV  from  B-lymphocytes  of  latently  infected  mice 
(mice  were  infected  in  utero  or  at  birth)  but  only  upon 
co-cultivation  of  the  explanted  cells  with  histocompatable 
(allogenic)  mouse  embryo  cells  (MEC)  or  when  B-lymphocytes 
were  stimulated  by  adding  lipopolysaccharide  (LPS)  to  the 
culture.  Other  studies  failed  to  detect  virus  in  brain, 
thymus,  liver,  kidney,  urine  or  serum  of  latently  infected 
mice  by  co-cultivation  techniques  or  by  host  DNA-MCMV  DNA 
hybridisation.  Virus  could  be  activated  from  spleen  cells 
(Olding  et  al.,  1976),  and  MCMV  DNA  was  detected  at  levels 
equivalent  to  3-4  virus  genomes/100  spleen  cells  and  2  virus 
genomes/100  salivary  gland  cells.  Further  studies  showed 
that  MCMV  was  harboured  in  the  reproductive  tissues  (sperm 
cells)  of  both  latently  and  acutely  infected  male  mice 
(Dutko  and  Oldstone,  1979)  and  in  macrophages  (Brautigam  et 
al.,  1979).  In  addition,  Cheung  and  Lang  (1977)  have 
described  a  mouse  model  that  mimics  many  of  the  features  of 
HCMV  infections  which  are  associated  with  transfusion  and 
perfusion.  Not  only  transfusions  from  uninfected  donors 
(mice)  into  latently  infected  mice  activated  MCMV  in 
heterologous  and  homologous  recipients,  but  also  infection 
can  be  transmitted  to  healthy  mice  by  the  inoculation  of 
blood  from  previously  inoculated  animals  who  were  apparently 83 
virus-negative.  Reactivation  and  dissemination  of  the 
latent  MCMV  following  the  use  of  immunosuppressive  therapy 
(antilymphocyte  serum  and  cortisone)  has  also  been  reported 
(Jordan  et  al.,  1977;  Shanley  et  al.,  1979). 
The  state  of  the  latent  virus  genome  within  the  cell 
is  not  known,  but  in  vitro  study  on  the  analysis  of  human 
cytomegalovirus  nucleoprotein  complexes  in  acutely  infected 
human  embryo  lung  cells  indicated  that  virus  DNA  is  present 
in  a  nucleosome-like  structure  (Jeor  et  al.,  1982).  Recent 
studies  on  the  association  between  HCMV  DNA  and  cellular  DNA 
in  latently  infected  human  embryonic  fibroblast  cells 
indicate  the  integration  of  viral  DNA  (Gadler  and  Wahren, 
1983).  Furthermore,  since  viral  replication  was  initiated 
after  the  removal  of  phosphonoformic  acid  (PFA),  it  is 
assumed  that  the  complete  viral  genome  persists  in  cells. 
However,  it  is  not  known  whether  the  genome  persists  as  a 
fragmented  or  as  a  continuous  sequence,  and  the  situation  in 
vivo  has  not  been  determined. MATERIALS  AND  METHODS 84 
MATERIALS 
Virus  - 
The  HSV-2  wild  type  virus  used  in  this  study  was  strain 
HG52;  from  which  all  the  type  2  temperature-sensitive  (ts) 
mutants  used  in  this  study,  had  been  derived  by 
5-bromodeoxyuridine  mutagenisation  (Timbury,  1971; 
Halliburton  and  Timbury,  1973,1976).  The  studied  mutants 
were  is  1,2,3,4,5,6,7,8,9,10,11,12  and  13. 
Tissue  Culture  Cells 
Both  baby  hamster  kidney  cells  (BHK21/C13)  described 
by  Macpherson  and  Stoker  (1962)  and  human  embryo  lung  cells 
(HeLu)  were  used. 
Radiochemicals 
32p  orthophosphate  (carrier-free)  was  purchased  from 
the  Radiochemical  Centre,  "Amersham". 
Chemicals  For  Liquid  Scintillation  Counting 
(2,5  diphenol-oxazole)  PPO  was  obtained  from 
Koch-Light  Laboratories  Ltd.  The  toluene  used  was  Analar 
Grade  (B.  D.  H.  Ltd).  Scintillation  fluid  contained  5g  PPO 
per  litre  of  toluene,  5  ml  of  the  solution  was  added  to 
screwtop  plastic  scintillation  vials. 
Tissue  Culture  Media 
BHK21/C13  cells  were  grown  in  burleys,  using  Glasgow 
modified  Eagles  medium  (Busby  et  al.,  1964).  The  medium  was 
supplemented  with  appropriate  antibiotic/antimycotic 
solutions  (100  units/ml  of  penicillin,  100  ug/ml 
Streptomycin,  0.02  ug/ml  of  antimycotic  agent, 
N-butyl-p-hydroxybenzoate).  In  some  cases,  the 
antibiotic/antimycotic  concentration  was  increased  to 
(150  units/ml  penicillin,  150  ug/ml  Streptomycin  and 85 
0.04  ug/ml  of  antimycotic),  Gentamicin  was  also  added  at  the 
concentration  of  25  ug/ml. 
The  medium  was  also  supplemented  with  tryptose 
phosphate  broth  and  different  concentrations  of  either 
normal  or  heat  inactivated  calf  serum  (CS)  or  fetal  calf 
serum  (FCS). 
Eagles  Supplemented  Medium 
5%  (v/w)  foetal  calf  serum  ............................. 
(EFC5) 
5%  (v/v)  pooled  human  serum  ............................ 
(EHu  5%) 
10%  (v/v)  glycerol  +  ETC10  .............................. 
(ETC1OgL) 
10%  (v/v)  tryptose  phosphate  broth  +  10%  (v/v)  calf  serum 
(ETC10) 
10%  (v/v)  calf  serum  .................................... 
(EC10) 
50%  (v/v)  foetal  calf  serum  ............................. 
(EFC50) 
G.  M.  E.  M.  -  P.  I.  C.  This  is  Glasgow  modified  Eagles  Medium, 
phosphate  free,  supplemented  with  1%  calf  serum 
Medium  For  Culturing  Dissociated  Ganglia 
Cells  from  dissociated  dorsal  root  ganglia  (DRG)  were 
grown  in  CMRL  -  1066  (Gibco)  medium  supplemented  with  2  mM 
glutamine,  6  g/L  glucose,  25  mM  potassium  chloride  KC1, 
25  ug/ml  gentamicin  and  50%  (v/v)  heat  inactivated  fetal 
calf  serum. 
Standard  Solutions 
1.  Phosphate  buffer  saline  (PBS). 
A  solution  of  0.17  M  NaCl,  0.0034  M  KC1,0.001  M 
NaH2pO4,0.002  M  KH2PO4  in  distilled  water  pH  7.2  (Dulbecco 86 
and  Vogt,  1954) 
2.  PBSCS 
The  PBS  supplemented  with  10%  (v/v)  calf  serum. 
3.  PBSA  +  gentamicin. 
A  phosphate  buffer  saline  solution  "A"  (i.  e  without 
B+C  constituents)  supplemented  with  25  ug/ml  gentamicin. 
4.  Versene  (EDTA). 
Ethylene  diaminetetraacetic  acid  (0.006  M)  dissolved 
in  PBS  containing  0.002%  (w/v)  phenol  red. 
5.  Trypsine-Versene. 
One  volume  of  0.25%  (w/v)  Difco  trypsin  (dissolved  in 
tris  saline)  and  four  volumes  of  0.006  M  versene. 
6.  Formal  Saline. 
A  solution  of  4%  (w/v)  formaldehyde  in  0.085  M  NaCl, 
0.1  M  Na2SO4. 
7.  Standard  Saline  Citrate  (SSC). 
A  solution  of  0.15  M  NaCl,  0.015  M  in  sodium  citrate 
in  distilled  water. 
8.1  XE  Buffer 
TRIS 
NaH2P04  H2O 
Na  EDTA 
H2O 
9.  SDS  in  SSC. 
43.6  g/lit 
46.8  g/lit 
3.7  g/lit 
1  lit 
A  5%  solution  of  sodium  dodecyl  sulphate  (SDS)  in  SSC, 
pH  7.0. 
10.  Giemsa  Stain.  A  1.5%  (v/v)  suspension  of  giemsa  stain 
in  glycerol  heated  to  560  for  120  minutes,  diluted  with  an 
equal  volume  of  methanol  and  filtered. 
11.  Saturated  Phenol  Solution 
Phenol  solution  saturated  with  75  mmol/1  NaCl, 87 
50  mmol/1  EDTA,  (pH  8.0). 
12.  RNA-ase  mixture. 
The  mixture  was  prepared  freshly  each  time  and  boiled 
for  10  minutes  immediately  before  use. 
(1  ml  distilled  H2O  +  100  ug  RNA-ase  A+  250  units  of 
RNA-ase  T1) 
Restriction  Endonuclease  Enzymes 
These  were  purchased  from  Bethesda  Research  Laboratories 
(BRL).  The  enzymes  were  EcoRI,  Bam  HI,  Bgl  II,  Hind  III  and 
Kpn  I. 
Reaction  Mixtures 
1.  Eco  Reaction  Mixture. 
Used  with  EcoRI  endonuclease  enzyme. 
10  ml  1M  TRIS  pH  7.5 
10  ml  1M  NaCl 
500  ul  1M  MgC12 
2.  Standard  Reaction  Mixture  (R.  Mixture). 
Used  with  endonuclease  enzymes  Hind  III,  Bgl  II  and 
Bam  HI. 
4.2  ml  1M  TRIS  pH  7.5 
4.2  ml  1M  MgC12 
4.0  ml  1M  KC1 
87.6  ml  deionized  H2O 
3.  Low  Salt  Reaction  Mixture. 
Used  with  Kpn  I  endonuclease  enzyme. 
4.2  ml  1M  TRIS  pH  7.5 
4.2  ml  1M  NaCl 
4.2  ml  1M  MgC12 
87.4  ml  deionised  H2O 
Each  of  the  above  mixtures  were  aliquoted  in  10  ml 
aliquots,  autoclaved,  then  30-35  ul  of  (v/v) 88 
P-mercaptoethanol  added  to  each  10  ml  volume  before  they 
were  cooled  down  and  stored  at  -20°C. 
4.  Restriction  Endonuclease  Stop  Mixture  (R.  E.  ) 
The  mixture  used  to  stop  restriction  endonuclease 
reactions  was:  - 
2g  Ficoll 
0.54  g  EDTA 
10  ml  of  10  xE  (buffet'.  ) 
10  ml  of  H2O 
Bromophenol  blue  (BPB)  is  added  to  produce  a  desirable 
colour. 
Collagenase 
A  0.25%  (w/v)  of  collagenase  (Worthington)  was 
prepared  in  PBSA  and  filtered. 
Anti  HSV  Serum 
Poly-specific  anti  serum  directed  against  HSV  was 
used.  This  was  purchased  from  Wellcome  Laboratories. 
Cells  Specific  Marker 
The  neurone  specific  marker  (monoclonal  antibody) 
designated  A2B5  (Eisenbarth  et  al.,  1979)  was  used  at 
concentration  of  1/40  (v/v)  in  PBSA. 
Laboratory  Animals 
Five  different  strains  of  mice  were  used;  these  were 
A,  PIRBRIGHT,  C57BLACK/6-J,  BALB/C  and  BIOZZI.  The  mice 
were  bred  on  site  at  the  breeding  unit  of  the  Institute  of 
Virology. 
Miscellaneous  Material 
Plastic  petri  dishes,  microtitreplates,  plastic  tissue 
culture  bottles,  Linbro  wells  were  purchased  from  Flow 
Laboratories,  Irvine,  Scotland. 
Kodirex  X-ray  films  were  supplied  by  Kodak  Ltd,  London. 89 
METHODS 
Management  of  Cell  Stocks 
Stocks  of  BHK21/C13  and  HeLu  cells  were  prepared  for 
storage  in  liquid  nitrogen  (-170°C)  as  follows. 
A  cell  suspension  at  a  concentration  of  2x108  cells/ml 
was  prepared  in  ETC10-91.  The  cell  suspension  was  dispensed 
as  1  ml  aliquots  in  screwcap  vials  and  gradually  brought 
down  to  liquid  nitrogen  temperature. 
Cells  were  checked  for  any  bacterial  contamination  by 
plating  a  sample  on  two  Blood  agar  and  on  two  nutrient  agar 
plates,  which  were  then  incubated  at  310  and  38°C  and 
checked  for  growth  of  contaminants.  Cells  were  also 
routinely  checked  for  the  presence  of  mycoplasma 
contaminants.  (Chen,  1977). 
Tissue  Culture 
(1)  Burler  Seeding 
BHK21/C13  cells  were  seeded  (at  a  density  of  2x107 
cells/bottle)  with  200  ml  ETC10  in  80  oz  burlers  (Winchester 
bottles)  in  an  atmosphere  of  58  C62  and  then  incubated  in 
the  hot  room  (37°C).  Three  days  later,  when  a  confluent 
monolayer  had  been  formed,  some  of  the  burlers  were  used  for 
virus  stock  production,  while  the  cells  of  other  burlers 
were  harvested,  by  two  washes  in  trypsin-versene  and 
resuspensed  in  ETC10  at  a  density  of  106  cells/ml.  The 
cells  were  then  used  to  reseed  further  burlers  for 
subsequent  experiments.  Cell  suspensions  were  stored  at  4°C 
for  up  to  5  days. 
(2)  Linbro  Well  Seeding 
Linbro  wells  (16  mm  well  diameter)  were  seeded  with 
BHK21/C13  at  a  density  of  2x104  cells/well  in  0.5  ml  ETC10 90 
and  incubated  at  37°C  in  5%  (v/v)  C02  in 
. 
humidified 
incubator.  When  the  cells  were  semiconfluent  (24  hour 
later),  they  were  used  to  assay  supernatant  fluids  from 
footpad  tissue  cultures. 
(3)  Seeding  BHK21/Ci3  in  Microtitre  Plates 
Cells  were  seeded  in  flat  bottomed  multi-well  tissue 
culture  microtitre  plates  at  a  density  of  6x103  cells/well 
in  0.15  of  ETC10.  The  plates  were  then  incubated  at  37°C  in 
a  humidified  incubator  containing  5%  (v/v)  CO2.  When  the 
cells  were  semiconfluent  (24  hours  later)  the  explanted 
ganglia  supernatants  were  replaced  and  assayed  (2-3  times  a 
week)  by  adding  them  to  individual  wells  of  microtitre 
plates. 
Production  of  Virus  Stock 
The  growth  medium  ETC10  was  removed  from  confluent 
monolayers  of  C13  cells  in  burlers  and  the  cells  infected 
with  virus  at  a  multiplicity  of  one  plaque  forming  unit 
(pfu)/300  cells  in  25  ml  ETC10. 
The  infected  culture  was  then  incubated  at  31°C  for  at 
least  three  days  or  until  extensive  cytopathic  effect  (CPE) 
was  obtained  (80%  or  more  of  the  cells  being  destroyed). 
These  cells  were  then  harvested  by  scraping  them  from  the 
glass  (using  sterile  glass  beads  if  necessary),  centrifuged 
at  500xg  for  10  minutes  at  40C  and  resuspended  in  5  ml  of 
the  supernatant  fluid.  The  suspension  was  then  sonicated 
for  2-3  minutes  to  release  cell  associated  virus.  After  a 
further  centrifugation  at  500xg  for  10  minutes,  the 
supernatant  was  then  poured  off  and  kept.  The  sonication 
procedure  was  repeated  and  the  supernatants  pooled.  The 
virus  stocks  were  then  dispensed  in  1  ml  aliquots  and  stored 
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Sterility  Test 
This  was  carried  out  for  every  virus  stock  preparation 
or  isolate.  A  loopful  of  the  virus  suspension  was  streaked 
on  two  Blood  Agar  and  two  Nutrient  Agar  plates.  A  plate  of 
blood  and  of  nutrient  agar  were  incubated  at  370C  and  the 
other  pair  incubated  at  31°C.  The  plates  were  checked  daily 
for  any  bacterial  growth. 
Only  sterile  HSV  stocks  were  retained. 
Titration  of  Virus  Stocks 
Virus  was  assayed  using  confluent  monolayers  of 
BHK21/C13  cells  seeded  onto  40  mm  tissue  culture  petri 
dishes  at  a  density  of  105  cells/petri  dish  in  two  ml  of 
ETC10.  Virus  was  serially  diluted  (10  fold  dilution  steps) 
in  PBSCS  and  plated  onto  confluent  BHK  monolayers  on  40  mm 
petri  dishes  (0.1  ml/petri  dish)  from  which  the  medium  had 
been  removed.  The  virus  was  allowed  to  absorb  for  45-60 
minutes  at  38°C,  then  the  monolayers  were  overlaid  with  2  ml 
of  EHu  5%. 
Duplicate  petri  dishes  were  used  for  each  dilution  at 
each  temperature  (310  and  38°C)  and  incubation  continued  for 
3  days  at  31°C  and  2  days  at  380C. 
After  staining  with  giemsa,  plaques  were  counted  using 
a  Wild  (M7A)  binocular  dissecting  microscope. 
Inoculation  of  Mice  for  the  Establishment  of  Latency 
Footpad  inoculation 
Both  male  and  female  mice  were  injected  at  weaning 
(3-4  weeks)  with  the  appropriate  dose  of  virus  (in  0.025 
ml),  into  the  right  rear  footpad  using  a  26  G  3/8  needle. 
B.  D  (Cat.  No.  US110  11).  For  the  inoculation  the  virus  was 
diluted  with  PBSCS  10.  The  remaining  virus  suspension  was 
also  titrated  on  C13  cells  at  31°C  and  38°C  after  each 92 
inoculation. 
Mice  were  examined  daily  for  the  first  three  weeks 
after  inoculation  for  the  presence  of  any  observable  lesion. 
At  least  three  months,  after  footpad  inoculation  and  in  the 
absence  of  clinical  lesions,  the  survivors  were  killed  with 
chloroform  and  tissue  explantation  carried  out. 
Intracerebral  inoculation 
For  intracerebral  inoculations,  the  virus  suspension 
was  similarly  diluted  with  PBSC10  to  the  required 
concentration  and  0.05  ml  was  inoculated  intracerebrally 
while  mice  were  under  ether  anaesthesia. 
Explantation  and  Cultivation  of  Tissues  from  Latently 
Infected  Mice 
Mainly  two  types  of  tissue  were  chosen  for 
explantation  from  latently  infected  mice,  the  'footpad'  (FP) 
and  the  'Dorsal  Root  Ganglia'  (DRG).  In  some  experiments  in 
addition  spinal  cord  and  brain  were  also  explanted. 
The  explantation  procedure  was  as  follows: 
(1)  Footpad  Tissue  (FP).  Both  hind  feet  (the  inoculated  and 
uninoculated)  were  cleaned  by  washing  with  absolute  alcohol, 
then  a  sliver  of  footpad  tissue  was  excised  with  separate 
sterile  instruments  from  both  sides  and  dipped  separately  in 
1  ml  of  absolute  alcohol  for  about  20  seconds. 
The  explanted  tissue  was  then  separately  washed  twice 
in  1  ml  of  EFC50,  then  each  fragment  was  placed  separately 
in  a  microtitre  well,  epidermis  facing  upward.  EFC50  was 
added,  sufficient  just  to  cover  the  surface  of  the  explanted 
tissue  and  incubation  at  310C  commenced. 
(2)  Dorsal  Root  Ganglia  (DRG).  Figure  (17)  shows  in 
sequence,  the  stages  of  mouse  dissection  and  explantation  of 
the  DRG. FIGURE  17 
DIAGRAMMATIC  REPRESENTATION  OF  THE  METHOD  FOR 
DISSECTION  AND  EXPLANTATION  OF  THE  MOUSE 
DORSAL  ROOT  GANGLIA 
A  mouse  fixed  on  dissecting  board  in  a  dorso-ventral 
position.  The  back  of  the  mouse  was  carefully  washed  with 
absolute  alcohol.  The  skin  was  dissected  away  from  the  body 
(on  either  side)  and  fixed  (A);  longitudinal  incisions  were 
made  laterally  to  the  vertebral  column  so  as  to  separate  the 
column  from  the  supporting  muscle.  A  cut  was  made  through 
the  vertebral  column  (transversely)  at  the  level  of  the  last 
two  ribs  (B);  the  dorsal  lamina  of  the  vertebral  column  was 
separated  and  removed  (C);  the  spinal  cord  was  then  removed 
and  the  dorsal  root  ganglia  (DRG)  identified  under  the 
dissecting  microscope  (D). 93 
Explanted  ganglia  were  either  incubated  individually 
as  organ  cultures  or  dissociated  then  incubated  as  cell 
cultures. 
(A)  DRG  -  Organ  culture 
Nine  dorsal  root  ganglia  were  explanted  from 
the  right  side  comprising  the  last  two  thoracic,  all 
six  lumbar  and  the  first  sacral  ganglia.  Two  ganglia 
(from  the  lumbar  region)  were  also  explanted  from  the 
left  side  as  an  internal  control. 
The  explanted  DRG  were  washed  separately  with 
150  ul  of  prewarmed  PBSA.  G,  then  placed  into  separate 
wells  of  a  microtitre  plate  containing  150  ul  of 
EFC50/well.  Microtitre  plates  were  incubated  at  31°C 
in  a  humidified  incubator  under  an  atmosphere  of  5% 
CO2  in  air. 
(B)  Dissociation  of  DRG 
The  last  two  thoracic,  all  lumbar  and  first 
sacral  DRG  from  each  side  (left,  right)  were  removed 
aseptically  and  washed,  as  above,  in  prewarmed  PBSA.  G. 
The  ganglia  from  4-5  mice  were  pooled  for  each 
experiment.  Throughout  all  procedures,  the  ganglia 
from  the  left,  right  or  uninfected  controls  were 
treated  separately.  Dissociated  cell  cultures  of 
adult  mouse  DRG  were  prepared  by  gently  teasing  the 
pooled  ganglia  with-fine  sterile  forceps  and  then 
transferring  to  vials  containing  2  ml  of  0.25% 
collagenase  (Worthington)  in  which  they  were  incubated 
for  2-3  hours  at  37°C.  Vials  were  shaken  gently  at  15 
minute  intervals.  The  ganglia  were  then  washed  twice 
in  PBSA.  G  and  dissociated  by  trituration  in  CMRL-1066 
medium  through  200  ul  size  Eppendorf  plastic  pipette 94 
tips.  The  resulting  cell  suspension  was  then  passed 
through  sterile  nylon  mesh,  centrifuged  at  500xg  for 
10  minutes,  and  the  cell  pellet  resuspended  in  0.5  ml 
of  CMRL-1066  medium.  0.1  ml  of  cell  suspension  was 
plated  onto  13  mm  collagen-coated  glass  coverslips 
(5x105  cells  per  coverslip)  in  Linbro  Multiwell  plates 
and  incubated  at  37°C.  After  24  hours  incubation, 
another  0.4  ml  of  CMRL-1066  medium  was  added  to  each 
coverslip  and  reincubated.  Cultures  were  screened 
daily  for  the  presence  of  released  HSV  by  plating 
0.1  ml  of  culture  supernatant  onto  BHK21/C13  cells  and 
observed  for  cpe. 
(3)  Brain  and  Spinal  Cord  Tissues  from  Latently  Infected  Mice. 
Either  one  cm3  "arrowed  needle  plug"  or  the  whole  brains 
of  latently  infected  mice  were  removed  aseptically,  then 
washed  with  PBS  +  gentamicin.  Tissues  were  then  cut  into 
small,  thin  pieces  and  cocultivated  with  HeLu  cells  in  40  mm 
petri  dishes  in  EFC  5%  (each  single  piece  is  allocated  one 
petri  dish).  Cultures  were  then  incubated  at  31°C  and 
checked  daily  for  CPE.  Cultures  were  kept  as  long  as 
possible  (usually  up  to  4  weeks).  After  that  period  of 
incubation,  cells  and  brain  pieces  from  negative  cultures, 
were  harvested,  sonicated  and  replated  to  a  suitable  number 
of  C13  petri  dishes.  Spinal  cord  was  removed,  washed  then 
gently  homogenised  in  5  ml  of  EFC  5%  either  by  passing 
through  sterile  hypodermic  syringes  of  different  gauges,  G19 
-  G26  (B.  D)  or  slicing  into  small  pieces.  Spinal  cord 
suspension  or  pieces  were  then  cocultivated  with  HeLu  cells 
in  petri  dishes  (0.5  ml  to  each  petri  dish)  or  (one 
piece/each  petri  dish).  Cultures  were  then  incubated  at 
31oC  and  observed  for  as  long  as  possible  (3-4  weeks). 95 
Negative  cultures  were  harvested  either  by  sonication  and/or 
freezing  and  thawing  cycles,  then  replated  on  BHK  cells. 
Mouse  Inoculation  for  the  Study  of  Virus  Replication  During 
the  Acute  Stage  of  Infection 
The  intracerebral  route  of  inoculation  was  used  to 
inoculate  either  HSV-2  wt  or  one  of  the  is  mutants. 
Procedure  was  as  for  the  establishment  of  latency  in  the 
mouse  brain,  except  that  mice  were  killed  after  a  shorter 
period  of  time  following  inoculation.  The  whole  brains  from 
acutely  infected  mice  were  removed  at  5',  10',  15',  30';  1, 
2,6,12  hours,  1,2,3,4,5,6,7  and  12  days  after 
inoculation.  At  least  two  mice  were  used  for  each 
particular  time  point  choosen  in  this  study. 
After  removal,  brains  were  individually  allocated 
(without  washing)  into  Universals  containing  5  ml  of  EC10. 
Brains  were  then  harvested  by  homogenisation,  sonic.  ation 
followed  by  freezing  and  thawing  cycle. 
Brain  suspensions  were  centrifuged  at  4000  rpm  (in  MSE 
cold  spin)  for  30'  at  +4°C,  and  the  supernatant  collected  as 
Si.  Pellets  were  resuspended  in  5  ml  of  fresh  EC10, 
sonicated,  then  centrifuged  as  before.  Supernatant  was 
collected,  pooled  then  titrated  at  both  31°C  and  38°C  by 
plating  0.1  ml  on  C13  seeded  petri  dishes.  Three  days  later 
petri  dishes  were  fixed  and  stained  and  the  plaque  titre 
determined. 
Immunofluorescence  experiments 
Indirect  immunofluorescence  experiments  were  performed 
to  ascertain  the  identity  of  the  neural  cell  types 
supporting  HSV  reactivation  in  cultures  from  dissociated 
DRG. 
The  monoclonal  antibody  A2B5  (neurone  specific  marker) 96 
and  poly-specific  antiserum  directed  against  HSV  (rabbit 
anti-HSV)  were  used  in  these  experiments. 
Cells  from  dissociated  DRG  were  grown  on  collagen-coated 
coverslips  at  37°C  in  linbro-wells.  After  a  time  interval 
either  when  a  CPE  was  first  noticed  in  cultures  of  the 
dissociated  DRG  or  when  there  was  virus.  release  in  the 
supernatant  (indicated  by  plating  the  supernatant  on 
BHK21/C13  cells),  the  coverslips  were  picked  up,  washed  and 
individually  treated  with  40  ul  of  A2B5  (diluted  1:  40  in 
PBS).  Binding  of  cell  marker  was  achieved  within  30'  at 
room  temperature  in  a  humid  chamber.  Coverslips  were  then 
washed  three  times  by  dipping  in  fresh  PBS  and  drained. 
Afterwards  coverslips  were  incubated  with  40  ul 
fluorescene-conjugated  rabbit  anti-mouse  immunoglobulin 
(Miles-Yeda),  diluted  1:  20  in  PBS,  for  30  minutes  at  room 
temperature.  The  coverslips  were  then  washed  in  PBS  and 
fixed  in  5%  acid/alcohol  (5  ml  of  glacial  acetic  acid-in 
95  ml  Ethanol)  for  15  minutes  at  -20°C.  They  were  then 
washed  and  drained  as  before. 
Forty  ul  of  rabbit  anti-HSV  (diluted  1:  40  in  PBS)  was 
then  added  to  each  coverslip  and  incubated  for  30'  at  room 
temperature,  followed  by  another  washing  step.  Coverslips 
were  then  incubated  with  40  ul  of  goat  anti-rabbit  IgG 
conjugated  to  rhodamine,  diluted  1:  20  in  PBS  for  30  minutes. 
Later,  coverslips  were  washed  3  times  in  PBS  then 
mounted  in  glycerol  on  glass  slides,  sealed  with  nail 
varnish  and  examined  under  a  fluorescence  microscope  (Leitz 
Ortholux)  and  viewed  with  phase  contrast  optics  or  for 
immunofluorescence. 
Temperature  Sensitivity  Assay  of  Recovered  Viruses 
Recovered  viruses  from  latently  infected  mice  were 97 
assayed  to  determine  if  they  retained  their  is  phenotype  by 
titrating  at  both  permissive  and  nonpermissive  temperatures 
(31°C  and  38.5°C)  in  the  presence  of  EHu  5%. 
Thermostability  of  HSV-2  is  Mutants 
The  ability  of  the  wt  HSV-2  and  is  mutants  to  survive 
under  explanted  ganglia  conditions  was  studied  as  follows. 
Virus  suspensions  were  prepared  (5x106  -  5x107  pfu/ml) 
in  EFC50  medium.  Virus  suspensions  were  then  aliquoted  in 
one  ml  volumes  in  screwcapped  vials.  Vials  were  then 
incubated  at  31°C  and  the  titres  determined  at  intervals  of 
0,2,4,8,12  hours;  and  1,2,3,4,5,6  &7  days  after 
incubation  by  plating  0.1  ml  of  each  virus  dilution  onto  two 
semiconfluent  petri  dishes  of  BHK21/C13  cells.  After  one 
hour  of  absorption  at  38°C,  two  millilitres  of  EHu  5%  were 
added  to  each  petri  dish.  The  cultures  were  then  incubated 
at  31°C  for  3  days  before  fixing  and  staining.  The  plaques 
were  counted  and  the  mean  value  of  two  different  readings 
was  recorded. 
Homogenisation  of  Explanted  Tissue: 
Tissues  from  acutely  infected  mice 
In  the  first  group,  the  footpads  were  inoculated  with 
a  known  concentration  of  HSV-2  (wt)  before  explantation. 
Then  they  were  immediately  explanted,  homogenised  and 
titrated  (six  footpads  were  used  in  this  group). 
In  the  second  group,  the  footpads  were  explanted,  then 
the  virus  was  added  before  homogenisation  and  titration. 
Tissues  from  Latently  Infected  Mice 
Footpad  tissues  and  dorsal  root  ganglia  were  explanted 
from  latently  infected  female  BALB/c  mice  that  were 
inoculated  with  106  pfu  of  HSV-2  wt  virus/mouse. 
Explanted  tissues  from  individual  footpads  were 98 
divided  into  two  halves.  The  first  half  was  homogenised  in 
0.15  ml  of  PBS  +  gentamicin  +  10%  CS  (using  glass 
homgeniser,  Duall  20).  The  homogenate  volume  was  increased 
to  0.5  ml  by  adding  another  0.35  ml  of  PBS  +  gentamicin. 
The  homogenate  suspension  was  then  titrated  in  duplicate  on 
BHK  cells.  After  one  hour  of  absorption  at  38.5°C,  plates 
were  overlaid  with  EHu  5%  and  incubated  at  38.5°C  for  three 
days  before  they  were  fixed,  stained  and  counted. 
In  each  case,  the  other  half  of  the  footpad  tissue, 
was  cultured  as  before  and  the  supernatant  screened  daily 
for  released  virus. 
Explanted  DRG  (from  the  same  mice)  were  also  cultured 
and  the  supernatants  screened  as  before  except  that  the 
screening  was  performed  5-6  times  a  week  instead  of  just 
twice  a  week. 
Replication  of  HSV-2  wt  and  is  Mutants  at  Different 
Temperatures  of  Incubation 
A  rapid  plaque  assay  was  used  to  determine  the  ability 
of  wt  and  is  mutants  to  grow  at  different  temperatures  of 
incubation.  The  selected  temperatures  were  31°C,  34.5°C, 
36.5°C  and  38.5°C. 
Serial  ten-fold  dilutions  of  each  virus  stock  were 
prepared  in  PBSCS.  0.1  ml  of  each  dilution  was  allowed  to 
absorb  to  BHK  21/C13  monolayers  in  40  mm  plates  at  38.5°C 
for  one  hour.  After  absorption,  2  ml  of  EHu  5%  were  added 
to  each  plate.  Plates  were  incubated  for  3  days  at  the 
selected  temperatures.  Plates  were  then  fixed,  stained  and 
the  plaques  were  counted.  The  virus  titre  at  each 
temperature  was  examined. 
Histology 
Dorsal  root  ganglia  from  healthy  non-infected  mice 99 
were  explanted  and  cultured  with  EFC50  for  varying  times. 
Cultured  tissues  were  formalin  fixed  (for  24  hours).  then 
embedded  in  paraffin,  sectioned  and  hematoxyline/eosin 
stained.  Sectioning  and  staining  procedures  were  carried 
out  in  the  Department  of  Pathology.  Sections  were  studied 
by  light  microscopy. 
Virus  Particle  Count  -  "Particle/pfu  ratio" 
This  was  done  in  the  E.  M.  Unit  in  the  Institute  of 
Virology.  The  method  used  was  that  described  by  Watson 
(1962). 
A  sample  of  stock  virus  was  diluted  in  PBSC  to  give 
approximately  108  pfu/ml.  This  was  mixed  with  an  equal 
volume  of  phosphotungstic  acid  (as  negative  stain)  and  the 
same  volume  of  a  suspension  of  latex  beads  at  a  known 
concentration.  The  latex  beads  were  sonicated  for  4-5 
minutes  before  use.  A  sample  of  the  mixture  (3  ul)  was 
spread  onto  a  carbon  grid,  allowed  to  dry  and  viewed  under 
the  electron  microscope  (40.000X)  magnification,.  the 
concentration  of  virus  particles  was  calculated  by  comparing 
the  number  of  virus  particles  present  with  the  number  of 
latex  beads  in  a  given  field  of  the  grid. 
The  number  of  particlesin  the  following  virus  stocks 
were  counted:  wt  (HG52),  is  3,  is  5,  is  9  and  is  10. 
Restriction  Endonuclease  Digestion  of  HSV  DNA 
Preparation  of  virus  DNA 
The  method  used  was  that  described  by  Lonsdale  (1979) 
with  slight  modifications. 
BHK  cells  were  seeded  on  Linbro  wells  at 
5x105  cells/well  in  1  ml  of  GMEM  -  PIC  medium.  Linbro  wells 
were  then  incubated  at  370C  for  24  hours  until  a  confluent 
monolayer  formed. 100 
After  the  medium  was  removed,  each  well  was  infected 
with  0.1  ml  of  virus  suspension  (m.  o.  i.  0.1  -  0.5  pfu/cell) 
and  allowed  to  absorb  for  one  hour  at  38.5°C. 
The  cells  were  washed  once  (to  remove  unabsorbed 
viruses)  with  700  ul  of  G.  M.  E.  M.  -  P.  I.  C.  after  which  450  ul 
of  fresh  G.  M.  E.  M.  -  P.  I.  C.  was  added  to  each  well.  Linbro 
wells  were  incubated  at  320C  for  2  hours,  before  50  uCi  of 
32P-orthophosphate  (Amersham,  carrier-free)  in  50  ul  volume 
was  added  to  each  well  and  incubation  continued  at  320C 
until  an  even  cpe  was  evident  (36-48  hours). 
To  harvest  the  infected  cells,  500  ul  of  5%  (w/v)  SDS 
was  added  directly  to  each  well  and  mixed  by  swirling.  The 
mixture  in  each  well  was  transferred  to  a  glass  conical 
centrifuge  tube  and  incubated  at  37°C  in  a  shaking  water 
bath  for  10  minutes.  While  standing  in  an  ice  bath,  the 
transferred  mixture  was  further  mixed'by  inversion  with  1  ml 
of  saturated  phenol.  The  tubes  were  inverted  10  times 
initially,  then  twice  during  the  following  5'  minutes  to 
ensure  sufficient  mixing  with  the  phenol. 
The  tubes  were  left  to  stand  in  the  ice  bath  for 
10  minutes  before  the  phases  were  separated  by 
centrifugation  for  10  minutes  at  2000  rpm  (MSE  cold  spin)  at 
+4°C.  The  aqueous  phase  (which  contains  the  nucleic  acid) 
was  carefully  removed  to  a  glass  centrifuge  tube  and  the 
nucleic  acid  precipitated  by  the  addition  of  2  volumes 
(2  ml)  ethanol  (Analar),  mixed  by  inversion  10  times  and 
"pelleted"  immediately  by  centrifugation  at  2000  rpm  (MSE 
cold  spin)  for  10  minutes  at  +4°C.  The  supernatant  was 
discarded,  the  tubes  were  inverted  to  drain  for  1-3  hours  at 
room  temperature. 
The  nucleic  acids  were  resuspended  in  0.2  ml  of 101 
distilled  H2O  containing  20  ug  of  RNA-ase  A,  50  units  of 
RNA-ase  T1  and  incubated  in  a  shaking  water  bath  at  37°C  for 
2  hours.  Ten  ul  of  the  disolved  nucleic  acids  were 
transferred  to  a  2.5  cm  Whatman's  no.  1  filterpaper  disc,  and 
the  remaining  were  transferred  to  Eppendorf  tubes  and  stored 
at  4°C.  The  filter  paper  discs  were  air  dried,  then  given 
three  washes  (5  minutes/each  time)  in  5%  trichloroacetic 
acid,  2.5%  sodium  tetrapyrophosphate,  then  two  washes  in 
absolute  ethanol  and  acetone.  Finally,  they  were  air  dried 
before  the  labelled  phosphate  incorporated  into  DNA  was 
counted  in  5  ml  of  5%  toluene  (P.  P.  O  Koch-Light 
Laboratories). 
Sample  preparation 
Immediately  before  using  the  samples  for  endonuclease 
digestion,  the  DNA 
suitable  volume  of 
RNA-ase  resistance 
the  same  amount  of 
The  endonucl, 
following  manner. 
The  required 
samples  were  standardised  by  adding  a 
water  so  as  to  have  samples  of  equal 
i.  e.  each  sample  containing  approximately 
radioactivity. 
gase  digestion  was  carried  out  in  the 
volumes  of  H2O  were  first  added  to  the 
wells  of  microtitre  plates.  This  was  followed  by  6  ul  of 
the  appropriate  reaction  mixture  (see  Materials).  The 
calculated  volume  of  the  prepared  DNA  was  then  added  and 
this  was  followed  by  the  endonuclease  in  a  volume  of 
1  ul/sample. 
Microtitre  plates  were  sealed  with  sellotape  and  their 
contents  mixed  by  swirling.  Plates  were  then  incubated  at 
38°c  for  4-6  hours  to  allow  the  complete  reaction  to  take 
place.  The  reactions  were  stopped  by  the  addition  of 
5  ul/sample  of  R.  E.  Stop  "Mixture". 102 
Agarose  Gel  Electrophoresis 
"Digests"  were  analysed  by  overnight  or  24  hour 
agarose  gel  electrophoresis.  Agarose  at  a  particular 
strength  was  dissolved  in  1XE  buffer  by  boiling  for  3 
minutes  (Microwave  oven). 
DNA  samples  were  carefully  loaded  onto  the  gels  and  a 
constant  ;  voltage  of  2  v/cm  at  room  temperature  was  applied 
for  approximately  12-24  hours.  The  agarose  concentrations 
used  were  0.6%  for  EcoRI,  Hind  III,  Bgl  II  and  Bam  HI,  while 
0.8%  agarose  concentration  was  used  for  Kpn  I. 
Autoradiography 
Gels  were  dried  onto  glass  plates  by  standing 
overnight  at  37°C  (hot  room)  and  then  exposed  to  "Kodirex" 
film  for  24-72  hours  at  -20°C.  In  some  experiments, 
autoradiographic  results  were  obtained  by  preflashing 
'Kodak'  XH1  film  and  exposing  this  in  conjunction  with  an 
intensifier  screen.  Development  of  exposed  films  was 
performed  in  an  X-Omat  processor. RESULTS 103 
Mortality  Following  Peripheral  Infection  with  Two  Different 
Doses  of  wt  Virus. 
After  footpad  inoculation  mice  were  scored  daily  (for 
the  first  3  weeks)  for  signs  of  illness,  paralysis  of  the 
hind  legs,  or  death.  Deaths  within  24-48  hours  or  more  than 
4  weeks  after  inoculation  were  excluded. 
The  results  of  this  experiment  are  shown  in  Table  6. 
No  deaths  or  signs  of  illness  were  noticed  in  C57  BL/6-J, 
BALB/C  or  BIOZZI  strain  mice  when  they  were  inoculated  with 
105  pfu  of  HSV-2  (HG52  wt)  virus.  However  2  cases  of 
paralysis  followed  by  death  were  observed  in  strain 
"PIRBRIGHT"  and  2  in  strain  "A",  inoculated  with  the  same 
dose.  The  paralysis  was  observed  on  the  18th  day 
(PIRBRIGHT)  and  on  the  11th  day  (A)  post  infection. 
Apart  from  BIOZZI  mice  (where  no  paralysis  or  death 
took  place  at  both  doses),  some  paralysis  and/or  deaths  were 
noticed  in  all  other  strains  when  the  virus  dose  was 
increased  to  106  pfu/mouse.  In  PIRBRIGHT  mice,  mortality 
increased  from  8.3%  (105  pfu)  to  16.6%  (106  pfu). 
Similarly,  it  increased  from  0%  to  27.7%  in  C57  BL/6-J  and 
0%  to  10%  in  BALB/C.  The  highest  mortality  occurred  with 
A/strain  mice:  33.3%  at  105  pfu  and  58.3%  at  106  pfu.  No 
illness  or  death  was  observed  before  8  days  or  after  21  days 
post  infection.  A  shorter  period  of  incubation  was  noticed 
in  some  mice  inoculated  with  high  doses. 
Latency  Establishment 
Virus  Reactivation  From  Latently  Infected  Mice 
Virus  released  in  the  supernatant  of  footpad  or  dorsal 
root  ganglia  organ  cultures  was  detected  by  screening  the 
supernatant  on  semiconfluent  BHK  cells  (grown  in  microtitre 
plates)  at  31oC.  The  screening  procedure,  unless  otherwise ro  c 
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indicated,  was  carried  out  daily  for  the  explanted  footpad 
cultures  and  twice  weekly  for  the  DRG  where  the  whole 
supernatant  was  removed  and  plated  on  BHK  cells.  Fresh 
medium  was  added  to  the  cultures  and  incubation  then 
continued  (see  Materials  and  Methods). 
Any  mouse  where  the  footpad  and/or  one  or  more  ganglia 
released  virus  (on  one  or  more  occasions)  was  scored  as 
positive.  The  first  screening  always  took  place  within 
24-48  hours  after  explantation. 
I.  Reactivation  of  WT  (HG52) 
(Comparison  of  two  different  doses) 
HSV-2  (wt)  was  inoculated  at  two  doses  of  105  pfu  and 
106  pfu/mouse  to  investigate  the  dose  effect  on  latency. 
A.  Reactivation  from  Dorsal  Root  Ganglia  (DRG). 
Table  7  presents  the  recovery  of  wt  virus  from  the  DRG 
of  latently  infected  mice.  Using  105  pfu/mouse,  the  wt 
virus  was  successfully  recovered  from  A,  BALB/C  and  BIOZZI 
mice  with  a  percentage  of  recovery  of  100%,  66.6%  and  84.6% 
respectively.  From  the  PIRBRIGHT  and  C57  BL/6-J  strains, 
virus  could  only  be  recovered  from  60%  and  40%  of  the  mice 
inoculated.  However,  after  initial  inoculation  with  the 
higher  dose  of  106  pfu/mouse  latency  was  established  and  the 
virus  could  be  recovered  from  100%  of  mice  in  all  strains 
except  C57  BL/6-J,  where  recovery  was  from  61.5%.  The 
(detection) 
average  time  for  virus  reactivation/was  15.5  -21.1  days 
after  initial  inoculation  with  105  pfu/mouse,  but  this  was 
decreased  to  7.6  -  12.7  for  the  106  pfu/mouse  dose.  The 
observed  limits  of  variation  in  time  of  reactivation  for 
each  mouse  strain  is  also  given  in  Table  9. 
B.  Reactivation  from  the  Footpad  Tissues. 
Attempts  were  made  to  reactivate  the  virus  from * 
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extraneural  tissue  by  explanting  footpad  tissues  immediately 
after  mouse  death  and  supernatants  were  screened  daily  for 
released  virus.  Table  8  presents  the  wt  virus  recovery  data 
from  the  footpad  and  also  the  average  time  when  reactivation 
was  first  observed.  With  the  exception  of  PIRBRIGHT  and 
A/mice,  the  percentage  of  virus  recovery  in  the  three  other 
strains  was  found  to  increase  with  increased  input  dose  of 
virus.  An  increase  in  the  initial  dose  of  infection  was 
correlated  with  subsequent  reduction  in  the  average  time 
required  for  virus  reactivation.  This  decreased  from  23 
days  to  15.7  for  C57  BL/6-J;  from  43  days  to  15  days  for 
BIOZZI,  and  from  17  days  to  9.7  days  for  BALB/C.  Although 
the  wt  virus  was  recovered  from  the  PIRBRIGHT  mice  when 
inoculated  with  the  low  dose  of  virus  (3/22),  yet, 
unexpectedly  no  virus  was  recovered  after  inoculation  with 
the  high  dose  (0/6).  This  result  could  be  due  to  the  small 
number  of  mice  inoculated  with  the  high  dose  of  input  virus. 
With  the  A/mice  the  footpad  cultures  of  mice  inoculated  with 
1x105  pfu  of  virus  were  unfortunately  lost  through 
contamination. 
Comparing  the  speed  of  recovery  of  wt  virus  following 
inoculation  with  106  pfu/mouse,  one  finds  recovery  from  the 
DRG  as  early  as  7  days  and  as  late  as  16  days  post 
explantation,  while  from  the  footpad  it  was  first  found  at  7 
days  and  latest  at  27  days  post  explantation.  Using  105  pfu 
of  input  virus,  the  FP  tissues  were  first  scored  positive  as 
early  as  7  days  and  as  late  as  43  days  post  explantation 
while  no  significant  changes  were  observed  with  the  ganglia 
(Table  9). 
C.  Distribution  of  Reactivable  wt  Virus  in  DRG. 
The  distribution  of  wt  virus  recovery  from  different 
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DRG  of  latently  infected  mice  was  investigated.  Results  are 
shown  in  Table  10,  for  virus  used  at  105  and  106  pfu  doses. 
Wt  virus  has  never  been  recovered  from  ganglia 
explanted  from  the  left  side  (contralateral  to  the  site  of 
inoculation).  Virus  was  predominantly  recovered  from  the 
lumbar  ganglia  particularly  from  6th  and  5th,  but  only 
rarely  from  the  right  side  ganglia  at  the  thoracic  or  sacral 
lumbar  level. 
At  106  pfu/mouse,  the  virus  was  very  often  recovered 
from  lumbar,  the  6th,  5th  and  4th  (22/31,28/31,17/31 
respectively)  while  at  105  pfu/mouse  the  virus  was 
predominantly  recovered  from  these  ganglia  but  to  a  lesser 
extent  (15/30,16/30,16/30  respectively). 
The  pattern  of  spreading  of  wt  virus  to  different 
ganglia  differed  between  mouse  strains.  The  virus  was 
widely  spreading  in  PIRBRIGHT  and  "A"  strain  mice  where  it 
reached  the  level  of  thoracic  ganglia,  while  in  the  other 
three  strains  the  virus  was  restricted  to  the  lumbar  region. 
2.  Reactivation  of  is  Mutant  Viruses  from  Different  Mouse 
Strains 
Temperature-sensitive  mutants  were  inoculated  into  the 
footpad  of  each  of  the  five  strains  of  mice.  The  capacity 
of  these  mutants  to  establish  latent  infection  and  to  be 
recovered  from  the  DRG  or  the  FP  were  then  checked. 
Tables  11,13,14,16,17,19,20,22,23,25  show  the  data 
of  is  mutant  experiments. 
PIRBRIGHT 
Ts  mutants  were  not  efficiently  recovered  from  the  DRG 
of  PIRBRIGHT  strain  mice  (Table  11).  No  virus  reactivated 
from  the  DRGs  of  mice  inoculated  with  is  2,3,5,9,10  and 
11;  with  the  exception  of  is  7,12  and  13  which  were y  ý+  w  w  n  ro  cn  3 
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recovered  from  a  signficant  number  of  mice  (40%,  21.4%  and 
18.1%  respectively),  the  remaining  mutants  were  rarely 
recoverable. 
No  signficant  sex  related  difference  was  detected  with 
regard  to  reactivation  from  latency.  The  distribution  of 
the  is  mutants  within  the  DRG  of  the  PIRBRIGHT  mice  was 
restricted  to  the  6th  and  5th  lumbar  ganglia  (Table  12). 
Recovery  of  the  is  mutants  from  the  footpad  tissues  of 
PIRBRIGHT  mice  was  even  lower  (Table  13).  Only  4  is  mutants 
(ts  2,3,12  and  13),  were  ever  recovered  from  cultured 
footpads,  and  these  only  on  one  occasion  each. 
On  average  is  mutants  established  latency  in  PIRBRIGHT 
mice,  in  the  DRG,  in  8.5%  of  individuals  (Table  11)  and  in 
the  footpad  in  2.5%  of  individuals  (Table  13). 
C57  BL/6-J 
The  reactivation  of  the  thirteen  is  mutants  from  the 
DRG  of  C57  BL/6-J  mice  is  presented  in  Table  14.  Five  of 
the  mutants  were  not  recovered  (ts  2,7,9,10  and  13). 
Ts  1  and  is  12  were  recovered  from  41.6%  and  45.4%  of  mice 
with  mutants  is  3,4,5,6,8  and  11  less  often  successful 
(8.3%,  30.7%,  8.3%,  16.6%,  30.7%  and  7.6%  respectively).  It 
seems  that  C57BL/6J  mice  are  more  susceptible  (14.7%)  than 
PIRBRIGHT  mice  to  is  mutant  induced  latent  infection  in  DRG. 
The  mutants  is  2,3,4,6,7,8,9  and  10  were  also 
recovered  from  the  footpad  tissue  of  C57BL/6J  mice  (Table 
15).  Ts  2,9  and  12  reasonably  frequently  (25%,  23%  and  30% 
respectively).  The  average  is  mutant  recovery  from  the 
footpad  of  this  mouse  strain  was  9.6%. 
The  spread  of  the  is  mutants  in  the  DRG  of  the 
C57  BL/6-J  mice  was  also  restricted.  Although  some  mutants 
were  recovered  occasionally  from  the  first  sacral  ganglion, H 
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none  of  the  mutants  were  recovered  from  a  ganglion  beyond 
the  4th  lumbar.  The  ganglia  most  frequently  releasing  virus 
were  again  the  5th  and  6th  lumbar  (Table  16).  There  was  no 
sex  dependent  difference  in  reactivation  from  latency. 
BIOZZI 
In  this  strain  four  mutants  (ts  1,2,4  and  8) 
reactivated  with  >33%  efficiency  (36.3%,  47%,  58.7%  and  35%) 
following  the  establishment  of  latent  infection  in  their 
DRG.  Four  other  mutants  (ts  6,7,11  and  13)  were  less 
frequently  reactivated  and  recovered,  but  mutants  is  3,5, 
9,10  and  12  were  never  recovered  from  the  DRG  of  this 
strain  of  mice.  The  average  recovery  of  mutants  was  19.6% 
(Table  17).  No  significant  difference  in  reactivation 
behaviour  was  found  between  males  and  females.  The  mutants 
behaved  differently  as  far  as  their  rate  of  recovery  from 
the  footpad  was  concerned  (Table  18).  Most  frequently 
recovered  was  is  3  where  5/15  of  the  cultured  footpad 
tissues  released  virus  while  all  is  3  infected  DRG  explants 
remained  negative.  Mutants  is  1,2,4,6,7,8,9  and  12 
were  also  recovered  from  the  footpad  but  only  on  one  or  two 
occasions  in  each  case.  On  average,  is  mutant  recovery  from 
BIOZZI  footpad  tissue  was  9.2%. 
No  virus  was  recovered  from  ganglia  beyond  the  4th 
lumbar,  and  the  pattern  of  is  mutants  spread  through  the 
(BIOZZI)  ganglia  was  similar  to  that  observed  in  PIRBRIGHT 
and  C57BL/6J  mice  (Table  19). 
BALB/C 
Seven  of  the  temperature  sensitive  mutants  (ts  1,4, 
7,8,10,11  and  12)  were  more  than  33%  efficient  in  their 
reactivation  from  the  latent  infection  in  the  DRG  of  BALB/C 
mice  and  only  4  mutants  (ts  3,5,9  and  13)  were  never * 
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recovered.  The  average  is  mutant  recovery  was  27.4% 
(Table  20).  Among  all  of  the  is  mutants  used  is  8  was 
recovered  from  8/9  mice.  Recovery  from  the  footpad  was  also 
good  with  five  is  mutants  (ts  1,2,4,8  and  10)  being 
successfully  isolated  from  a  third  or  more  of  the  inoculated 
mice.  Only  three  mutants  is  5,  is  11  and  is  12  were  not 
recovered  from  the  footpad  of  BALB/C  mice  (Table  21). 
Average  is  mutant  reisolation  from  footpad  tissues  was 
22.6%. 
Although  the  is  mutants  were  restricted  to  the  lumbar 
ganglia  in  their  distribution,  both  is  1  and  is  4  were 
reactivated  and  recovered  from  the  3rd  lumbar  ganglion  and 
is  1,4,11  and  12  were  also  recovered  from  the  lst  sacral 
ganglion  (Table  22). 
Strain  "A" 
The  DRG  latency  negative  group  of  is  mutants  in  "A" 
strain  mice  consist  of  is  3,5  and  7  (Table  23).  All  other 
mutants  were  demonstrated  to  establish  latent  infection  in 
the  DRG  of  this  strain  of  mice  bringing  the  average 
efficiency  to  25%.  According  to  their  efficiencies,  the 
mutants  can  be  listed  in  a  decreasing  order  as  is  2,8,1, 
4,12,6,10,11,13  and  9.  The  differences  between  males 
and  females  observed  in  this  strain  remain  to  be  confirmed. 
The  results  of  is  mutant  recovery  from  the  footpad  are  shown 
in  Table  24.  Eight  mutants  were  reisolated  from  footpad 
explants.  Three  mutants  were  recovered  from  a  third  or  more 
of  the  footpads,  namely  is  4,  is  10  and  is  3.  The  mutants 
that  could  not  be  reisolated  were  is  1,5,7,9  and  11.  The 
average  percentage  of  recovery  of  is  mutants  reached  18.7% 
in  this  particular  strain  of  mice. 
No  virus  has  been  isolated  from  the  explanted  1st y 
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sacral  ganglion,  but  mutants  is  2  and  is  4  have  been 
recovered  from  the  3rd  lumbar  ganglion.  Reactivation  was 
never  observed  from  ganglia  other  than  those  of  the  lumbar 
region  (Table  25). 
In  addition  to  the  generally  lower  capacity  to  induce 
latency,  the  is  mutants  were  also  found  to  need  a  longer 
time  for  reactivation  compared  to  that  of  the  wild  type. 
The  average  time  of  reactivation  of  the  mutants  from  either 
sites  (DRG  and  FP)  of  different  mouse  strains  is  presented 
in  Table  26.  In  general,  is  mutant  viruses  are  slower  to 
reactivate  from  the  footpad  than  from  the  ganglia. 
3.  Reactivation  of  wt  virus  from  the  Brain  and  Spinal  Cord 
of  Peripherally  Inoculated  Mice 
Brain  or  spinal  cord  tissues  from  mice  that  had 
survived  for  three  months  after  being  infected  with  HSV-2  wt 
(105-106  pfu  per  mouse)  were  explanted  and  cocultivated  with 
HeLu  cells  at  31°C.  Slight  cell  toxicity  was  observed  in 
some  cultures  when  the  spinal  cord  or  brain  pieces  were 
cocultivated. 
The  results  of  the  experiment  show  that  the  wt  virus 
can  be  recovered  from  the  spinal  cord,  but  not  from  the 
brain,  of  "A"  strain  of  mice.  No  virus  was  recovered  either 
from  the  brain  or  from  the  spinal  cord  of  PIRBRIGHT, 
C57BL/J,  BIOZZI  mice  even  though  it  was  recovered  from  the 
DRG  of  all  but  one  of  the  animals  tested  (Table  27). 
One  of  the  two  mice  that  released  virus  from  their 
spinal  cord  also  shed  virus  from  the  footpad. 
4.  Behaviour  of  HSV-2  (wt)  in  a  Paralysed  and  in  a 
Clinically  Normal  Latently  Infected  Mouse 
Attempts  were  made  to  reactivate  HSV-2  (wt)  from 
different  sites  of  paralysed  and  non-paralysed  mice. * 
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HSV-2  (wt)  was  inoculated  into  the  footpad  of  male 
PIRBRIGHT  mice  at  a  dose  of  106  pfu/mouse.  Mice  were  left 
to  survive  the  infection  and  recover.  Many  mice  appeared 
well  again  and  free  of  overt  signs  of  infection.  However, 
some  mice  (3/18)  were  showing  persistent  limb  paralysis,  one 
the 
of/latter  mice  was  left  to  survive  for  another  5  months 
after  inoculation  (Figure  18).  Subsequently  mice  were 
killed  with  chloroform  and  their  left  and  right  footpads, 
sciatic  nerves,  dorsal  root  ganglia  and  the  spinal  cord  and 
the  brain  were  explanted,  cultured  and  screened  for 
reactivated  virus. 
In  the  latently  infected,  non-paralysed  mouse  wt  virus 
proved  recoverable  from  right  side  sensory  ganglia  only  and 
there  only  from  the  5th  and  6th  lumbar  (Table  28). 
In  the  mouse  with  the  paralysed  right  rear  limb,  the 
virus  proved  recoverable  not  only  from  six  right  side 
ganglia  but  also  from  the  left  side  6th  and  5th  lumbar 
ganglia  and  from  the  spinal  cord.  Virus  reactivation  was 
first  observed  from  the  right  side  DRG  of  the  paralysed 
mouse  ten  days  after  explantation.  Three  days  later  the 
left  side  ganglia  and  the  spinal  cord  released  virus  and  at 
the  same  time  virus  was  first  recovered  from  the  DRG  of  the 
non-paralysed  mouse.  Virus  was  not  recovered  from  the 
footpads,  sciatic  nerves  or  brains  of  these  two  mice. 
5.  Latency  Establishment  and  Reactivation  of  is  Mutants 
Viruses  in  the  Mouse  Brain 
The  ability  of  some  of  the  HSV-2  is  mutants  to 
establish  latent  infection  and  to  be  recovered  from  BALB/C 
mouse  brains  was  studied.  The  mutants  chosen  had  been  found 
to  be  either  non  recoverable  (ts  3,  is  5  and  is  9)  or  the 
least  recoverable  (ts  6)  from  the  DRG  of  latently  infected FIGURE  18 
Persistent  hind  limb  (right)  paralysis  in  PIRBRIGHT 
mouse  5  months  after  footpad  inoculation  with  106 
pfu  of  HSV-2  strain  HG52. (D  r"  fl  rt 
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BALB/C  mice.  The  mutants  were  inoculated  at  a  dose  of  105 
and  106  pfu/mouse  in  0.05  ml  intracerebrally.  Six  weeks 
later  brain  tissues  were  explanted  and  cocultivated  as  small 
pieces  with  HeLu  cells  (one  piece  of  tissue  cultivated  in 
each  petri  dish)  at  31°C.  Some  of  the  brain  pieces  were 
cultured  alone  with  EFC50  as  an  organ  culture  and  the 
supernatants  screened  for  released  virus  (see  Materials  and 
Methods).  Cultures  were  screened  for  any  cytopathic  effect. 
No  virus  was  recovered  from  the  mouse  brains 
inoculated  with  is  3,  is  5  or  is  9  at  either  dose  even  after 
25  days  of  incubation,  and  even  when  the  cultures  (brain 
pieces  and  HeLu  cells)  were  sonicated  and  replated  on  C13 
cells.  However,  one  cocultivated  brain  tissue  from  the  is  6 
inoculated  mouse  released  virus  after  23  days  of 
co-cultivation.  Moreover,  when  tissues  and  cells  from  the 
is  6  inoculated  mice  were  harvested,  sonicated  and  replated 
on  C13  cells,  another  mouse  brain  tissue  was  found  to  have 
released  virus  (Table  29). 
A  normal,  uninoculated,  mouse  brain  and  virus 
inoculated  HeLu  cell  culture  were  used  as  controls 
respectively.  The  viruses  isolated  proved  to  be  still 
temperature  sensitive. 
6.  Immunofluorescence  Studies  and  Virus  Reactivation  From 
Dissociated  Ganglia  in  Culture 
Left  and  right  side  dorsal  root  ganglia  from  mice  that 
had  survived  for 
explanted,  disso, 
Ganglia  from  3-4 
experiment.  The 
sampled  (100  ul) 
cultures.  Virus 
three  months  after  being  infected  were 
ciated  and  cultured  at  either  31°C  or  37°C. 
mice  were  pooled  and  dissociated  in  each 
supernatants  of  the  DRG  cell  cultures  were 
daily  and  plated  on  BHK21/C13  cell 
reactivation  was  recognised  by  the TABLE  29 
LATENT  INFECTION  AND  RECOVERY  OF 
TS  MUTANTS  FROM  MOUSE  BRAIN' 
Virus  Dose  No.  of  +ve/total 
pfu/mouse 
is  3  105  0/7 
is  5  105  0/7 
is  5  106  0/4 
is  6  105  2/13** 
is  9  105  0/10 
is  9  106  0/5 
*3  week  old  male  and  female  BALB/c  mice  were 
used. 
**  One  isolate  was  recovered  23  days  after 
co-cultivation;  the  other  isolate  was 
recovered  on  the  32nd  day  and  only  after 
harvesting 
and  sonication  of  the  cultured  cells. 113 
appearance  of  cpe  either  in  BHK21/C13  cells  or  in  the 
dissociated  DRG  cultures. 
The  wt  virus  was  successfully  reactivated  from 
dissociated  right  side  DRG  of  PIRBRIGHT  mice  (Table  30), 
though  reactivation  of  the  virus  from  two  other  strains 
(BALB/C  and  BIOZZI)  were  not  achieved.  The  likely 
explanation  for  this  observation  is  that  mice  of  the  latter 
two  strains  have  been  used  only  in  one  experiment  each, 
while  four  dissociation  experiments  were  carried  out  using 
PIRBRIGHT  mice. 
In  addition,  attempts  to  reactivate  is  3  from 
dissociated  DRG  cultures  of  "A"  strain  mice  at  31°C  were 
also  carried  out.  No  virus  was  recovered  and  no  positive 
immunofluorescence  was  detected  in  cultures  of  left  or  right 
side  ganglia  6-8  days  post  incubation,  or  in  cultures  of 
dissociated  ganglia  explanted  from  normal  uninfected  mice. 
Some  dissociated  DRG  from  uninfected  mice  were 
directly  infected  with  is  3  or  wild  type  HSV-2  (at  a 
multiplicity  of  5  pfu  per  cell)  and  reincubated  at  31°C. 
Cytopathic  changes  started  to  appear  12  hours  post  infection 
and  progressed  rapidly  within  the  next  few  hours.  Eighteen 
hours  later,  more  than  50%  of  the  cell  population  (infected 
with  is  3  at  31°C  or  with  the  wt  virus  at  38°C)  were  showing 
cpe  (Fig.  19-a).  At  this  time  cells  were  fixed  and  labelled 
with  fluorescence  conjugated  rabbit  anti-HSV  (Fig.  19-b). 
No  difference  was  observed  in  the  pattern  of 
immunofluorescence  in  cell  cultures  infected  in  vitro  with 
is  3  or  wt. 
Cytopathic  changes,  due  to  virus  reactivation,  were 
noticed  in  HSV-2  infected  dissociated  DRG  cultures  on  the 
5th-6th  day  post  dissociation  (Fig.  20).  However,  virus  was FIGURE  19 
a-  cytopathic  changes  in  cell  culture  of  dissociated  DRG 
infected  with  is  3  virus  (in  vitro),  18  hours  post 
infection  at  31°C;  magnification  x320. 
b-  is  3  infected  ganglion  cell  showing  positive,  anti-HSV 
immunofluorescence,  18  hours  after  infection  (in  vitro); 
magnification  x400. a 
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CYTOPATHIC  CHANGES  DUE  TO  REACTIVATION  OF  WILD  TYPE  VIRUS 
IN  CELL  CULTURE  OF  DISSOCIATED  DRG 
(OF  LATENTLY  INFECTED  MICE)  5  DAYS  AFTER  DISSOCIATION 
Photographed  with  phase-contrast  illumination  showing 
the  morphology  and  distribution  of  cells  within  the  culture, 
magnification  x320. 114 
detected  in  the  culture  supernatant  as  early  as  the  3rd  day 
after  dissociation  (see  Table  30).  The  cpe  areas  were 
initially  limited  in  distribution  (1-2  foci  per  coverslip) 
but  within  the  next  48  hours  more  than  40%  of  the  cell 
population  were  showing  cpe. 
In  some  of  the  experiments  (when  the  cpe  was  first 
noticed),  the  cultured  cells  were  double-labelled  with  the 
neurone  specific  monoclonal  antibody  A2B5  and  also  with  the 
poly-specific  rabbit  anti-HSV  serum.  All  cells  exhibiting  a 
cpe  were  expressing  viral  antigen,  and  labelling  of  the 
cells  with  A2B5  showed  that  some  of  these  cells  were  the 
neurones  (Fig.  21a,  b).  A  difference  in  the  pattern  of 
staining  of  cells  with  the  two  antibodies  were  observed. 
The  DNA  restriction  enzyme  profiles  of  the  original 
inoculated  virus  (HG52)  was  compared  to  those  of  the 
recovered  viruses.  The  DNA  profiles  were  studied  by  using 
the  restriction  endonucleases  Hind  III,  EcoRI,  Kpn  I  and 
Bar  HI. 
The  pattern  of  the  DNA  of  the  recovered  virus  was 
similar  to  that  of  the  standard  HSV-2  (HG52).  However,  a 
shift  in  the  mobility  of  some  of  the  restriction  fragments 
(HindIIl  m,  EcoRI  m,  Kpn  r,  s,  BamHI  g,  u,  z,  a')  was 
observed  (Fig.  22).  As  discussed  below  experiments  with  is 
mutants  also  revealed  that  some  restriction  fragments 
exhibited  variable  mobility. 
7.  Particle:  pfu  Ratio 
In  order  to  ascertain  that  the  inoculated  stock  of 
virus  does  not  have  a  large  proportion  of  non-infectious 
particles,  the  wild  type  HSV-2  virus  particles  and  that  of 
is  3,5,9  and  10  from  the  same  stock  used  for  mouse 
inoculation  were  counted  using  the  electron  microscopy ** 
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CYTOPATHIC  CHANGES  DUE  TO  REACTIVATION  OF  WILD  TYPE  VIRUS 
IN  CELL  CULTURE  OF  DISSOCIATED  DRG 
(OF  LATENTLY  INFECTED  MICE)  5  DAYS  AFTER  DISSOCIATION 
Same  field  as  in  Fig.  20  viewed  under  imcnunofluorescence 
microscopy;  magnification  x240.  Note  the  positive  rhodamin 
anti-HSV  (a)  and  fluorescence  A2B5  staining  (b)  in  cells 
expressing  viral  antigen  (large  arrows).  Also  note  the 
specific  staining  of  some  cells  (expressing  no  viral 
antigen)  with  the  A2B5  (small  arrows). a 
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AUTORADIOGRAPHY  OF  HINDIII,  EcoRI,  KpnI 
AND  BamHI  RESTRICTION  ENDONUCLEASE  DIGESTS  OF 
32P-LABELLED  DNA  OF  HSV-2  (HG52)  REACTIVATED  FROM 
DISSOCIATED  DORSAL  ROOT  GANGLIA 
A  latent-reactivated  virus 
B  HSV-2  strain  HG52 
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negative  staining  technique. 
The  particle  to  pfu  ratios  of  these  virus  stocks  were 
found  to  be  within  the  acceptable  limit,  (633,102,48,54 
and  110  respectively). 
8.  Growth  of  Wild  Type  HSV-2  and  Some  of  the  is  Mutants  in 
Mouse  Brain 
To  determine  whether  is  3,  is  5,  is  9  (which  were  very 
deficient  in  establishing  latent  infection  in  sensory 
ganglia)  and  is  10  grow  in  the  mouse  brain,  these  viruses 
were  inoculated  (at  a  dose  of  103  pfu/0.05  ml)  directly  into 
the  brains  of  female  BALB/C  mice.  After  a  given  time 
interval  the  mice  were  killed  then  their  whole  brains  were 
individually  removed,  homogenised,  sonicated  and  later 
titrated  both  at  the  permissive  and  non  permissive 
temperatures.  The  growth  curves  of  these  mutants  and  that 
of  the  wild  type  were  then  estimated  and  compared  (fig.  23). 
The  results  show  that  inoculated  viruses  start  to 
disappear  in  the  first  30  minutes  after  inoculation  and  were 
no  longer  demonstrable  in  the  mouse  brain  2  hours  after 
infection.  The  wild  type  HSV-2  virus  started  to  reappear  12 
hours  later  and  continued  to  increase  in  titre  attaining  the 
maximum  level  3-5  days  post  infection;  but  the  is  mutants 
could  not  be  demonstrated  in  the  mouse  brain  following  the 
initial  2  hours  of  infection.  Some  wild  type  virus  presence 
in  the  brain  tissue  was  still  detectable  as  late  as  12  days 
post  infection. 
9.  Titration  of  HSV-2  Wild  Type  and  is  Mutants  at  Different 
Temperatures  of  Incubation 
In  order  to  ascertain  whether  the  is  mutants  produced 
plaques  at  temperature  other  than  the  (31°C)  permissive 
temperature,  the  mutants  and  the  wild  type  virus  were FIGURE  23 
GROWTH  CURVES  OF  THE  WT  AND  TS  MUTANTS 
VIRUSES  IN  THE  MOUSE  BRAIN 
Two  or  more  mice  were  used  at  each  time  interval. 
"  wt 
   is  3 
"  is  5 
o  is  9 
o  is  10 
The  experiment  for  the  mutants  and  wt  viruses  were 
carried  out  for  12  days  post  inoculation. PFU/9m  of  brain  tissue 
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titrated  in  BHK  cells  at  four  different  temperatures  (31°C, 
34.5°C,  36.5°C  and  38.5°C)  of  incubation. 
The  result  of  such  experiments  (Fig.  24)  indicated 
that  none  of  the  is  mutants  produced  plaques  at  the 
nonpermissive  temperature  (38.50c).  All  the  mutants, 
however,  produced  similar  plaque  yields  at  the  other  three 
temperatures  of  incubation;  except  that  progressive  drop  in 
is  9  plaque  formation  was  observed  at  34.5  and  36.5°C 
temperature  of  incubation. 
10.  Thermostability  of  HSV-2  wt  and  is  Mutants  Under 
Explanted  Ganglia  Conditions 
In  order  to  determine  the  thermostability  of  the  wt 
virus  and  the  is  mutants  at  31°C,  the  virus  stocks  (3  ml  of 
virus  suspension  in  EFC  50%)  in  screw  capped  vials  were 
incubated  at  this  temperature  for  up  to  seven  days.  Stocks 
were  sampled  and  titrated  at  31°C  at  a  chosen  interval  of 
time.  Results  are  given  in  Fig.  25. 
The  pH  of  the  incubated  virus  stocks  were  not 
estimated,  however,  a  slight  change  in  the  colour  of  viral 
suspension  was  noticed  in  the  later  days  of  the  incubation. 
At  this  temperature  of  incubation  all  the  is  mutants 
progressively  lost  titre,  1,000  fold  (3  logs)  being  the 
minimum  in  seven  days  (ts  1).  Most  mutants  (ts  2,3,4,6, 
7,10  and  12)  survived  seven  days  incubation  losing  4-5  logs 
of  titre,  while  is  5,8,9,11,13  and  the  wt  viruses  were 
all  essentially  lost  by  day  7.  The  titre  of  is  5,11  and  13 
appeared  to  drop  more  rapidly  from  the  second  day  post 
incubation  than  did  the  titre  of  most  other  mutants.  The 
results  of  these  experiments  provides  evidence  that  the 
method  used  for  screening  ganglia  (2-3  times/week)  and 
footpads  (daily)  should  have  allowed  the  efficient  recovery FIGURE  24 
TITRATION  OF  WT  AND  TS  MUTANT  STOCKS  AT 
FOUR  DIFFERENT  TEMPERATURES  OF  INCUBATION: 
310C,  34.50C,  36.5°C  &  38.50C 
None  of  the  mutants  showed  any  detectable  plaque 
formation  at  38.5°C. PE'U 
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of  released  viruses.  In  addition,  all  the  recovered  viruses 
were  infectious,  growing  in  BHK  cells  and  hence  replication 
of  reactivated  viruses  in  explanted  ganglia  or  footpad 
tissue  can  be  expected  at  the  temperature  of  incubation 
(31°C). 
11.  Homogenisation  of  Footpad  Tissues 
In  order  to  check  for  the  presence  of  infectious  wt 
virus  in  the  footpad  tissues  of  latently  infected  mice  at 
the  time  of  explantation,  the  individually  explanted  footpad 
tissue,  from  BALB/C  mice,  was  divided  into  two  halves.  One 
half  was  homogenised  and  titrated  while  the  other  half  was 
kept  in  organ  culture  and  screened  for  released  virus.  The 
sensory  ganglia  of  all  of  the  six  latently  infected  mice 
shed  virus  in  their  supernatants. 
Tissues  from  acutely  infected  and  from  uninfected 
BALB/C  mice  were  also  homogenised  and  titrated  as  positive 
and  negative  controls  respectively. 
The  wt  virus  could  not  be  demonstrated  in  any  of  the 
homogenised  halves  of  footpad  tissue  while  4/6  cultured 
halves  released  wt  virus  after  8-12  days  of  incubation 
(Table  31).  No  virus  was  recovered  from  the  homogenised  or 
cultured  tissues  explanted  from  uninoculated  left  hind 
limb. 
No  loss  of  virus  has  been  observed  to  take  place 
during  the  process  of  homogenisation  of  footpad  tissues 
explanted  from  acutely  infected  mice  or  when  the  virus  was 
added  to  already  explanted  footpad  tissue  which  was  then 
homogenised  (Table  32). 
The  results  of  these  experiments  showed  that  the  virus 
can  be  recovered  from  the  footpad  tissue,  in  a  fashion 
similar  to  its  recovery  from  the  latent  state  in  the  sensory ** 
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ganglia  i.  e.  only  after  several  days  of  incubation  and  not 
by  homogenisation. 
12.  Temperature-Sensitivity  of  Reactivated  Viruses 
Viruses  reisolated  after  reactivation  from  mice  which 
had  been  initially  infected 
possible  reversion.  All  reg 
retained  their  is  genotype; 
at  38°C. 
13.  Analysis  of  Restriction 
of  Recovered  Viruses 
Stocks  of  reactivated 
with  is  mutants  were  checked  for 
covered  viruses  proved  to  have 
all  grew  at  31°C  but  not 
Endonuclease  Digest  of  the  DNA 
viruses  were  prepared  and  their 
DNA  restriction  enzyme  profiles  were  compared  with  that  of 
the  respective  virus  initially  used  for  mouse  inoculation. 
32P-labelled  DNA  was  prepared  from  individual  recovered 
viruses  and  digested  with  BamHI,  BglII,  HindIII  and  EcoRI. 
DNA  fragments  were  then  separated  on  agarose  gels  which  were 
dried  and  autoradiographed.  Results  are  shown  in  Fig. 
26a-e.  All  recovered  viruses  were  identified  as  HSV-2  by 
comparison  with  the  standard  HG52  strain  of  HSV-2. 
Restriction  fragments  BamHI  g,  p,  u,  z,  a';  EcoRI  m  and 
HindIIl  m  exhibited  variable  mobility.  These  fragments 
contain  sequences  from  the  terminal  repeat/inverted  repeat 
regions  of  the  genome  (see  restriction  endonuclease  map, 
Fig.  27)  and  have  previously  been  recognised  as  having 
variable  mobility  (Chaney  et  al.,  1983).  Mobility  variation 
was  also  observed  in  BamHI  w  and  y  which  map  in  UL  (Fig.  26 
a  and  b).  Loss  of  the  HindIII  m-1  restriction  site  was 
observed  in  a  single  case  of  is  3  virus  recovered  from  the 
footpad  (Fig.  26d).  This  will  be  discussed  later. FIGURE  26  (a-e) 
AUTORADIOGRAPHS  OF  THE  RESTRICTION  ENDONUCLEASE  DIGESTS 
OF  32P-LABELLED  DNA  OF  TS  MUTANTS  VIRUSES 
REACTIVATED  FROM  GANGLIA  AND  FOOTPADS  EXPLANTS 
Figure 
a  BamHI  restriction  endonuclease  digests 
b  BamHi  restriction  endonuclease  digests 
c  EcoRI  restriction  endonuclease  digests 
d  HindIIl  restriction  endonuclease  digests 
e  Bg1II  restriction  endonuclease  digests 
Restriction  fragments  with  variable  mobility  are 
indicated  with  the  symbol  (o) 
F  virus  recovered  from  the  footpad 
G  virus  recovered  from  the  ganglia 
0  initially  inoculated  viruses Ba  III 
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RESTRICTION  ENDONUCLEASES  PHYSICAL  MAPS  OF  HSV-1 
(STRAIN  GLASGOW  17)  AND  HSV-2  (STRAIN  HG52)  DNAS 
Letters  above  the  genome  model  refer  to  HSV-1  DNA 
fragments  while  those  of  HSV-2  are  shown  below  the  genome 
model. 
The  composition  of  the  joint  fragments  is  given  beside 
the  maps.  Only  the  prototype  arrangement  of  UL  and  US  is 
shown  (after  Davison,  1981). 
Lines  below  the  genome  model  refer  to  the  fragments 
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14.  Histologic  Studies  of  Explanted  DRG 
The  aim  of  this  particular  study  was  to  determine  the 
survival  time  of  ganglion  cells  after  explantation  and 
incubation  at  31°C. 
Explanted  ganglia  'from  uninfected  mice  were  formalin 
fixed,  paraffin  sectioned  and  stained  with  haematoxylin  & 
eosin  stain  after  culturing  for  various  times  post 
explantation.  The  slides  of  sectioned  ganglia  were  studied 
under  light  microscopy  (Fig.  28). 
Healthy  ganglion  cells  (neurones)  have  been  observed 
in  sections  of  ganglia  that  were  fixed  and  stained 
immediately  after  explantation  (zero  time).  The  cells 
appear  as  rounded  bodies  of  large  and  small  sizes.  Their 
nuclei  were  large  with  prominent  nucleoli.  Neurones  were 
separated  from  the  surrounding  connective  tissue  by 
flattened  (satellite)  cells.  Some  shrinking  neurones  were 
also  observed  in  this  section,  this  could  be  due  to  the 
traumatising  effect  of  the  explantation  and/or 
fixation-staining  procedure.  The  number  of  healthy  neurones 
decreases  in  sections  of  ganglia  that  have  been  incubated 
for  a  longer  period.  Pathological  changes  and  cell 
degeneration  start  to  appear  on  the  fourth  day  post 
incubation  and  progress  rapidly  with  the  subsequent  days.  A 
complete  degeneration  of  the  neurones  was  observed  in 
sections  of  ganglia  that  have  been  incubated  for  10  days  or 
more  post  explantation.  However,  other  supporting  cells, 
satellite  and  connective  tissue  cells,  have  retained  a 
normal  looking  morphology  even  after  incubation  for  up  to  3 
or  4  weeks. FIGURE  28 
PHOTOMICROGRAPHS  OF  GANGLION  CELLS  AS  THEY  APPEAR 
IN  SECTIONS  STAINED  WITH  HEMATOXYLIN  AND  EOSIN 
Mouse  sensory  ganglia  were  explanted  and  incubated  as 
described.  Note  the  healthy  looking  neurones  (both  large 
and  small  size)  in  the  first  two  photomicrographs,  where  the 
explanted  ganglia  were  fixed  and  stained  immediately  after 
explantation  (a),  or  2  days  after  being  in  culture  (b); 
magnification  x250  and  x200  respectively.  Pathological 
changes  in  ganglion  neurones  were  first  noticed  on  day  four 
post  incubation  (c)  and  progress  rapidly  with  the  subsequent 
days  (6,8,10  days)  of  incubation  (d,  e,  f),  magnification 
x250.  However,  a  substantial  number  of  neurones  have 
retained  the  normal  morphology.  Almost  complete 
degeneration  of  ganglion  cells  (except  the  connective  tissue 
cells)  was  observed  in  ganglia  incubated  for  2  and  4  weeks 
post  explantation  (g,  h);  magnification  x200. 
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For  a  very  long  time,  Herpesviruses  have  been  known  to 
cause  latent  infection;  in  fact  the  ability  of  the  fever 
blister  (cold  sore)  causative  agent  to  establish  latent 
infection  has  been  postulated  (Goodpasture,  1929)  in  the  early 
years  of  this  century. 
Herpes  simplex  virus  is  of  two  distinct  serotypes,  HSV-1 
and  HSV-2,  and  both  are  known  to  produce  recurrent  herpes. 
Following  a  primary  infection  in  man,  herpes  simplex  virus 
usually  persists  in  the  latent  state  and  remains  there  life 
long.  Man  may  be  infected  with  both  types  1  and  2  and  have 
recurrences  caused  by  either  or  both  (Wheeler,  1975).  The  site 
of  recurrence  appears  to  be  determined  by  the  location  of  the 
primary  infection  (Change,  1971)  and  the  viral  genome  appears 
to  be  latent  within  the  sensory  neurones  of  dorsal  root  ganglia 
(McLennan  and  Darby,  1980).  Though  the  virus  has  been  isolated 
from  other  sites  within  the  body  for  example  from  the 
trigeminal  nerve  root  (Warren  et  al.,  1982),  cervical  tumour 
cells  grown  in  culture  (Aurelian  et  al.,  1971)  and  from  the 
uterosacral  ligament  (Eglin  et  al.,  1981);  it  is  not  clear 
whether  the  virus  is  truly  latent  in  these  tissues  or  has 
reactivated  from  the  corresponding  ganglia  and  subsequently 
travelled  to  these  sites.  The  possible  existence  of  latent 
virus  in  peripheral  tissue  has  not  been  excluded.  The  physical 
state  of  the  viral  genome  during  the  latent  phase  of  infection 
is  unknown  and  neither  viral  genes  involved  in  latent  infection 
in  man  nor  host  factors  that  may  determine  the  susceptibility 
or  resistance  of  man  to  the  latent  infection  have  been 
identified. 
The  aim  of  the  work  presented  in  this  thesis  was  to 
identify  and  to  study  viral  genes  that  may  influence  the 
ability  of  HSV  to  induce  latency  in  the  mouse.  It  is  axiomatic 121 
that  such  genes  can  be  characterized  through  the  use  of  HSV 
temperature-sensitive  mutants  that  may  be  deficient  in 
establishing  latent  infection.  The  possible  occurrence  of 
variation  in  the  (genetically  determined)  host's  defense  system 
of  resistance  both  to  the  acute  and  latent  HSV  infection  can 
also  be  studied  through  the  observation  of  virus  behaviour  in 
different  host  strains. 
Recovery  of  wt  Virus  From  the  Latent  State 
After  virus  inoculation  (see  Methods),  mice  were  observed 
for  signs  of  acute  infection  and  then  survivors  were  left  for 
(at  least)  another  3  months  before  they  were  sacrificed  and  the 
presence  of  reactivable  virus  in  their  explanted  tissues 
scored. 
The  results  of  the  experiments  presented  in  this  study 
show  that  strain  HG52  of  HSV-2  (wt)  behaves  differently  in 
individual  mouse  strains  which  differ  in  their  resistance  both 
to  the  acute  and  latent  infections.  As  seen  from  the  data  of 
Table  6  mouse  susceptibility  to  acute  HSV-2  infection  is 
influenced  partly  by  the  dose  of  infection  and  partly  by  the 
host.  The  resistance  of  BIOZZI  mice  to  the  acute  infection  at 
both  tested  doses  was  high.  However,  since  the  virus  was  not 
inoculated  at  doses  higher  than  106  pfu,  the  effect  of  still 
larger  doses  of  virus  has  not  been  investigated.  Published 
studies  with  inbred  strains  of  mice  infected  with  HSV-1  showed 
that  mouse  strains  are  either  resistant  to  106  pfu  C57BL/6-J, 
moderately  susceptible,  BALB/c,  or  very  susceptible  A-J  (Lopez, 
1975;  Kirchner  et  al.,  1978a).  The  results  in  Table  6 
confirmed  the  high  susceptibility  of  "A"/mice  to  HSV  infection 
by  extending  observations  to  HSV-2.  This  susceptibility  is 
shown  not  only  by  the  criterion  of  the  number  of  mice  which 
died  after  infection  (7/12  at  106  pfu),  but  in  addition  by  the 122 
fact  that  paralysis  or  death  was  also  noticed  in  mice  that  were 
inoculated  with  lower  doses  of  virus,  and  the  observation  of  a 
shorter  incubation  period  in  this  particular  strain  of  mice. 
However,  the  results  with  HSV-2  are  not  completely  consistent 
with  the  categorization  of  the  inbred  strains,  C57BL/6-J  and 
BALB/c  as  resistant  and  susceptible  respectively  (Lopez,  1975). 
In  my  experiments  (Table  6)  BALB/c  strain  mice  were  resistant 
to  moderately  susceptible.  However,  it  is  important  to  note 
that  i,  small  numbers  of  BALB/c  mice  were  used  in  this 
particular  experiment,  ii,  different  routes  of  inoculation  were 
used  in  the  two  studies  (i.  e.  intraperitoneal  compared  to 
footpad  inoculation),  iii,  there  is  a  difference  in  virulence 
between  the  two  serotypes  (HSV-1  and  HSV-2).  Although,  HSV-1 
and  HSV-2  are  very  similar  they  are  far  from  identical  and  it 
is  noteworthy  that  there  is  much  evidence  of  genetic  divergence 
between  the  genomes  of  the  two  serotypes  (Halliburton,  1972; 
Kieff  et  al.,  1972;  Ludwig  et  al.,  1972;  Cortini  and  Wilkie, 
1978).  The  two  serotypes  differ  in  many  aspects  of  their 
biological  properties  including  the  nature  of  the  infections 
they  induce  in  their  natural  host  (Nahmias  and  Roizman,  1973a, 
b,  c).  Furthermore,  it  has  been  reported  that  HSV-2  is  more 
neurovirulent  in  mice  than  HSV-1  when  inoculated  either 
intramuscularly  or  into  the  footpad,  however,  there  were  no 
differences  in  virulence  upon  intracerebral  inoculation  or  when 
a  high  dose  of  inoculum  was  used  (McKendall,  1980). 
Based  on  the  experiments  reported  here  (Table  6)  mouse 
strains  can  be  categorized  (judged  by  the  total  percentage  of 
mortality)  as  resistant  (BIOZZI,  BALB/c,  C5715L/6-J),  moderately 
susceptible  (PIRBRIGHT)  and  very  susceptible  (A/mice)  when 
inoculated  with  105  pfu.  However,  when  mice  were  inoculated 
with  106  pfu  the  categorization  will  be  slightly  different,  for 123 
now  C57BL/6-J,  BALB/c  and  the  PIRBRIGHT  mice  all  appeared  to  be 
moderately  susceptible.  This  effect  of  dose  on  the 
classification  scheme  reinforces  the  importance  of  precisely 
defining  the  infectious  doses  used  when  ascertaining 
comparative  resistance  or  susceptiblity  of  mouse  strains  and  it 
underlines  the  conclusion  that  resistance  is  not  an  "all  or 
none"  phenomenon  (Lopez,  1981). 
It  is  well  known  that  macrophages  (mononuclear  phagocyte 
system)  can  respond  to  viral  infection  in  a  specific  (immune) 
and  non  specific  (non  immune)  fashion,  and  that  the  latter 
function  of  macrophages  plays  an  important  role  in  interfering 
with  and  in  limiting  virus  dissemination  within  the  host  in  the 
early  stages  of  primary  infection  (Mogensen,  1979).  It  is  of 
interest  to  know  that  A/J  mice  (very  susceptible  to  HSV 
infection)  were  found  to  have  a  profound  defect  in  macrophage 
(tumour  cytotoxicity)  function  (Borraschi  and  Meltzer,  1980), 
and  it  follows  that  macrophages  might  play  a  role  in  the 
increased  susceptiblity  of  A/mice  to  intraperitoneal  infection 
with  HSV-1  (Lopez,  1981).  However,  at  the  present  time  no 
information  is  available  about  the  cytotoxicity  function  of 
macrophages  in  other  strains  of  mice  and  analysis  of 
interaction  between  HSV-2  and  macrophages  (derived  from 
susceptible  and  resistant  mice)  is  relevant  and  important. 
Although  the  exact  mechanism  of  virus  restriction  by 
macrophages  is  not  known,  it  is  probable  that  macrophages 
induce  their  effect  through  the  release  of  virus-destructive 
products,  probably  lysosomal  enzymes,  and/or  by  processing  and 
presenting  captured  antigens  to  lymphocytes  for  immune 
recognition  (Unanue,  1972).  Further,  macrophages  have  been 
shown  to  be  of  importance  in  the  production  (by  specifically 
sensitized  lymphocytes)  of  immune  type  II  interferon  (Epstein 124 
et  al.,  1972).  It  is  relevant  that  a  higher  titre  of 
interferon  (IF)  is  produced  by  HSV-1  resistant  C57BL/6  (B6) 
mice  than  by  susceptible  DBA/2  (D2)  mice,  both  in  vivo  and  in 
spleen  cells  explanted  from  these  mice;  and  further,  spleen 
cells  derived  from  BALB/c  and  A/mice  were  found  to  produce  a 
very  low  level  of  IF  compared  to  C57BL/6  and  B6D2  FLhybrid  mice 
(Kirchner  et  al.,  1978b).  Interferon  can  also  be  found  at 
local  inoculation  sites  such  as  in  brain  (Bostandzhyan  and 
Bikbulatov,  1967)  or  in  the  skin  (Force  et  al.,  1965;  Sydiskis 
and  Schultz,  1966)  of  rabbits  and  mice  inoculated  with  herpes 
simplex  virus.  Preliminary  experiments  revealed  IF  antiviral 
(anti  VSV)  activity  in  skin  samples  from  HSV  infected  mice  as 
early  as  8  hours  post  infection  and  a  high  level  of  interferon 
was  detected  in  the  skin  within  24  hours  post  infection  (a  time 
at  which  viral  concentrations  in  the  skin  are  still  relatively 
of  low  levels,  (Sydiskis  and  Schultz,  1966)). 
Although  during  my  work  no  attempts  were  made  to  estimate 
the  interferon  response,  it  can  be  assumed  that  interferon  is 
either  not  produced  by  the  susceptible  mice  or  the  level  of 
interferon  induced  by  HSV-2  infection  is  not  sufficient  to 
achieve  a  potent  antiviral  effect.  It  has  been  concluded  that 
the  early  production  of  IF  is  an  important  element  in  the 
response  of  mice  to  several  virus  infections  including  HSV 
(Gresser  et  al.,  1976).  However,  the  role  played  by  interferon 
in  this  context  is  still  a  matter  of  speculation.  Recent 
studies  (Collier  et  al.,  1983)  showed  that  there  is  no 
relationship  between  interferon  production  and  HSV-1 
replication  in  mouse  embryo  cells  derived  from  susceptible  (A-J 
and  DBA/2)  or  resistant  (C57BL/6)  or  C57BL/6  x  DBA/2  (FI)  mice. 
Higher  natural  killer  (NK)  cell  activity  was  observed  in 
resistant  mice  than  in  susceptible  mice  (Kirchner  et  al.,  1980) 125 
and  preliminary  results  showed  that  resistant  strain  mice, 
resistant  FI  mice  and  back  cross  mice  (resistant  to  challenge 
with  106  pfu  of  HSV-1)  had  spleen  cells  which  responded 
significantly  better  than  susceptible  BALB/c  and  A-J  mice; 
suggesting  a  strong  correlation  between  NK  cells  and  genetic 
resistance  of  mice  to  HSV-1  (Lopez,  1981).  Mogensen  (1977)  has 
shown  that  resistance  of  mice  to  HSV-2-induced  focal  necrotic 
hepatitis  is  under  genetic  control  and  is  determined  by  one 
dominant  gene  (or  complex  of  closely  linked  genes)  located  on 
the  X-chromosome.  Other  studies  (Lopez,  1975,1980a)  indicated 
that  resistance  to  HSV-1  in  mice  is  a  dominant  genetic  trait 
governed  by  two  major  loci  (genes)  and  that  other  minor  loci 
may  also  influence  this  resistance.  It  has  also  been  shown 
that  loci  within  the  H-2  (gene.  complex)  do  not  influence 
resistance  or  susceptiblity  to  HSV  and  since  resistance  genes 
do  not  segregate  with  the  H-2  phenotype  (in  back  crosses),  the 
loci  do  not  appear  to  be  linked  (Lopez,  1981).  The  data 
presented  in  this  study  indicate  that  there  are  considerable 
differences  in  susceptibility  between  mouse  strains  both  in 
reaction  to  acute  infection  and  also  in  their  ability  to 
establish  a  reactivable  latent  HSV-2  infection.  As  far  as 
effect  of  mouse  sex  is  concerned,  both  male  and  female  mice 
were  found  to  be  equally  susceptible  to  acute  infection  and 
equal  in  their  ability  to  become  latently  infected.  It  should 
be  emphasized  that  all  the  mice  used  were  bred  at  the  Institute 
of  Virology  and  that  the  breeding  system  used  was  the  same  for 
all  strains  of  mice:  each  breeding  nucleus  started  with  6  pairs 
of  mice  which  have  been  subsequently  brother:  sister  mated  for 
four  generations  after  which  the  mice  of  each  strain  were 
random  bred  as  a  closed  colony.  It  is  noteworthy  that 
paralysis  or  death  were  observed  with  all  the  other  strains  of 126 
mice  (Table  6)  except  the  BIOZZI  mice  which  are  known  (Biozzi 
et  al.,  1970)  to  be  a  "high  antibody  responder"  strain  (Ab/H). 
Their  resistance  to  HSV-2  infection  is  probably  determined  by 
factors  additional  to  their  high  antibody  response,  since 
specific  neutralizing  antibodies  can  be  detected  in  mouse  serum 
only  after  6-7  days  post  infection  with  herpes  simplex  virus 
(Sydiskis  and  Schultz,  1966)  by  which  time  HSV  infection  has 
long  been  established  at  other  sites  e.  g.  sensory  ganglia  (Cook 
and  Stevens,  1973).  Further,  it  has  been  shown  that  humoral 
responses  alone  are  of  limited  importance  in  eliminating  acute 
infection  (Openshaw  et  al.,  1979a)  and  in  maintaining  latency 
(Sekizawa  et  al.,  1980).  In  addition,  it  has  been  suggested 
that  cell  mediated  immunity  is  important  in  clearing  the 
primary  infection  whereas  antibody  is  important  in  restricting 
the  spread  of  virus  to  the  central  nervous  system  of  BALB/c 
mice  infected  with  HSV-1  (Kapoor  et  al.,  1982).  However,  the 
possible  involvement  of  antibodies,  particularly  in  the  latent 
stages  of  the  infection  can  not  be  totally  excluded. 
Evidence  that  HSV-1  can  persist  in  a  latent  state  in 
sensory  ganglia  of  man  and  experimental  animals  has  been  amply 
provided  (Stevens  and  Cook,  1971,1973;  Bastian  et  al.,  1972; 
Barringer,  1974;  Warren  et  al.,  1978;  Lonsdale  et  al.,  1979). 
The  results  in  Table  7  clearly  indicate  that  in  my  own 
experiments  the  HG52  strain  of  HSV-2  has  also  successfully 
invaded  the  sensory  ganglia  and  established  latent  infection. 
It  can  be  seen  that  all  mouse  strains  were  harbouring 
reactivable  latent  virus  even  when  they  were  inoculated  with 
the  lower  dose  (105  pfu)  of  input  virus.  At  this  dose  HSV-2 
has  been  recovered  with  similar  efficiencies  from  the  DRGs  of 
resistant  (BIOZZI),  moderately  susceptible  (BALB/c)  and  very 
susceptible  (A)/mice.  Even  more  striking  similarities  can  be 127 
observed  in  the  recovery  of  HSV-2  wt  virus  from  all  strains 
except  C57BL/6-J  when  the  dose  of  the  inoculum  was  increased  to 
106  pfu/mouse.  These  similarities  together  with  the  increase 
in  number  of  positive  mice  releasing  virus  from  their  explanted 
DRGs  confirm  the  dose  dependency  of  acute  and  latent  HSV-2 
infection  and  indicate  that  mouse  susceptibility  to  acute 
infection  is  not  necessarily  correlated  with  ability  to 
establish  latent  ganglionic  infection.  -In  support  of  the  above 
is  that  C57BL/6-J  mice  were  resistant  to  105  pfu  of  HSV-2  but 
moderately  susceptible  to  106  (Table  6),  yet  latent  HSV-2  has 
been  recovered  from  their  DRGs  at  both  doses  (Table  7).  BIOZZI 
mice  were  resistant  to  acute  HSV-2  infection,  but  a  high 
proportion  (11/13  at  105  pfu  and  6/6  at  106  pfu)  of  inoculated 
mice  subsequently  released  latent  viruses  from  their  explanted 
DRG.  These  observations  are  in  agreement  with  those  reported 
by  Lofgren  and  colleagues  (1977)  who  found  no  apparent 
relationship  between  the  capacity  of  the  HSV-1  mutants  to 
induce  encephalitis  and  the  establishment  of  latent  infection 
in  mice. 
Here  for  the  first  time  reactivation  of  HSV  from  the 
explanted  footpad  tissues  of  mice,  three  months  after  recovery 
from  initial  infection,  has  been  reported.  When  one  looks  at 
the  possible  effect  of  mouse  strain  differences  a  similar  kind 
of  observation  can  be  seen  (Table  8)  where  HSV-2  has  been 
recovered  from  the  footpad  tissues  of  both  resistant, 
moderately  susceptible  and  very  susceptible  mice.  However, 
mouse  strains  appear  '  to  differ  in  their  typical  frequency 
of  releasing  virus  from  the  footpad,  for  the  susceptible  (A) 
and  moderately  susceptible  (BALB/c)  mice  were  more  likely  to 
release  virus  from  the  footpad  than  the  other  strains  of  mice. 
Increasing  the  dose  of  input  virus  was  accompanied  by  an 128 
increase  in  the  number  of  mice  that  released  virus  from  their 
footpads.  In  addition,  virus  reactivation  was  observed  to 
occur  after  a  shorter  time  from  tissues  (FP  and  DRG)  explanted 
from  mice  that  had  been  inoculated  with  the  higher  dose 
(Table  7  and  8).  This  observation  could  be  due  to  a  greater 
number  of  potentially  reactivable  latent  foci  in  mice  that  were 
inoculated  with  higher  doses  of  input  virus.  Unexpectedly, 
however,  no  virus  was  recovered  from  the  footpad  tissue  of 
PIRBRIGHT  mice,  but  this  could  be  due  to  the  small  number 
inoculated  with  106  pfu  compared  to  the  relatively  large  number 
of  mice  inoculated  with  105  pfu  of  HSV-2. 
The  distribution  of  virus  releasing  ganglia  within 
animals  at  a  given  dose  of  infection  and  the  proportion  of 
animals  positive  appeared  to  begenerally  related  (Table  10).  As 
can  be  seen  from  the  results  in  Table  9  virus  was  never 
detected  in  the  supernatant  earlier  than  7  days  after 
explantation:  this  is  good  evidence  that  the  virus  subsequently 
detected  had  been  truly  latent  rather  than  merely  persistent. 
Frequently  virus  was  reisolated  after  a  much  longer  time. 
Histological  studies  (Fig.  28)  showed  that  under  the  culture 
conditions  used,  a  substantial  proportion  of  neurones  survive 
for  one  week  but  subsequently  most  appear  to  degenerate  and 
disintegrate.  It  is  not  certain  whether  some  latently  infected 
neurones  in  the  ganglia  can  survive  longer  or  whether  virus  is 
also  latent  in  another  not  yet  recognised  cell  type  -  the  fact 
is  that  the  virus  was  first  recovered  in  some  instances  as  long 
as  4  weeks  post  explantation  (Table  9)  . 
Warfen  cß(1978)  rOWR$ 
colleagues  (1979)  -  also  reported  some  very  late  reactivations 
and  in  addition  were  able  by  superinfection  with  is  mutants  to 
rescue  HSV  ts+  virus  from  human  trigeminal  and  vagus  ganglia 
that  had  failed  to  release  virus  spontaneously  after  30-45  days 129 
in  culture. 
HSV-2  wt  virus  seems  to  become  widely  distributed  in  the 
ganglia  of  At  BALB/c  and  PIRBRIGHT  mice  following  infection 
into  the  footpad  (Table  10),  a  result  which  is  consistent  with 
the  degree  of  susceptibility  of  these  mice  to  the  acute 
infection.  The  virus  distribution  seems  to  be  slightly  more 
restricted  in  C57BL/6-J  than  in  BIOZZI  mice.  In  every  case, 
and  not  surprisingly,  the  ganglia  that  most  frequently  release 
virus  were  5th  and  the  adjacent  4th  and  6th  lumbar  ganglia 
which  innervate  the  footpad.  Occasionally,  virus  was  recovered 
from  other  ganglia  including  the  sacral  and  thoracic  ganglia. 
This  warrants  some  discussion:  the  virus  can  reach  ganglia 
other  than  those  innervating  the  footpad  by  one  of  the 
following  routes:  i,  virus  may  be  spread  through  viremia  so 
reaching  ganglia  and  settling  there;  this  route  appears  to  be 
unlikely  as  no  virus  was  ever  recovered  from  the  left  side 
ganglia;  moreover  it  would  not  explain  why  the  virus  is  most 
frequently  recovered  from  ganglia  innverating  the  infected 
footpad  than  from  other  adjacent  ganglia  (Table  10).  In 
addition,  it  has  been  conclusively  shown  that  HSV  travels  to 
the  CNS  through  the  intraaxonal  route  (Cook  and  Stevens,  1973); 
ii,  alternatively,  virus  may  pass  to  other  ganglia  either  via 
the  spinal  cord  or  by  travelling  in  nerves  that  are  in 
anatomical  communication  with  the  ganglia  that  innervate  the 
footpad.  The  observed  pattern  of  virus  reactivation  (Table  10) 
from  the  explanted  ganglia  of  some  mice  e.  g.  PIRBRIGHT  and  A, 
demonstrates  that  the  virus  can  be  recovered  from  ganglia  not 
innervating  the  footpad,  i.  e.  13th  and  12th  thoracic.  Further, 
virus  was  also  isolated  from  the  spinal  cord  of  two  A/mice 
(Table  27).  These  observations,  together  with  the  failure  to 
recover  the  virus  from  the  spinal  cord  of  other  mice  used  in 130 
the  same  experiment  whose  ganglia  were  releasing  virus  suggest 
that  the  virus  may  travel  through  the  spinal  cord  and/or 
nerves.  Besides,  free  virus  was  demonstrated  in  the  spinal 
ganglia  of  mice  in  which  either  the  sciatic  or  the  femoral 
nerve  was  severed  (Klein,  1982).  The  successful  isolation  of 
virus  from  the  spinal  cord  of  A/mice  (2/5)  and  not  from  other 
strains  of  mice  may  reflect  the  higher  susceptibility  of  A/mice 
to  the  infection  and  is  in  agreement  with  the  previous 
observations  (Nesburn  et  al.,  1972;  Knotts  et  al.,  1973;  Price 
et  al.,  1975;  Cook  and  Stevens,  1976;  Warren  et  al.,  1978; 
Cabrera  et  al.,  1980)  that  HSV  can  induce  and  can  be  recovered 
from  the  latent  state  both  in  peripheral  and  in  central  nervous 
tissues.  No  virus  was  recovered  from  the  brains  of  mice  used 
in  this  study  after  footpad  inoculation.  However,  latent  virus 
could  be  recovered  from  the  sensory  ganglia  of  mice  which  also 
released  latent  virus  from  their  explanted  spinal  cord.  No 
significant  difference  was  noticed  in  the  time  of  virus 
reactivation  from  sensory  ganglia  or  spinal  cord.  It  can  not 
be  deduced,  however,  whether  virus  recovered  was  directly 
derived  from  that  originally  inoculated  in  the  footpad  or 
whether  the  virus  had  replicated  in  nervous  tissue  before  the 
establishment  of  the  latent  infection.  The  virus  was  also 
demonstrated  in  the  spinal  cord  of  PIRBRIGHT  mice  which  had 
recovered  from  acute  infection  but  were  still  paralysed  5 
months  post  infection  (Fig.  18).  The  result  of  this  experiment 
(Table  28)  indicates  that  latent  HSV  can  be  retrieved  not  only 
from  sensory  ganglia  ipsilateral  to  the  site  of  inoculation  but 
also  from  the  contralateral  ganglia  as  well  as  from  the  spinal 
cord  in  some  cases.  It  is  not  clear  how  the  virus  reached  the 
left  side  ganglia.  Recovery  of  virus  from  the  spinal  cord  and 
from  the  non-inoculated  side  confirms  the  early  observations 131 
reported  by  Knotts  and  colleagues  (1973)  and  suggests  the 
possibility  that  HSV  may  establish  latency  in  the  central 
nervous  system  of  man. 
The  results  described  here  suggest  that  symptomatic 
infection  is  not  a  necessary  step  in  the  establishment  of 
latency.  No  sign  of  illness,  paralysis  or  death  was  observed 
in  the  survivors.  However,  it  can  be  assumed  that  some  viral 
replication  and  release  which  is  restricted  by  the  host  defence 
system  occurs  first  at  the  site  of  inoculation  and  at  the  level 
of  the  ganglia  with  subsequent  prevention  of  the  development  of 
clinically  overt  disease.  Evidence  for  the  productive 
infection  has  been  shown  by  the  presence  of  viral  mRNA  (Puga  et 
al.,  1978)  and  by  the  increase  of  the  amount  of  virus  (Cook  and 
Stevens,  1973)  in  the  ganglia.  -However,  it  has  also  been  shown 
that  topical  treatment  at  the  site  of  inoculation  with 
phosphonoacetic  acid  reduced  the  amount  of  virus  in  the  ganglia 
(Klein  and  Destefano,  1981)  and  that  (ACVr)  resistant  mutants 
can  establish  acute  but  not  latent  infection  in  trigeminal 
ganglia  of  mice  (Klein  et  al.,  1980).  Furthermore,  no 
relationship  was  found  between  the  establishment  of  latent 
infection  and  the  development  of  acute  encephalitis  in  mice 
inoculated  with  HSV-1  mutants  (Lofgren  et  al.,  1977).  In 
support  of  the  conclusions  of  McLennan  and  Darby  (1980)  that 
there  is  no  absolute  requirement  for  a  productive  infection 
during  the  establishment  of  latency  in  neurones  is  the 
observation  that  HSV-2  is  mutants  were  non-pathogenic  when 
inoculated  into  the  footpads  of  mice  (Al-Saadi  et  al.,  1983) 
and  that  these  HSV-2  is  mutants  were  not  able  to  grow  at 
(38.5°C)  the  non  permissive  temperature  either  in  vitro 
(Halliburton  and  Timbury,  1973,1976)  or  in  vivo  when 
inoculated  in  the  mouse  brain  (Fig.  23).  However,  as  will  be 132 
discussed  later  the  mutants  were  able  to  induce  latent 
infection  in  all  strains  of  mice  including  the  resistant  BIOZZI 
line. 
The  method  of  detection  of  latent  virus  by 
sampling  the  supernatant  which  has  been  used  in  this  study  and 
by  other  workers  (Stevens  and  Cook,  1971;  Nesburn  et  al.,  1972; 
Knotts  et  al.,  1973;  Price  et  al.,  1975,1976;  Walz  et  al., 
1976)  has  proven  to  be  more  effective  than  the  method  of 
homogenizing  the  tissue  several  days  after  explantation  (Knotts 
et  al.,  1973;  Price  et  al.,  1975).  Very  frequently  virus  takes 
a  longer  time  to  reactivate  and  homogenization  of  explanted 
tissue  may  give  an  underestimated  figure  of  reactivable 
viruses.  The  two  methods,  however,  give  no  information  about 
the  type  of  cell  in  the  ganglion  in  which  the  reactivation 
occurs,  or  about  the  possible  infection  of  other  ganglionic 
cells  by  reactivated  viruses. 
To  get  such  information  another  approach  was  also  used  to 
induce  reactivation  of  latent  viruses  during  the  course  of  this 
study.  Ganglia  from  latently  infected  mice  were  dissected  and 
dissociated  into  a  single  cell  suspension  and  subsequently 
cultured.  Latent  virus  was  first  recovered  (Table  30)  from  the 
supernatant  of  cultured  cells  3-5  days  after  dissociation,  a 
much  shorter  period  of  time  than  that  required  to  detect 
reactivated  virus  in  the  supernatants  of  cultured  intact 
ganglia.  The  earlier  detection  of  latent  virus  by  the 
dissociation  method  is  thought  to  reflect  the  ready  access 
released  virus  has  to  the  supernatant.  It  may  be  that  in  some 
cases  virus  is  trapped  for  varying  periods  in  intact  ganglia 
during  culture,  reducing  somewhat  the  sensitivity  of  this  assay 
for  latent  virus  reactivation.  However,  any  such  reduced 
sensitivity  can  not  invalidate  the  differences  observed  in  the 133 
frequencies  of  reactivation  of  the  13  is  mutants  and  the  wild 
type  virus. 
It  was  essential  to  pool  all  the  ganglia  from  four  mice 
in  order  to  have  a  viable  number  of  cells  in  culture  after 
dissociation  and  consequently  this  approach  does  not  allow  the 
experimenter  to  determine  which  mouse  released  virus  and  from 
which  ganglion.  In  addition,  there  will  be  some  loss  of  cells 
as  a  consequence  of  the  physical  manipulation  during 
dissociation  and  plating,  which  is  difficult  to  estimate 
accurately.  Walz  and  colleagues  (1976),  also  using  the 
dissociation  and  immunofluorescent  technique,  have  reported 
that  the  number  of  infected  ganglionic  cells  varies 
considerably  in  different  experimental  conditions.  Kennedy, 
Al-Saadi  and  Clements  (1983)  reported  the  successful 
reactivation  of  HSV-1  and  HSV-2  from  dissociated  DRG  cultures 
of  mice  by  the  third  day  after  dissociation  of  the  tissue.  A 
cytopathic  effect  was  observed  in  cells  of  the  dissociated 
ganglia  5-6  days  post  dissociation  an  observation  which 
indicated  that  cells  other  than  neurones  were  likely  to  be 
infected  (at  least  in  vitro)  by  reactivated  virus.  Moreover, 
immunofluorescence  studies  with  A2B5  (neuronal  cell  marker)  and 
anti  HSV  serum  revealed  -.  that 
_=  only  a  small  proportion 
of  the  cell  population  (approximately  0.1-0.2%)  were  both  A2B5+ 
and  anti  HSV+;  however,  a  large  proportion  of  the  cell 
population  Was  anti  HSV+  4  days  post  dissociation,  presumably 
due  to  the  infection  of  further  cells  by  reactivated  virus. 
Although  it  is  known  that  neurones  harbour  the  latent  virus 
(Cook  and  Stevens,  1973;  McLennan  and  Darby,  1980),  it  has  also 
been  shown  that  both  neurones  and  supporting  cells  produce 
virus-specific  antigens  during  the  acute  phase  of  infection 
(Cook  and  Stevens,  1973)  and  that  HSV  could  be  isolated  from 134 
the  trigeminal  nerve  roots  of  some  human  cadavers  (Warren  et 
al.,  1982)  possibly  suggesting  that  the  virus  may  also 
establish  latency  in  cells  other  than  ganglionic  neurones.  In 
addition,  evidence  that  HSV  can  establish  latent  infection  in 
non-neural  sites  of  guinea  pigs  and  mice  has  also  been  reported 
by  Scriba  (1977,1981)  and  Al-Saadi  et  al.  (1983). 
In  conclusion,  experiments  using  wt  of  HSV-2  strain  HG52 
have  produced  the  following  information:  1,  the  virus  was  found 
to  be  able  to  establish  latent  infection  in  the  sensory  ganglia 
of  the  PIRBRIGHT,  C57BL/6-J,  BALB/c,  BIOZZI  and  A  strains  of 
mice  and  in  the  spinal  cord  of  both  PIRBRIGHT  and  A  strain 
mice;  2,  the  virus  was  also  recoverable  from  tissues  explanted 
from  the  site  of  inoculation  (FP);  3,  the  establishment  of 
latent  infection  and  recoverability  of  the  virus  both  from  the 
DRG  and  FP  is  dose  dependent;  4,  the  distribution  of  the  latent 
virus  in  the  ganglia  of  different  strains  of  mice  is  correlated 
with  susceptibility  of  the  mice  to  HSV  infection;  5,  successful 
establishment  of  latent  infection  apparently  is  not  related  to 
the  susceptibility  of  the  mice  to  the  acute  HSV  infection;  6, 
mouse  strains  differ  widely  in  their  ability  to  support  the 
establishment  of  reactivable  latent  ganglionic  infections; 
A/mice  were  found  to  be  most  susceptible  while  BIOZZI,  BALB/c 
and  PRIBRIGHT  mice  were  relatively  less  susceptible  and 
C57BL/6-J  were  the  least  susceptible;  7,  virus  could  be 
reactivated  from  the  latent  state  both  in  explanted  and  in 
dissociated  sensory  ganglia,  HSV-specific  immunofluorescence 
first  appearing  in  neurones. 
Temperature  Sensitive  Mutants 
Unlike  the  wild  type  virus,  HSV-2  derived  temperature 
sensitive  mutants  were  avirulent  when  inoculated  subcutaneously 
in  the  footpad  of  the  mice  used  in  this  study.  None  of  the 135 
inoculated  mice  showed  evidence  of  illness  and  none  died, 
though  shortly  after  inoculation,  swelling  and  reddening  of  the 
inoculated  footpad  was  observed  in  some  cases.  The  mouse  core 
body  temperature  (38.5°C)  is  non  permissive  for  the  is  mutants, 
which  might  explain  the  inability  of  the  mutants  to  induce 
symptomatic  acute  infection.  However,  the  footpads  may  be 
somewhat  below  the  core  temperature  when  the  mice  are  active 
and  a  possible  development  of  microscopic  lesions  in  the 
footpad  has  not  been  excluded.  Nevertheless,  the  wild  type 
virus  (from  which  the  is  mutants  derive)  never  produced 
clinically  detectable  lesions'in  the  footpad  skin.  Though  the 
mutants  may  replicate  to  a  limited  extent  at  the  site  of 
inoculation  the  likely  explanation  for  the  lack  of  virulence  of 
the  mutants  is  the  restriction  in  replication  of  the  is  mutants 
by  the  non  permissive  temperature  of  the  mouse  core.  In 
addition,  both  non  specific  responses  such  as  interferon 
production  and  macrophages  (particularly  in  the  early  stages  of 
infection),  as  well  as  specific  cell  mediated  and  humoral 
immunity  (in  later  stage  of  infection)  may  play  a  part  in 
limiting  virus  spread. 
In  vitro  studies  (Fig.  24)  indicated  that  some  of  the 
mutants  grow  slightly  less  efficiently  at  36.5°C  than  at  34.5°C 
or  31°C.  However,  none  of  the  mutants  showed  any  detectable 
growth  at  the  non  permissive  38.50C  temperature,  which  is  in 
accord  with  earlier  reports  (Halliburton  and  Timbury,  1973, 
1976).  Further,  in  vivo  studies  showed  that  none  of  the 
mutants  inoculated  were  able  to  grow  in  the  mouse  brain 
(Fig.  23)  so  that  infectious  virus  had  become  non  detectable  2 
hours  or  more  after  the  intracerebral  inoculation.  Some  of  the 
mutants  (ts  5  and  is  10)  appeared  to  absorb  slightly  faster 
than  the  others  to  the  mouse  brain.  In  contrast  the  wt  virus 136 
which  was  also  not  demonstrable  at  2  hours  post  infection, 
could  be  shown  to  be  replicating  subsequently  for  some  days. 
Despite  their  inability  to  induce  acute  symptomatic  infection 
in  the  mouse,  when  inoculated  both  into  the  brain  or  into  the 
footpads,  some  of  the  is  mutants  were  found  to  be  able  to 
establish  latent  infection  in  sensory  ganglia,  and  to  be 
recovered  from  the  footpad  tissues  as  well.  Thus  the  is  mutant 
virus  genomes  though  unable  to  complete  the  lytic  cycle  in  the 
DRG  which  are  at  the  nonpermissive  temperature,  were  able  to 
travel  up  the  nerve  and  enter  the  ganglion  cell  body;  if  the 
particular  is  lesion  does  not  affect  a  function  vital  for 
latency,  then  the  viral  genomes  that  travelled  up  the  nerve 
fibre  may  have  successfully  established  and  maintained  latency, 
even  though  not  actually  able  to  complete  the  lytic  cycle.  In 
such  cases,  one  might  expect  latency  to  be  detectable  but 
perhaps  at  low  efficiency;  in  addition  this  might  be  influenced 
by  the  dose  of  input  virus  and  the  number  of  nerve  endings 
exposed  to  the  virus  at  the  site  of  inoculation.  As  was  the 
case  after  infection  with  wt  virus,  mouse  strains  varied  in 
their  ability  to  become  latently  infected  by  the  is  mutants, 
and  between  different  is  mutants  differences  in  establishing 
reactivable  latency  were  also  observed.  It  can  be  concluded 
from  the  cumulative  mutant  totals  (see  Discussion  Table  1  at 
the  end  of  this  chapter)  that  the  strains  most  prone  to 
reactivable  latent  infection  in  the  ganglia  were  BALB/c  and 
A/mice;  least  prone  were  mice  of  the  PIRBRIGHT  strain  while 
C57BL/6-J  and  BIOZZI  mice  were  intermediate.  On  the  whole 
these  results  are  in  reasonable  agreement  (bearing  in  mind  the 
small  number  used)  with  results  obtained  with  the  wild  type 
virus.  The  following  conclusions  can  be  drawn  from  the 
analysis  of  the  results  presented  in  Discussion  Table  1: 137 
(a)  the  mutants  behaved  differently.  They  are 
heterogeneous 
(b)  they  can  be  subdivided  into  at  least  three 
subgroups;  the  first  group  of  low  recoverability 
comprised  of  is  3,5  and  9,  the  second  group  (high 
recoverability)  consists  of  is  1,4  and  8,  while  the 
rest  of  the  mutants  are  members  of  the  middle  group, 
however,  it  is  not  clear  whether  they  constitute  one 
group  (middle)  or  indeed  some  may  belong  to  the 
lower  or  higher  group.  Larger  numbers  of  samples 
would  be  required  to  ascertain  the  state  of  the 
mutants  of  the  middle  group. 
(c)  if  one  takes  the  wild  type  virus  into  consideration 
it  would  fall  into  another  subgroup 
(d)  there  is  evidence  that  some  mutants  behave  sometimes 
differently  in  different  mouse  strains  for  example 
is  7,8,4,2  and  12;  or  similarly  is  3  and  5;  is  1 
and  8.  This  is  is  mutant:  mouse  strain  interaction 
(e)  even  in  the  two  highly  prone  strains  of  mice  A  and 
BALB/c,  some  mutants  behave  very  differently  e.  g. 
ts'2,7.  This  is  also  true  for  C57BL/6-J  and  BIOZZI 
e.  g.  is  2  and  4 
With  respect  to  mouse  strain  exactly  similar  conclusions  can  be 
drawn  from  the  data  concerning  the  recovery  of  the  is  mutants 
from  the  footpads  (see  Discussion  Table  2).  The  order  from 
most  to  least  frequent  was  BALB/c>  A>  C57BL/6-J,  BIOZZI> 
PIRBRIGHT.  Statistical  analysis,  using  the  multiple  comparison 
procedures  of  Cox  (1970)  which  has  an  overall  significance 
level  of  0.05,  confirmed  the  following  conclusions: 
(a)  the  mutants  can  be  subdivided  into  three  subgroups: 
the  first  group  consists  of  two  members  i.  e.  is  5 138 
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and  is  11  which  were  not  recovered  from  the  footpad; 
the  second  group  has  one  member,  is  3,  that  has  been 
frequently  recovered  from  the  footpad.  The  third 
group  is  the  middle  group  comprised  of  the  rest  of 
the  is  mutants.  As  in  the  case  of  their  recovery 
from  the  DRG,  larger  samples  of  these  middle  group 
members  would  be  required  to  ascertain  their  state. 
(b)  unlike  its  recovery  from  the  DRG  the  wild  type  virus 
falls  within  the  middle  group  of  viruses  recovered 
from  the  footpad 
(c)  some  mutants  behave  similarly,  for  example  is  5  and 
is  11,  have  never  been  recovered  from  the  footpad  of 
any  of  the  mouse  strains,  or  is  2  and  is  3  which 
were  recovered  even  from  the  footpad  of  the  least 
prone  strain  of  PIRBRIGHT  mice 
(d)  also  there  is  evidence  that  some  mutants  behave 
differently  in  different  mouse  strains,  for  example 
is  10  and  is  11  in  BALB/c  and  A  mice  but  not  in 
PIRBRIGHT,  C57BL/6-J  and  BIOZZI;  or  the  behaviour  of 
is  1  in  the  two  highly  prone  strains  of  mice  A  and 
BALB/c.  Again  this  is  is  mutant:  host  interaction 
Thus  reactivation  from  latency  is  least  frequently 
obtained  in  the  PIRBRIGHT  strain  of  mice  both  from  explanted 
DRG  and  FP,  most  frequently  from  BALB/c  and  A  strains  and 
intermediate  for  BIOZZI  and  C57BL/6-J.  However,  with  the 
number  of  mice  used  in  this  study,  it  was  not  possible  to 
demonstrate  a  statistically  significant  difference  between 
BALB/c,  A,  BIOZZI  &  C57BL/6-J  mice  strain  at  the  DRG  level  or 
between  PIRBRIGHT,  BIOZZI  &  C57BL/6-J  at  the  FP  level.  In 
general  it  can  be  concluded  that  the  pattern  of  the  infection 
seems  reproducible  in  each  particular  strain  of  mice  and  that 139 
host  factors  influence  the  incidence  of  reactivable  latent 
infection  at  either  site  (FP  and  DRG).  As  will  be  shown  later, 
reactivable  latent  infection  can  be  established  at  both  sites 
(FP  and  DRG)  independently. 
In  addition,  to  these  mouse  strain-dependent  differences 
in  response  to  is  mutant  infection,  striking  variations 
distinguishing  the  various  is  mutants  were  also  observed 
(Discussion  Table  1).  Each  of  the  mutants  was  found  to  behave 
in  a  characteristic  way  (in  respect  of  ability  to  establish  a 
reactivable  latent  infection  in  the  sensory  ganglia)  in  a 
particular  mouse  strain:  for  example  the  results  of  is  1,  is  8, 
is  10  and  is  11  are  in  total  agreement  with  the  overall 
classification  of  mouse  strains  into  highly  susceptible  (BALB/c 
and  A)  least  susceptible  (PIRBRIGHT)  and  intermediate 
(C57BL/6-J  and  BIOZZI)  whereas  the  results  observed  with  is  2 
and  is  7  would  lead  to  quite  different  hierarchies;  A  >BIOZZI 
>BALB/c,  C57BL/6-J,  PIRBRIGHT  and  PIRBRIGHT,  BALB/c  >BIOZZI 
>C57BL/6-J,  A.  Mutants  is  3  and  is  5  were  only  recovered  from 
the  sensory  ganglia  of  a  single  C57BL/6-J  mouse  each  (even 
though  is  3  had  been  inoculated  into  as  many  as  24  A/strain 
mice).  Mutant  is  9  was  only  recovered  once  but  in  this  case 
from  an  A/mouse.  Clearly  these  three  mutants  are  each 
defective  in  different  functions  that  affect  latency.  Mutants 
is  6,10,11  and  13  were  also  only  infrequently  recovered  and 
seem  to  modify  the  potential  of  the  virus  to  induce  latency. 
Ts  4,12  and  13  differ  somewhat  in  their  reactivation 
patterns:  is  4  was  found  to  induce  reactivable  latent  infection 
more  efficiently  in  the  sensory  ganglia  of  BIOZZI  mice  than  in 
the  other  mouse  strains,  while  is  12  was  readily  recovered  from 
all  other  strains  except  BIOZZI.  Ts  13  was  not  recovered  from 
the  sensory  ganglia  of  C57BL/6-J  or  BALB/c  mice,  only  once  from 140 
the  DRG  of  A/mice  and  twice  each  from  PIRBRIGHT  and  BIOZZI.  It 
is-interesting  that  the  is  mutants  also  differ  in  their 
distribution  within  the  ganglia  of  particular  mouse  strains 
(see  Discusion  Table  4);  those  mutants  that  were  recovered  from 
all  mouse  strains  (ts  1,  is  4,  is  6  and  is  8)  were  found  in  a 
wider  range  of  ganglia  in  the  mouse  strains  where  they  induced 
a  high  level  of  latent  infection  and  were  more  restricted  in 
distribution  within  the  ganglia  of  mice  from  strains  where  the 
level  of  latent  infection  was  low.  It  can  be  seen  that  in  the 
most  prone  BALB/c  and  A  strain  mice  the  mutants  were 
occasionally  being  recovered  from  the  3rd  and  often  from 
the  4th  lumbar  ganglia,  whereas  no  virus  was  ever  recovered 
from  a  ganglion  beyond  the  4th  lumbar  in  other  less  prone 
strains  (C57BL/6-J  and  BIOZZI)  of  mice.  The  mutants  were  even 
more  restricted  to  the  6th  and  5th  lumbar  ganglia  in  PIRBRIGHT 
mice.  In  all  strains  of  mice  the  mutant  viruses  as  well  as  the 
wild  type  were  most  frequently  recovered  from  the  5th  and  6th 
lumbar  ganglia,  which  indicates  that  these  two  ganglia  were  the 
main  target  sites  for  the  establishment  of  reactivable  latent 
infection  following  the  footpad  inoculation.  The  combined 
experimental  observations  indicate  conclusively,  that  the 
sequelae  of  virus  infection  are  influenced  by  the  host  genetic 
makeup  and  equally  importantly  the  virus  genotype. 
Analysis  of  the  data  (Discussion  Table  1)  revealed  that  ' 
the  is  mutants  also  vary  in  their  overall  ability  to  establish 
latent  infection  in  the  sensory  ganglia  of  mice.  Some  mutants, 
viz,  is  1,  is  4  and  is  8  were  found  to  be  of  high  latency 
capacity  and  as  a  result  virus  was  recovered  from  ganglia  of 
>37%  of  the  inoculated  mice.  These  mutants  were  able  to  induce 
latent  infection  in  all  five  strains  of  mice;  one  other  mutant, 
is  6,  was  also  able  to  establish  latent  infection  in  all 141 
strains  of  mice  though  at  a  much  lower  level  (-10%).  This 
mutant  is  known  to  have  a  temperature  sensitive  DNA  polymerase 
(Hay  et  al.,  1976).  The  latency  capacity  of  is  2  and  is  12  was 
fairly  high  so  that  about  one  fourth  of  the  inoculated  mice 
could  be  shown  to  harbour  latent  virus.  Ts  7  was  fairly  easily 
reactivated  from  PIRBRIGHT,  BALB/c  and  BIOZZI  mice,  but  not  at 
all  from  A  or  C57BL/6-J.  Ts  6,  is  10,  is  11  and  is  13  were 
each  recovered  from  about  10%  of  the  mice.  The  remaining 
mutants,  is  3,  is  5,  is  9  were  severely  limited  in  the  ability 
to  establish  latent  infection  in  the  DRG  and  clearly  are  each 
genetically  impaired  in  functions  which  affect  latency  as  well 
as  ability  to  replicate  at  non  permissive  temperature.  In 
general,  the  mutants  were  much  less  efficient  than  the  wt  in 
the  establishment  of  the  latent  infection  in  the  DRG.  However, 
in  some  mouse  strains  some  mutants  were  found  to  possess  a 
similar  capacity  to  that  of  the  wt  virus;  for  example  is  4  in 
the  BIOZZI  and  is  8  in  the  BALB/c  mice  suggesting  that  certain 
levels  of  latency  can  be  experimentally  controlled  by  selecting 
the  appropriate  host  and  virus.  It  is  important  to  note  that 
the  mutants  were  inoculated  at  105-106  pfu/mouse,  however,  the 
variations  in  the  latency  capacity  of  the  mutants  seems  not  to 
be  determined  simply  by  the  dose  of  the  input  virus;  since 
viruses  inoculated  at  the  lower  input  dose  (105  pfu)  were  found 
to  establish  the  latent  infection  with  high  efficiency  (ts  1 
and  is  8);  similarly  some  mutants  inoculated  at  high  input  dose 
(106  pfu/mouse)  were  found  not  efficient  (ts  5)  or  of  poor 
efficiency  (ts  6)  in  the  establishment  of  reactivable  latent 
infection.  All  mutants  used  in  this  study  survived  reasonably 
when  incubated  at  310C  (Fig.  25)  and  thus  loss  of  virus  by 
thermal  inactivation  after  shedding  and  before  sampling  is  not 
thought  to  have  contributed  materially  to  the  results.  It  can 142 
be  argued  that  only  a  very  small  amount  of  virus  may  be 
released  during  each  incident  of  reactivation,  but  that 
released  viruses  are  then  amplified  by  replication  in  the 
supporting  cells  within  the  ganglion  culture. 
Recovered  viruses  must  have  passed  through  the  classical 
3  stages  of  successful  latent  infection,  i.  e.  initiation  of 
latency,  maintenance  and  reactivation.  Besides,  the  viruses 
must  have  travelled  from  the  site  of  inoculation  (FP)  to  the 
sensory  ganglia.  The  fact  that  is  3,  is  5  and  is  9  were 
reactivated  in  the  sensory  ganglia,  though  only  on  one  occasion 
each,  precludes  the  assumption  that  these  mutants  were  not  able 
to  reach  the  ganglia  or  were  totally  incapable  of  the 
reactivation  process.  In  addition,  is  3  and  is  9  have  been 
reactivated  and  recovered  quite  readily  from  the  footpad  tissue 
3  months  after  inoculation.  Hence,  it  seems  that  these  mutants 
are  deficient  in  functions  essentially  involved  in  the 
establishment  and/or  maintenance  of  the  latent  infection  in  the 
sensory  ganglia.  Additional  evidence  for  the  deficient 
capacity  for  latency  of  is  3  is  the  observation  that  no  virus 
was  recovered  and  no  immunofluorescence  positive  foci  were 
observed  in  cultures  of  dissociated  explanted  ganglia  from  mice 
inoculated  with  the  virus  (Table  30).  It  was  important  to 
determine  the  latency  capacity  of  these  particular  mutants  by 
inoculating  them  directly  into  the  tissues  of  interest  (i.  e. 
nervous  tissue)  and  since  the  DRG  were  not  accessible,  the 
mouse  brain  was  chosen  for  this  purpose.  The 
particle/infectivity  ratio  was  determined  for  is  3,  is  5  and 
is  9  and  found  to  be  48,54  and  102  respectively,  and  the 
growth  of  these  mutants  compared  with  that  of  the  wt  virus  in 
the  mouse  brain  was  studied.  None  of  'these  mutants  were  able 
to  grow.  Further,  brains  from  inoculated  mice  (six  weeks  after 143 
the  intracerebral  inoculation)  were  removed  and  cultured  as 
described.  The  results  (Table  29)  showed  that  none  of  the 
mutants  (ts  3,  is  5  and  is  9)  were  recoverable  despite  the 
increase  in  the  dose  inoculated  (ts  5  and  is  9)  from  105  to 
106  pfu/mose  brain.  On  the  other  hand,  is  6  which  is  of  low 
latency  capacity  in  the  DRG,  was  recovered  from  the  latent 
state  in  the  mouse  brain. 
HSV-2  wt  was  recovered  from  the  footpads  (Discussion 
Table  2)  with  approximately  comparable  frequency  as  some  of  the 
is  mutants,  although  some  mutants  (ts  3  and  is  10)  appeared 
possibly  superior  to  wild  type.  On  the  other  hand  is  5  and 
is  11  were  not  recovered  from  any  culture  of  the  explanted 
footpad  tissues.  Recovery  of  other  mutants  ranged  from  6-9% 
for  is  6,  is  7  and  is  12  and  from  11-16%  for  is  1,  is  2,  is  8, 
is  9  and  is  12  (Discussion  Table  2).  As  was  the  case  with 
their  recovery  from  the  sensory  ganglia,  differences  were 
observed  in  the  frequencies  of  recovery  of  the  mutants  (FP) 
between  strains  of  mice;  for  example  is  2  and  is  3  were 
recovered  from  the  footpad  tissues  of  all  strains  of  mice, 
whereas  other  mutants  either  were  not  recovered  at  all  (ts  5 
and  is  11)  or  recovered  from  some,  but  not  all  strains  of  mice. 
Further,  the  frequency  of  recovery  of  each  mutant  appeared  to 
be  different  in  each  particular  mouse  strain  e.  g.  is  1  in 
BALB/c  and  BIOZZI  mice  or  is  4  in  the  first  four  strains  of 
mice  compared  to  A/mice.  The  differences  between  the  viruses 
were  statistically  significant  and  analysis  of  the  data  leads 
to  the  conclusion  that  is  3  is  more  prone  than  most  other  used 
mutants  (particularly  is  5  and  is  11)  to  be  recovered  from  the 
explanted  FP. 
It  is  relevant  to  discuss  the  subject  of  virus  recovery 
from  the  two  sites  i.  e.  the  dorsal  root  ganglia  and  the  footpad 144 
together.  Interestingly,  some  mutants  (ts  3,  is  9  and  is  10) 
have  been  recovered  more  frequently  from  the  footpad  than  from 
the  ganglia,  however  the  majority  of  the  viruses  including  the 
wt  virus  were  recovered  more  often  from  the  ganglia.  Of 
special  significance  is  the  observation  that  is  5  and  is  11 
were  never  recovered  (0/59  and  0/58)  from  the  footpads  and  only 
once  recovered  (ts  5)  or  recovered  to  a  limited  extent  (ts  11) 
from  the  dorsal  root  ganglia.  This  suggests  that  the 
impairment  of  is  5  affects  almost  completely  its  recovery  from 
both  DRG  and  FP  whereas  that  of  is  11  has  its  main  effect  on 
the  recovery  from  FP. 
Further  analysis  of  the  data,  where  the  recovery  of  the 
mutants  from  the  DRG  and  FP  in  individual  mice  was  compared, 
revealed  that  viruses  were  either  recoverable  both  from  the  DRG 
and  FP,  or  only  from  the  DRG,  or  only  from  the  FP  (Discussion 
Table  3).  Remarkably  viruses  (including  wt  virus)  were  only  in 
a  minority  of  cases  recovered  from  both  the  footpad  and  DRG  of 
the  same  mouse.  The  viruses  were  much  more  often  independently 
recovered  either  from  the  ganglia  or  from  the  footpads;  for 
example,  is  11  was  recovered  from  the  sensory  ganglia  and  never 
from  the  footpads  while  is  3  and  is  9  were  recovered  from  the 
footpad  tissues  very  much  more  frequently  than  they  were 
recovered  from  ganglia.  In  fact,  is  3  was  recovered  from  the 
ganglia  of  only  1/16  mice  but  from  15/16  of  the  footpads  of 
these  mice  (Discussion  Table  3).  Similarly,  is  9  and  is  10 
were  both  recovered  from  the  footpads  of  7/8  and  9/15  mice 
respectively  compared  to  1/8  and  4/15  from  the  ganglia. 
Moreover,  none  of  the  mutants,  is  3,  is  6  and  is  9  were  ever 
recovered  from  the  DRG  and  FP  of  the  same  mouse.  The  number  of 
mice  which  released  virus  from  both  their  DRG  and  FP  was 
overall  24/195.  It  is  noteworthy  that  the  number  of  mice 145 
releasing  virus  from  their  DRG  only  was  108/195  and  from  the  FP 
was  63/195  (see  Discussion  Table  3). 
The  recovery  of  wt  as  well  as  is  mutant  viruses  from 
footpad  tissue  both  from  resistant  and  susceptible  mouse 
strains  suggests  that  the  host  defense  responses  do  not 
correlate  with  recoverability  from  this  site.  Recovery  of 
virus  from  the  peripheral  regions  may  be  due  either  to, 
reactivation  of  virus  latent  within  nervous  tissues  (DRG)  which 
subsequently  travels  via  a  nerve  to  the  peripheral  site,  or  to 
the  presence  of  virus,  over  a  long  period  of  time  either 
persistent  (slowly  replicating)  or  latent  at  the  peripheral 
site.  However,  no  virus  was  ever  released  from  the  FP  earlier 
than  8  days  after  explantation  and  no  virus  was  ever  recovered 
immediately  after  explantation  from  homogenised  FP  (Table  31). 
No  symptoms  of  reactivation  in  the  footpad  were  ever  detected. 
Moreover,  it  has  been  concluded  (McLennan  and  Darby,  1980)  that 
virus  reactivation  will  eventually  lead  to  the  death  of  the 
infected  cell,  presumably  due  to  virus  replication.  The 
mutants  were  not  able  to  grow  at  the  non  permissive  (38.5°C) 
temperature  (this  thesis  and  Halliburton  and  Timbury,  1973, 
1976);  hence  viruses  recovered  from  the  footpad  could  not  have 
undergone  a  normal  replication  process  involving  the  complete 
lytic  cycle  in  vivo  within  the  mouse  sensory  ganglia.  It  is 
however  possible  to  imagine  that  the  genomes  of  some  of  the 
mutants  could  have  passed  down  the  nerve  fibre  to  the  periphery 
without  becoming  enveloped-into  an  infectious  virus  particle, 
but  there  is  no  evidence  for  this.  The  evidence  therefore 
strongly  favours  some  form  of  latency  at  the  peripheral  site. 
As  neurone  cell  bodies  have  never  been  described  as  located  in 
the  mouse  footpad,  cells  other  than  neurones  must  shelter  the 
latent  virus.  In  accord  with  the  latter  conclusion  is  the 146 
difference  in  time  of  virus  reactivation  from  the  ganglia  and 
from  the  footpads.  Both  the  wild  type  and  is  mutant  viruses 
required  a  longer  time  in  order  to  reactivate  from  the  footpad 
than  from  the  ganglia  (Discussion  Table  5)  and  in  some  cases 
(for  example  the  wt  and  is  7  in  BIOZZI  mice,  is  2  and  is  3  in 
PIRBRIGHT  and  C57BL/6-J  mice,  is  10  in  A/mice  or  is  1  in  BALB/c 
mice)  viruses  were  not  recovered  from  the  footpad  cultures 
until  32-45  days  post  explantation.  In  contrast,  the  latest 
time  of  virus  reactivation  from  the  ganglia  in  these 
experiments  was  28  days  post  explantation.  Of  course,  the 
possibility  that  mechanical  trapping  after  reactivation  from 
the  footpad  tissue  but  before  release  of  virus  into  the  medium 
might  contribute  to  the  differences  in  timing,  cannot  be 
excluded.  It  does  not  seem  very  likely  that  trapping  alone 
could  lead  to  the  large  and  consistent  difference  observed. 
It  would  be  important  to  determine  the  type  of  cells  that 
were  (possibly)  latently  infected  at  the  footpad,  and  it  would 
be  interesting  to  compare  the  mechanism  of  latency  in  both 
"  types  of  cell  (i.  e.  the  ganglion  sensory  neurones  and  the  non 
neurona(cells  in  the  FP).  The  use  of  in  situ  hybridization  and 
immunofluorescent  techniques  should  identify  the  types  of  cells 
involved  in  the  lytic  cycle  at  the  FP  and  eventually  may  also 
determine  the  latently  infected  cells  though  positive 
immunofluorescence  is  not  necessarily  to  be  expected  during  the 
true  latent  phase  of  infection.  Such  experiments  remain  to  be 
done. 
Reactivated  viruses  both  from  the  DRG  and  FP  were 
randomly  chosen  and  their  DNA  restriction  enzyme  profiles  were 
compared  to  that  of  the  standard  HSV-2  and  to  the  is  mutant 
viruses  initially  used  for  inoculation. 
Comparative  studies  of  restriction  endonuclease  (RE) 147 
digests  of  the  DNA  of  different  strains  of  HSV-1  and  HSV-2 
revealed  that  the  two  subtypes  can  be  readily  differentiated 
(Lonsdale,  1979)  and  that  strains  exhibited  characteristic 
profile  within  each  subtype  (Hayward  et  al.,  1975a;  Skare  et 
al.,  1975).  Variation  in  RE  patterns  within  a  subtype  could 
result  from:  1)  loss  and/or  gain  of  restriction  sites,  due  to 
point  mutation  within  the  restriction  site  or  due  to  small 
deletions  or  insertions;  2)  size  (mobility)  variability  of 
restriction  fragments  probably  due  to  a  variable  copy  number  of 
tandemly  reiterated  sequences  within  these  fragments.  Both 
types  of  variations  have  been  observed  in  viruses  recovered 
`  from  human  ganglia  (Lonsdale  et  al.,  1979,1980;  Chaney  et  al., 
1983).  However,  studies  of  clonally  related  isolates  very 
rarely  showed  instances  of  the  loss  or  gain  of  restriction 
endonuclease  cleavage  sites  (Lonsdale  et  al.,  1980).  On  the 
other  hand,  size  variability  of  particular  restriction 
fragments  was  regularly  observed  both  in  isolates  prepared  by 
plaque  purification  of  parent  strain  and  in  isolates  from 
different  clinical  episodes,  including  reactivated  viruses. 
In  the  present  study,  changes  in  RE  cleavage  pattern  were 
most  frequently  confined  to  the  size  variability  of  restriction 
fragments,  particularly  Bam  HI  g,  p,  u,  w,  z,  a'.  The 
fragments  Bam  p,  z  and  a'  are  known  to  contain  tandemly 
reiterated  DNA  sequences  (Lindsay  Whitton  -  personal 
communication)  and  their  variation  in  mobility  is  most  probably 
due  to  variation  in  copy  number  of  the  tandem  repeats,  a 
phenomenon  previously  observed  in  HSV-1  (Davison  et  al.,  1981) 
and  in  human  genomic  DNA  (Spritz,  1981).  It  is  not  known 
whether  the  other  variable  fragments  contain  similar  tandem 
reiterated  sequences. 
In  one  case,  the  loss  of  a  restriction  site  (Hind  III 148 
m-1)  was  observed  (Figure  26-d).  This  is  the  first, 
demonstration  that  this  phenomenon  which  has  previously  been 
shown  to  occur  in  HSV-2  strains  freshly  isolated  from  the  human 
population  (Chaney  et  al.,  1983)  can  be  experimentally 
reproduced  by  a  single-latent-passage  of  HSV-2  in  mice.  This 
single  observation  among  the  studied  isolates  supports  the 
proposal  that  loss  or  gain  of  a  restriction  site  is  a 
relatively  rare  event  during  virus  growth  (Lonsdale  et  al., 
1980;  Roizman  and  Tognon,  1982).  It  is  unknown  at  which  stage 
of  the  whole  latency  producing  process  these  alterations  in  the 
viral  genome  occurred.  No  significance  could  be  attached  to 
the  differences  between  RE  profiles  of  virus  isolated  from  the 
footpad  and  from  the  ganglia  of  individual  mice. 
The  viral  genome  appears  to  be  latent  within  the  sensory 
neurones  of  the  ganglia  (McLennan  and  Darby,  1980;  Cook  and 
Stevens,  1973)  and  certain  stimuli  applied  to  the  area  of  the 
latent  infection,  such  as  epinephrine  iontophoresis  (Kown  et 
al.,  1981;  Hill  et  al.,  1982)  or  surgical  manipulation  (Walz  et 
al.,  1974;  McLennan  and  Darby,  1980;  Klein,  1982)  have  been 
shown  to  lead  to  the  reactivation  of  virus  with  subsequent 
shedding  at  the  periphery.  Virus,  however,  has  also  been 
recovered  from  central  nervous  tissue,  autonomic  ganglia  and 
the  adrenal  gland  (Nesburn  et  al.,  1972;  Knotts  et  al.,  1973; 
Price  et  al.,  1975;  Cook  and  Stevens,  1976;  Warren  et  al., 
1978).  Skin  explants  from  the  sites,  in  man,  at  which  HSV 
recurrences  have  been  observed  have  never  yielded  virus, 
however  these  attempts  have  not  been  repeated  recently  and  it 
is  noteworthy  that  only  the  superficial  layers  of  the  skin  were 
cultured  (Rustigan  et  al.,  1966).  However,  recurrent  herpetic 
lesions  have  been  observed  in  patients  with  'blow  out' 
fractures  which  had  severed  the  nerve  supply  to  the  area  of 149 
skin  involved  (Hoyt  and  Billson,  1976). 
Further,  HSV  has  been  shown  to  be  present  in  peripheral 
tissues  of  latently  infected  animals.  Scriba  (1976,1977) 
isolated  HSV-1  and  HSV-2  from  the  site  of  inoculation  (footpad 
and  vagina)  of  latently  infected  guineag  pigs;  Donnenberg  and 
colleagues  (1980)  have  also  isolated  HSV-2  from  guinea  pig 
footpad.  HSV-1  has  been  isolated  from  the  site  of  inoculation 
(i.  e.  ear  skin)  in  8%  of  latently  infected  mice  in  the  absence 
of  overt  clinical  lesions  (Hill  et  al.,  1980).  Recently,  Park 
and  Macnab  (1983)  have  suggested  that  in  the  inbred  Hooded 
Lister  rat,  the  fibroblast  cells  (transformed  or  tumour  cells) 
has  the  capacity  to  harbour  non  replicating  HSV  genomes.  It  is 
not  precisely  known  what  viral  gene(s)  functions,  are  essential 
for  the  successful  establishment  of  the  latent  infection, 
however,  studies  with  HSV-1  mutants  (Watson  et  al.,  1980)  have 
already  clearly  indicated  that  at  least  one  immediate  early  and 
one  or  more  later  virus  genes  are  necessary  for  the 
establishment  and/or  maintenance  of  the  latent  state. 
Comparison  of  latency  characteristics  with  the  phenotypic 
properties  of  the  mutants  expressed  under  the  restrictive 
conditions  (Halliburton  and  Timbury,  1973;  Macnab,  1974; 
Halliburton  and  Timbury,  1976;  Hay  et  al.,  1976;  Moss  et  al., 
1979;  Moss,  1982)  revealed  that  there  is  no  correlation  between 
the  latency  phenotype  and  viral  DNA  synthesis,  DNA  polymerase 
and  DNAase  activity,  or  cell  transformation  ability.  For 
example,  is  3  is  known  to  synthesize  a  limited  amount  of  viral 
specific  polypeptides  at  the  non  permissive  temperature,  while 
is  5  synthesized  normal  amounts  of  the  viral  polypeptides,  both 
mutants  are  DNA+  and  both  were  found  to  be  severely  limited  in 
the  ability  to  establish  a  reactivable  latent  infection  in  the 
mouse  DRG.  On  the  other  hand,  is  9  is  a  DNA-  virus  and  have  the 150 
earliest  block  (see  Table  1)  synthesizing  very  little  viral 
polypeptides  in  BHK  cells  at  the  non-permissive  temperature. 
Ts  9  was  also  found  to  be  defective  in  the  establishment  of 
reactivable  latent  infection  in  the  sensory  ganglia.  Of  the 
three  mutants,  is  3  was  recovered  very  frequently  from  the 
footpad  tissues  while  is  5  was  never  recovered  from  the 
footpad.  It  is  noteworthy  that  the  above  virus-specific 
activities  were  measured  in  virus-infected  BHK  cells,  and  it  is 
not  known  how  relevant  is  the  behaviour  of  these  mutants  in  BHK 
cells  to  their  behaviour  in  the  differentiated  cells  of  the 
hosts.  However,  these  observations  confirm  and  extend  the 
conclusions  reported  by  Watson  and  colleagues  (1980)  and 
Stevens  (1981)  that  viral  genes  essential  for  the  establishment 
of  latent  infection  are  not  confined  or  clustered  on  the 
physical  and  genetic  map  of  HSV.  For  the  time  being,  there  is 
not  sufficient  information  to  allow  possible  correlation  of  the 
latency  characteristics  of  the  viruses  to  their  phenotypes  and 
it  is  extremely  important  to  better  characterise  the  is 
mutations  of  these  HSV-2  is  mutants.  It  has  been  reported 
(Tenser  and  Dunstan,  1979)  that  TK  gene  expression  is  important 
in  the  pathogenesis  of  HSV  infection  and  necessary  for  the 
establishment  of  the  infection  in  the  sensory  ganglia,  however, 
some  TK-  mutants  were  able  to  establish  latent  infection,  but 
with  more  difficulty,  in  the  ganglia  of  mice  (Field  and  Wildy, 
1978;  Tenser  and  Dunstan,  1979;  Field  and  Darby,  1980).  The 
results  presented  in  this  study  showed  that  some  thymidine 
kinase  positive  (TK+)  mutants  (namely  is  3,5  and  9)  were  also 
very  deficient  in  the  establishment  of  the  latent  infection  in 
sensory  ganglia.  This  indicates  that  in  the  presence  ofirOact 
TK&other  gene  functions  are  also  important  and  perhaps 
essential  for  the  viral  genome  to  pass  through  all  the  stages 151 
involved  in  a  latent  infection. 
The  is  mutants  were  found  to  grow,  in  vitro,  at  36.5°C  (2 
degrees  below  the  non  permissive  temperature)  and  it  is  not 
possible  to  exclude  the  possibility  that  some  leakiness 
allowing  replication  may  have  occurred  at  times  in  the  mouse 
footpad;  any  leak-through,  however,  would  tend  to  increase  the 
capacity  for  viral  gene  expression  and  therefore  favour  the 
establishment  of  latency.  These  considerations  cannot  help  to 
explain  the  non  recovery  of  mutants  is  5  and  is  11  from  the 
footpad  or  the  recovery  of  is  3,  is  5  and  is  9  (only  on  one 
occasion  each)  from  the  sensory  ganglia. 
The  results  of  this  study  using  HSV-2  (HG52)  is  mutants 
leads  to  the  following  conclusions:  - 
1.  non  recovery  of  is  5  from  the  footpad  and  its  single 
recovery  (1/59)  from  the  sensory  ganglia  suggest  that  this 
mutant  is  deficient  in  functions  either  necessary  for 
establishment  or  maintenance  of  latency  in  mice  or  for 
reactivation 
2.  recovery  of  some  mutants  (ts  3  and  is  9)  from  the  footpad  at 
frequencies  (15/56,7/53)  much  greater  than  their  recovery 
from  the  sensory  ganglia  (1/80,1/66)  and  the  recovery  of 
is  5  and  is  11  only  from  the  DRG  support  the  notion  of 
independent  establishment  of  latency  in  the  footpad  and  DRG 
and  imply  that  these  viruses  can  go  latent  in  tissues  other 
than  the  ganglia  or  the  CNS 
3.  only  a  minority  of  mice  produced  virus  both  from  the  footpad 
and  ganglia.  This  is  in  keeping  with  the  hypothesis  that 
HSV-2  can  induce  latent  infection  independently  at  the  two 
sites 
4.  the  observed  differences  in  successful  reactivation  between 
i 
HSV-2  is  mutants  from  the  DRG  and  from  the  FP,  are  also 152 
evidence  that  the  genetic  control  of  the  ability  of  HSV  to 
produce  latent  infection  is  influenced  by  several  viral 
genes.  Observations  of  is  mutants  in  different  genes  with 
impaired  latency  give  us  a  minimum  estimate  of  genes 
essential  (ts  5)  and  genes  that  modify  latency 
5.  differences  in  susceptibility  of  mouse  strains  to  the  latent 
infection  underline  the  important  roles  of  host  (genetically 
determined)  factors  in  modulating  the  events  involving  virus 
-  host  interaction  leading  to  the  establishment  of  latency 
and  recovery  of  virus 
6.  the  RE  study  also  suggests  that  modifications  of  the  viral 
DNA  can  occur  during  one  or  more  of  the  stages  in  the 
process  of  initiating,  maintaining  or  reactivating  from 
latency. 
As  a  result  of  these  studies,  the  mouse  model  of  HSV-2 
latency  has  to  be  modified  so  as  to  include  the  footpad  tissues 
as  another  possible  site  for  latent  HSV  infection  in  addition 
to  the  DRG. 
It  has  been  suggested  that  stimuli  to  the  sensory  neurone 
will  result  in  reactivation  of  the  latent  virus  from  the 
ganglion  cells  presumably  due  to  the  direct  effect  of  the 
stimulus  on  the  neurone  (ganglion  trigger  theory)  or  indirectly 
by  acting  on  the  skin  area  (skin  trigger  theory)  innervated  by 
that  neurone  (Hill  and  Blyth,  1976).  It  is  now  necessary  to 
postulate,  the  presence  of  virus  latent  at  the  periphery  in  a 
cell  other  than  the  neurone,  and  that  stimuli  causing  virus 
reactivation  at  this  site  may  either  act  directly  on  the  skin 
or  via  the  sensory  neurones  or  a  combination  of  the  two.  Virus 
can  therefore  reactivate  independently  from  either  DRG  or  the 
footpad. 
In  humans,  herpes  simplex  virus  has  never  been  recovered 153" 
from  the  skin  or  other  peripheral  tissues  of  apparently  healthy 
individuals.  However,  it  should  be  noted  that  in  the 
experiments  described  in  this  thesis  the  whole  layers 
comprising  the  skin  tissue  were  excised  from  the  footpad  and 
that  HSV  took  a  long  time  to  reactivate  from  the  footpad.  In 
addition,  the  total  number  of  footpads  checked  during  this 
study  was  not  less  than  725  for  the  is  mutants  and  81  for  the 
wild  type  (Discussion  Table  2).  Thus  previous  negative  results 
in  man  (Stadler  and  Zurukzoglu,  1936;  Findlay  and  MaCullum, 
1940;  Rustigan  et  al.,  1966)  may  have  a  trivial  explanation  and 
could  be  of  questionable  significance.  HSV  recurrences  on  the 
face  occur  at  sites  where  biopsy  would  be  difficult  to  justify 
ethically  as  a  reasonable  experimental  procedure  that  could 
treat  the  patient.  Of  course,  it  would  be  of  value  to  examine 
the  skin  from  other  sites  between  recurrences  in  humans  -  for 
example  the  genital  region.  The  possibility  of  latent  virus  in 
peripheral  tissue  of  man  is  given  credence  by  some  clinical 
reports  of  recurrences  repeatedly  at  exactly  the  same 
anatomical  site  with  the  ,  same  prodromal  symptoms. 
In  experimental  animals,  however,  the  virus  has  been 
recovered  from  guinea  pig  footpad  and  vagina  (Scriba,  1976, 
1977)  and  from  the  mouse  footpad  (Al-Saadi  et  al.,  1983  and  the 
work  in  this  thesis).  In  addition,  HSV  genomes  have  been 
recovered  (by  superinfection)  from  in  vitro  HSV  transformed 
cells  that  had  been  inoculated  into  rats  with  subsequent  tumour 
production  (Park  and  Macnab,  1983).  Analysis  of  the  recovery 
of  HSV  genomic  material  from  such  sites  may  shed  some  light  on 
the  relationship  between  HSV-2  and  cervical  cancer  in  the  human 
and  could  help  us  to  gain  a  better  understanding  of  long  term 
interactions  between  viral  sequences  and  host  cells. 
The  observation  that  HSV-2  can  be  reactivated  from  the 154 
footpad  tissue  of  the  mouse  does  open  a  new  area  for  further 
research  and  could  be  of  clinical  importance,  and  ultimately  of 
help  in  our  understanding  of  herpes  simplex  virus  as  a  disease 
causing  agent. y 
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11-- Statistical  analysis  of  the  data  of  the  recovery  of  TS 
mutants  from  the  ganglia  + 
(A)  Comparison  of  mouse  strains 
Group  Group  Int.  Est. 
1  2  -1.5603  0.3405 
1  3  -1.8382  -0.0622* 
1  4  -2.2448  -0.5222* 
1  5  -2.1355  =0.3779* 
2  3  -1.1565  0.4759 
2  4  -1.5606  0.0135 
2  5  -1.4529  0.1594 
3  4  -1.1437  0.2772 
3  5  -1.0380  0.4251 
4  5  -0.5721  0.8257 
Estimated  Probabilities 
0.0851  0.1474  0.1966 
Where  group  1= 
2= 
3= 
4= 
5= 
0.09  0.15  0.20  0.25 
0.2749  0.2500 
PIRBRIGHT 
C57BL/6-J 
BIOZZI 
BALB/c 
A/MICE 
0.27 
12354 
Conclusion 
Group  1  (PIRBRIGHT)  is  significantly  smaller  in  terms  of 
proportion  of  positive  than  group  3,5  and  4. 
+  The  method  used  to  compare  the  strains  of  mice  and  the  is 
mutant  viruses,  involved  a  Bonferroni  multiple  comparisons 
procedure  using  empirical  logistic  transformation  of  COX  (1970) 
on  the  number  of  'positive'  for  each  strain  and  virus.  The 
procedure  has  an  overall  significance  level  of  0.05. 
*  signficant  difference 
continued/.... (B)  Comparison  of  is  mutants 
Group  Group  Int.  Est. 
1  2  -0.7195  1.8651 
1  3  0.8434  6.1231* 
1  4  -1.3102  1.0011 
1  5  0.5213  5.8318* 
1  6  0.0097  3.1584* 
1  7  -0.4110  2.3000 
1  8  -1.4725  1.0442 
1  9  0.6405  5.9386* 
1  10  0.0298  3.3210* 
1  11  -0.1752  2.8804 
1  12  -0.8342  1.7712 
1  13  -0.0534  3.4330 
2  3  0.2412  5.5799* 
2  4  -1.9488  0.4942 
2  5  -0.0808  5.2883 
2  6  -0.6119  2.6345 
2  7  -1.0403  1.7838 
2  8  -2.1059  0.5321 
2  9  0.0384  5.3952* 
2  10  -0.5898  2.7951 
2  11  -0.7988  2.3580 
2  12  -1.4657  1.2572 
2  13  -0.6704  2.9045 
3  4  -6.2438  -1.0319* 
3  5  -3.8431  3.2296 
3  6  -4.7159  0.9175 
3  7  -5.2392  0.1618 
3  8  -6.3505  -1.0444* 
3  9  -3.7254  3.3380 
3  10  -4.6650  1.0493 
3  11  -3.9216  0.6603 
3  12  -5.6892  -0.3404* 
3  13  -4.7079  1.1210 
4  5  0.7096  5.9526* 
4  6  0.2219  3.2554* 
4  7  -0.1891  2.3873 
4  8  -1.2450  1.1259 
4  9  0.8289  6.0594* 
4  10  0.2394  3.4206* 
4  11  0.0388  2.9795* 
4  12  -0.6094  1.8556 
4  13  0.1530  3.5357* 
5  6  -4.4236  1.2386 
5  7  -4.9476  0.4835 
5  8  -6.0591  -0.7223* 
5  9  -3.4302  3.6562 
5  10  -4.3725  1.3703 
5  11  -4.6295  0.9816 
5  12  -5.3976  -0.0185* 
5  13  -4.4151  1.4416 
6  7  -2.3135  1.0345 
6  8  -3.3945  -0.2019* 
6  9  -1.1198  4.5308 
6  10  -1.8251  2.0078 
6  11  -2.0478  1.5849 
6  12  -2.7471  0.5160 
6  13  -1.8951  2.1066 7  8  -2.5397  0.2223 
7  9  -0.3644  5.0545 
7  10  -1.0103  2.4721 
7  11  -1.2222  2.0384 
7  12  -1.8576  0.9433 
7  13  -1.0884  2.5790 
8  9  0.8415  6.1659* 
8  10  0.2229  3.5562* 
8  11  0.0163  3.1172* 
8  12  -0.6466  2.0119 
8  13  0.1409  3.6670* 
9  10  -4.4798  1.2515 
9  11  -4.7366  0.8627 
9  12  -5.5049  -0.1376* 
9  13  -4.5225  1.3230 
10  11  -2.2013  1.5556 
10  12  -2.9074  0.4935 
10  13  -2.0431  2.0718 
11  12  -2.4708  0.7026 
11  13  -1.6273  2.3017 
12  13  -0.5737  3.0163 
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IN Statistical  analysis+  of  the  data  of  the  recovery  of  is 
mutants  from  the  footpad. 
(A)  Comparison  of  mouse  strains 
Group  Group  Int.  Est. 
1  2  -2.8192  0.1971 
1  3  -2.7371  0.2236 
1  4  -3.7102  -0.8913* 
1  5  -3.4760  -0.6525* 
2  3  -1.0332  1.1418 
2  4  -1.9784  -0.0009* 
2  5  -1.7452  0.2389 
3  4  -1.9899  -0.0981* 
3  5  -1.7568  0.1418 
4  5  -0.5979  1.0709 
Estimated  Probabilities 
0.0258  0.0963  0.0920  0.2266  0.1875 
Where  group  1=  PIRBRIGHT 
2=  C57BL/6-J 
3=  BIOZZI 
4=  BALB/c 
5=  A/MICE 
0.025  0.029  0.09  0.18  0.22 
13254 
Conclusion 
Group  4  (BALB/c)  is  definitely  greater  in  proportion  of 
+ve  than  group  1,2  and  3.  Also  group  5  is  greater  than 
group  1. 
+  See  Discussion  Table  1  for  details  of  the  method  of  the 
statistical  analysis 
*  significant  difference 
continued/..... (B)  Comparison  of  is  viruses 
Group  Group  Int.  Est. 
1  2  -2.1047  1.5903 
1  3  -2.5623  0.7987 
1  4  -2.2027  1.1856 
1  5  -0.8492  6.6741 
1  6  -1.4937  2.3502 
1  7  -1.4579  2.7491 
1  8  -2.1612  1.6467 
1  9  -1.9280  1.8438 
1  10  -2.2871  1.2147 
1  11  -0.8670  6.6581 
1  12  -1.8654  2.0239 
1  13  -1.6238  2.6038 
2  3  -2.2655  1.0163 
2  4  -1.9061  1.4035 
2  5  -0.5744  6.9138 
2  6  -1.2020  2.5728 
2  7  -1.1691  2.9748 
2  8  -1.8691  1.8691 
2  9  -1.6356  2.0658 
2  10  -1.9919  1.4339 
2  11  -0.5923  6.8978 
2  12  -1.5740  2.2469 
2  13  -1.3352  2.8296 
3  4  -1.0928  1.8393 
3  5  0.1297  7.4588* 
3  6  -0.4143  3.0343 
3  7  -0.3971  3.4520 
3  8  -1.0796  2.3288 
3  9  -0.8443  2.5237 
3  10  -1.1858  1.8769 
3  11  0.1118  7.4428* 
3  12  -0.7885  2.7106 
3  13  -0.5640  3.3076 
4  5  -0.2498  7.0918 
4  6  -0.8008  2.6743 
4  7  -0.7823  3.0907 
4  8  -1.4663  1.9690 
4  9  -1.2312  2.1640 
4  10  -1.5739  1.5185 
4  11  -0.2677  7.0758 
4  12  -1.1748  2.3504 
4  13  -0.9491  2.9461 
5  6  -6.2656  1.2971 
5  7  -6.1436  1.6100 
5  8  -6.9420  0.6026 
5  9  -6.7178  0.8086 
5  10  -7.1461  0.2487 
5  11  -4.9931  4.9592 
5  12  -6.6262  0.9597 
5  13  -6.3049  1.4599 
6  7  -1.9212  2.3561 
6  8  -2.6281  1.2573 
6  9  -2.3953  1.4547 
6  10  -2.7574  0.8285 
6  11  -1.3150  6.2496 
6  12  -2.3315  1.6336 
6  13  -2.0869  2.2105 7  8  -3.0254  1.2196 
7  9  -2.7941  1.4185 
7  10  -3.1682  0.8044 
7  11  -1.6278  6.1276 
7  12  -2.7254  1.4926 
7  13  -2.4682  2.1569 
8  9  -1.6919  2.1222 
8  10  -2.0527  1.6946 
8  11  -0.6205  6.9259 
8  12  -1.6287  2.3016 
8  13  -1.3854  2.8799 
9  10  -2.2484  1.2601 
9  11  -0.8265  6.7017 
9  12  -1.8263  2.0690 
9  13  -1.5844  2.6486 
10  11  -0.2666  7.1301 
10  12  -1.2017  2.4327 
10  13  -0.9710  3.0234 
11  12  -6.6101  0.9776 
11  13  -6.2889  1.4778 
12  13  -1.7583  2.5798 
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ANALYSIS  OF  THE  DATA  ACCORDING  TO  THE  SITE  OF  REACTIVATION 
PIRBRIGHT  C57BL/6-J  BIOZZI 
Virus  pfu/  No.  of  No.  of  No.  of 
mouse  mice- 
(FP  &  DRG)-  (FP)+  (DRG)+  (FP  S  DRG)+ 
mice, 
(FP  &  DRG)-  (FP)+  (DRG)+  (FP  &  DRG)+ 
mice- 
(FP  &  DRG)-  (FP)+  (DRG)+  (PP  &  DRG)+ 
tsl  1x105  11  10  0  1  0  10  6  0  4  0  9  4  2  3  0 
ts2  1.7x106  11  10  1  0  0  8  6  2  0  0  16  7  1  8  0 
ts3  1.2x105  5  4  1  0  0  9  7  1  1  0  15  10  5  0  0 
ts4  5x106  15  13  0  2  0  13  8  1  4  0  14  2  0  11  1 
ts5  1.7x106  13  13  0  0  0  12  11  0  1  0  12  12  0  0  0 
ts6  1x106  14  13  0  1  0  12  9  1  2  0  15  14  1  0  0 
ts7  8x105  15  9  0  6  0  9  8  1  0  0  9  7  0  1  1 
ts8  2.5x105  11  11  0  0  0  5  3  0  1  1  9  6  0  2  1 
ts9  7.5x105  13  13  0  0  0  13  10  3  0  0  10  8  2  0  0 
ts10  2.5x105  11  11  0  0  0  12  12  0  0  0  9  9  0  0  0 
tall  4.2x105  12  12  0  0  0  12  12  0  0  0  12  11  C  1  0 
ts12  5x105  12  8  1  3  0  7  3  1  2  1  14  13  1  0  0 
ts13  6x105  9  6  1  2  0  7  7  0  0  0  14  12  0  2  0 
Total  (mutants)  152  133  4  15  0  129  102  10  15  2  158  115  12  28  3 
wt  1x105  12  5  0  7  0  4  0  1  3  0  11  1  0  9  1 
1x106  5  0  0  5  0  11  2  3  5  1  6  0  0  4  2 
Total  (wt  only)  17  5  0  12  0  15  2  4  8  1  17  1  0  13  3 
BALD/c  A 
Virus  pfu/  No.  of  No.  of 
mouse  mice,  mice,  (F  P&  DRG)-  (FP)+  (DRG  )+  (FP  &  DRG)+  (FP  &  DRG)-  (FP)+  (DRG)+  (FP  6  DRG)+ 
tsl  1x105  11  3  2  3  3  10  5  0  5  0 
ts2  1.7x106  6  4  2  0  0  9  1  0  6  2 
ts3  1.2x105  13  10  3  0  0  12  7  5  0  0 
ts4 
ts5 
5x106 
1.7x106 
9 
11 
3 
11 
2 
0 
3 
0 
1  10  2  2  0  6 
ts6  1x106  15  13  1*  1 
0 
0 
11 
10 
11 
5 
0 
3 
0 
2 
0 
0 
ts7  8x105  10  3  2  5  0  11  11  0  0  0 
ts8  2.5x105  9  1  0  4  4  8  1  0  6  1 
ts9  7.5x105  9  7  2  0  0  8  7  0  1  0 
ts10 
tall 
2.5x105 
4  2x05 
9 
10 
1 
6 
4  2  2  10  3  5  2  0  Not  isolated 
ts12  .  5x105  3  2 
0 
0 
4 
1 
0  11  10  0  1  0 
0 
**  No.  of  positive  mice  -  total  no. 
ts13  6x105  10  9  1  0 
0 
0 
11  7  1  3 
1  0  of  mice  -  (FP  and  DRG)-ve 
11  8  2  NC  Not  considered  due  to  loss  of 
cultured  FP  by  contamination 
Total  (mutants)  125  73  19  23  10  132  78  18  27  9  Only  cultures  of  footpad  and 
ganglia,  from  a  single  mouse, 
that  proved  to  be  clean  for  more 
wt  1x105  3  1 
than  3  weeks  afr  a  l  i 
1x106  r  n 
0 
- 
2  0  NC 
-  -  - 
anal  w  s  sia  ere  considered  in  th  7 
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SUMMARY 
Herpes  simplex  virus  type  2  wild-type  and  13  temperature-sensitive  mutants  have 
been  examined  for  their  ability  to  be  recovered  from  latently  infected  Biozzi  mice. 
After  inoculation  into  the  rear  footpad,  virus  could  be  recovered  from  both  the  dorsal 
root  ganglia  (DRG)  and  the  footpad  (FP)  at  the  site  of  inoculation  (wt,  is  1,  is  2,  is  4,  is 
6,  is  7  and  is  8),  or  from  the  DRG  only  (is  11  and  is  13),  or  from  FP  only  (is  3,  is  9,  is  12). 
Two  mutants  (is  5  and  is  10)  have  not  been  recovered  from  either  site.  Both  DNA- 
positive  and  DNA-negative  mutants  have  been  shown  to  be  capable  of  establishing 
latent  infection. 
Following  a  primary  infection  in  man,  herpes  simplex  virus  (HSV)  usually  establishes  latency, 
from  which  it  may  periodically  reactivate  and  release  virus;  this  can  result  in  overt  clinical 
disease.  HSV  genetic  information  persists  in  sensory  ganglia  both  in  man  and  in  experimental 
animals,  and  after  explantation  of  ganglia  followed  by  culture  in  vitro  the  latent  virus  can  be 
reactivated  (Stevens  &  Cook,  1971;  Stevens,  1975;  Bastian  et  a!.,  1972;  Barringer,  1975). 
HSV-1  temperature-sensitive  (is)  mutants  have  been  used  to  probe  the  mechanism  of  latency, 
and  differences  in  ability  to  be  recovered  from  latency  have  been  described  (Lofgren  et  al.,  1977; 
Watson  eta!.,  1980;  Clements  &  Subak-Sharpe,  1983).  In  this  paper  we  describe  for  the  first  time 
the  ability  of  HSV-2  is  mutants  to  be  recovered  from  the  latent  state  in  mouse  dorsal  root  ganglia 
(DRG).  In  addition,  we  have  been  able  to  recover  HSV-2  from  another  tissue,  the  footpad  (FP) 
at  the  site  of  inoculation  3  months  or  more  after  infection. 
HSV-2  wild-type  (wt)  virus  and  a  set  of  13  is  mutants  were  used  (Timbury,  1971;  Halliburton 
&  Timbury,  1973,1976)  to  inoculate  3-  to  4-week-old  Biozzi  high  antibody  responder  strain  mice 
of  both  sexes  via  the  rear  FP  (105  to  106  p.  f.  u.  ).  No  significant  difference  in  response  between 
males  and  females  was  found.  It  is  relevant  that  the  mouse  body  core  temperature  (38.5  °C)  is 
non-permissive  for  the  is  mutants  used.  The  FP  may  be  somewhat  below  the  core  temperature 
when  the  mice  are  active;  however,  when  they  are  closely  packed  asleep  in  the  nest,  the  FP 
temperature  is  probably  at,  or  very  close  to,  that  of  the  core.  No  animal  died  or  became  paralysed 
following  infection  of  Biozzi  mice  with  the  HSV-2  wt  and  is  mutants  at  the  doses  indicated  in 
Table  1.  Some  mice  showed  slight  FP  swelling  immediately  after  the  initial  inoculation,  but  no 
swelling  or  symptoms  of  active  infection  were  noted  subsequently. 
At  least  3  months  after  primary  infection  (when  the  mice  were  asymptomatic),  the  animals 
were  killed  using  chloroform.  Nine  ipsilateral  (one  sacral,  six  lumbar,  two  thoracic)  and  two 
contralateral  DRG  were  rapidly  dissected  out  and  explanted  under  aseptic  conditions.  In 
addition,  FP  tissue  from  both  the  left  and  the  right  rear  limbs  was  also  explanted  from  each 
mouse  and  grown  as  organ  cultures  in  vitro at  31  °C.  In  16  cases  out  of  a  total  of  199,  the  explanted 
FP  became  contaminated  during  culture  and  had  to  be  discarded.  Explant  cultures  of  individual 
ganglia  and  FP  tissue  were  maintained  in  150  pl  Eagle's  minimum  essential  medium  (Glasgow 
modified)  supplemented  with  50%  foetal  calf  serum,  penicillin  (100  units/ml),  streptomycin  (100 
µg/ml),  gentamicin  (25µg/ml)  and  nystatin  (25  units/ml)  in  microtitre  plates.  Released  virus  was 
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Table  1.  Recovery  of  wild-type  HSV  and  is  mutants  follo  wing  explantation  of  dorsal  root  ganglia 
(DRG)  and  footpad  (FP)  from  latently  infected  mice 
Input  dose  Virus  DNA  DRG  positive/  FP  positive/ 
(p.  f.  u.  /mouse)  (105-106  p.  f.  u.  /mouse)  phenotype  total  (%)  total  (%) 
Ix  106  wt  HG52  +  6/6  (100)  2/6  (33) 
Ix  105  wt  HG52  +  11/13  (85)  1/14  (7) 
1x  105  is  1-  4/11  (36)  2/10  (20) 
1.7  x  106  is  2-  8/17  (47)  1/16  (6) 
1.2  x  105  is  3+  0/16  (0)  5/15  (33) 
5x  106  is  4+  12/14  (86)  1/14  (7) 
1.7  x  106  1s  5+  0/12  (0)  0/12  (0) 
Ix  106  is  6-  1/16  (6)  1/16  (6) 
8x  105  is  7-  2/14  (14)  1/11  (9) 
2.5  x  105  1s  8-  5/14  (35)  1/9  (11) 
7.5  x  10,  is  9-  0/11  (0)  2/11  (18) 
2.5  x  105  is  10  -  0/13  (0)  0/9  (0) 
4.2  x  105  is  11  -  1/12  (8)  0/12  (0) 
5x  105  is  12  +  0/14  (0)  1/14  (7) 
6x  105  is  13  +  2/14  (14)  0/14  (0) 
detected  by  screening  the  supernatant  on  semi-confluent  BHK  cells  grown  in  microtitre  plates. 
On  several  occasions,  an  FP  was  divided  into  two:  one  half  was  incubated  as  above,  and  the 
other  homogenized  and  immediately  screened.  At  no  time  was  virus  found  in  the  homogenate, 
although  virus  reactivated  from  the  cultivated  half-FP  in  several  cases.  The  screening  procedure 
was  carried  out  daily  for  the  explanted  FP  cultures  and  twice  weekly  for  DRG.  Recovered 
viruses  were  checked  for  growth  on  BHK  C13  cells  both  at  31  °C  and  at  38.5  °C  (the  permissive 
and  non-permissive  temperatures).  A  mouse  in  which  either  the  FP  and/or  any  ganglion  released 
virus  on  one  or  more  occasions  was  scored  as  positive.  The  first  screening  always  took  place 
within  24  h  after  explantation. 
As  no  mice  died  after  inoculation  of  105  p.  f.  u.  of  HSV-2  strain  HG52  wt  virus,  the  Biozzi 
high  antibody  responder  strain  falls  into  the  group  of  mouse  strains  relatively  resistant  to 
acute  infection  with  HSV  to  which,  for  example,  C57BL/6  mice  also  belong  (Lopez,  1975; 
Kirchner  et  al.,  1978;  Clements  &  Subak-Sharpe,  1983).  Details  of  comparative  work  using 
HSV-1  and  HSV-2  with  five  mouse  strains  will  be  published  in  due  course. 
Virus  was  never  detected  in  the  supernatant  from  explanted  DRG  earlier  than  the  6th  day 
after  dissection.  The  majority  of  HSV-2  reactivants  from  explanted  ganglia  first  appeared 
between  day  7  and  14  and  the  latest  time  at  which  virus  was  first  detected  was  24  days  after  DRG 
explantation.  To  our  surprise,  we  reproducibly  obtained  virus  reactivation  also  from  FP 
explants  of  mice  infected  with  HSV-2.  The  FP  cultures  never  shed  virus  before  the  10th  day  after 
explantation  and  on  one  occasion  not  before  42  days  after  explantation.  No  virus  has  ever  been 
detected  in  tissue  homogenates  immediately  after  explantation,  which  is  in  keeping  with  other 
reports  (Cook  &  Stevens,  1976;  Hill  &  Blyth,  1976).  At  the  doses  of  HSV  used  in  the  present 
study,  virus  was  never  recovered  from  the  left  DRG  or  the  left  FP,  contralateral  to  the  site  of 
inoculation.  The  virus  that  reactivated  from  mice  initially  infected  with  a  is  mutant  was  checked 
and  in  every  case  proven  to  have  retained  the  is  phenotype.  Using  the  restriction  enzymes 
BamHI,  BglII,  HindI1l,  KpnI  and  EcoRI  (Lonsdale,  1979),  the  DNA  fragment  profiles  of 
reactivated  viruses  were  compared  to  the  profiles  of  the  virus  used  for  initial  infection.  In  every 
case  the  profiles  were  shown  to  be  unchanged. 
As  can  be  seen  from  Table  1,  HSV-2  wt  virus  was  recovered  with  high  efficiency  from  the 
DRG  but  only  infrequently  from  the  FP;  the  efficiency  of  recovery  was  dose-dependent.  Two 
HSV-2  mutants,  is  5  and  is  10,  have  not  been  recovered  following  explantation  either  from  DRG 
or  from  the  FP;  mutants  is  3,  is  9  and  is  12  have  only  been  recovered  from  explanted  FP,  while 
mutants  is  11  and  is  13  have  been  recovered  from  DRG  only.  The  remaining  HSV-2  mutants 
were  all  recoverable  both  from  DRG  and  FP,  but  whilst  is  1,  is  6  and  is  7  were  obtained  from 
either  site  with  approximately  equal  frequency,  is  2,  is  4  and  is  8  were  much  more  frequently 
reactivated  from  the  DRG. 
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Table  2.  Anatomical  distribution  of  DRG  from  which  HSV-2  was  successfully  reactivated  in 
latently  infected  Biozzi  mice* 
Right  side  DRG$ 
Lumbar  Thoracic 
No.  of 
Virust  mice  Sacral  1  6  5  432  I  13  12 
wt  13  1  1  5  621  0  00 
131  11  0  1  2  100  0  00 
ts2  17  2  4"  3  200  0  00 
ts4  14  2  5  6  400  0  00 
ts6  18  0  0  0  100  0  00 
ts7  14  0  0  2  200  0  00 
is8  14  0  3  2  000  0  00 
is  11  12  0  1  0  000  0  00 
is13  14  0  2  1  000  0  00 
"  The  figures  under  each  column  indicate  the  number  of  mice  positive  with  respect  to  virus  recovery  from  that 
DRG. 
t  Mutants  is  3  (16  mice),  is  5  (12),  is  9  (11),  is  10  (13)  and  is  12  (14)  have  not  been  recovered  from  DRG. 
$  No  virus  was  ever  recovered  from  the  left  side  DRG. 
The  distribution  of  ganglia  from  which  HSV-2  was  recovered  was  not  the  same  for  all  the 
latency-positive  mutants.  Mutants  is  2  and  is  4  were,  like  wt,  recovered  from  a  number  of 
ganglia,  some  of  which  would  not  be  expected  to  innervate  the  footpad  directly,  whereas  the 
other  mutants  were  shed  from  only  one  or  two  of  the  ganglia  innervating  the  footpad  (Table  2). 
The  above  results  suggest  the  following  tentative  conclusions.  (i)  Non-recovery  of  HSV-2 
mutants  is  5  and  is  10  from  either  site  suggests  that  these  mutants  are  deficient  in  functions 
either  necessary  for  the  establishment  or  maintenance  of  latency  in  Biozzi  mice,  or  for  the  ability 
to  reactivate  upon  explantation.  (ii)  The  recovery  of  some  HSV-2  mutants  (ts  3  and  also  is  9  and 
is  12)  only  from  the  explanted  FP  suggests  that  HSV-2  can  become  latent  in  tissues  other  than, 
and  apparently  independent  of,  the  DRG.  (iii)  The  recovery  of  the  HSV-2  mutants  is  11  and  is  13 
only  from  DRG  supports  the  notion  of  independent  latency  in  FP  and  DRG.  (iv)  Only  four  mice 
produced  virus  both  from  the  FP  and  from  DRG  following  explantation,  one  infected  with 
HSV-2  wt  and  one  each  with  is  4,  is  7  and  is  8.  This  is  in  keeping  with  the  hypothesis  that  HSV-2 
can  produce  latent  infection  independently  at  the  two  sites.  (v)  The  observed  differences  in 
reactivation  of  HSV-2  is  mutants  from  DRG  and/or  FP,  and  the  apparent  differences  between  is 
mutants  in  recoverability,  are  evidence  that  the  genetic  control  of  the  ability  of  HSV  to  produce 
latent  infection  is  not  simple  and  at  least  in  part  due  to  several  virus  gene  functions.  It  is  relevant 
in  this  context  that  both  DNA-positive  and  DNA-negative  mutants  were  shown  to  induce  latent 
infection. 
All  the  reactivants  had  retained  the  is  phenotype  which  excludes  reversion  to  the  wt, 
temperature-resistant  phenotype  as  an  explanation  for  the  recovery  of  some  of  the  is  mutants.  It 
is  not  possible  to  exclude  that  some  leakiness  allowing  replication  may  have  occurred, 
particularly  in  the  mouse  FP  which  may  not  always  have  been  at  the  mouse  core  temperature. 
Any  leak-through  would  tend  to  increase  the  capacity  for  viral  gene  expression  and  therefore 
favour  the  establishment  of  latency.  These  considerations  can  not  help  to  explain  the  non- 
recovery  of  mutants  is  5  and  is  10. 
There  is  good  evidence  that  the  viral  genome  is  latent  within  the  sensory  neurones  of  DRG 
(McLennan  &  Darby,  1980),  but  recovery  from  central  nervous  tissue,  autonomic  ganglia  and 
the  adrenal  gland  has  also  been  reported  (Cook  &  Stevens,  1976;  Nesburn  et  al.,  1972;  Warren  et 
a!.,  1978;  Price  et  al.,  1975;  Knotts  et  al.,  1973).  Skin  explant  cultures  from  the  sites  in  man  at 
which  HSV  recurrences  had  been  observed  did  not  yield  virus  (Rustigan  et  a!.,  1966).  However, 
HSV  has  been  shown  to  be  present  in  peripheral  tissues  of  latently  infected  animals  under  some 
circumstances.  Scriba  (1976,1977)  isolated  HSV-1  and  HSV-2  from  the  site  of  inoculation  of 
latently  infected  guinea-pigs  (FP  and  vagina).  Donnenberg  eta!.  (1980)  have  also  isolated  HSV-2 1178  Short  communication 
from  guinea-pig  FP.  Hill  et  al.  (1980)  reported  the  isolation  of  HSV-1  from  the  ear  skin  (the  site 
of  inoculation)  in  8  °%  of  latently  infected  mice  in  the  absence  of  clinical  lesions.  Recurrent  HSV 
in  patients  with  `blow-out'  fractures,  which  had  severed  the  nerve  supply  to  the  area  of  skin 
involved,  has  also  been  observed  (Hoyt  &  Billson,  1976).  Scriba  (1981)  recovered  latent  HSV-2 
from  FP  skin,  but  not  the  DRG,  of  guinea-pigs  infected  with  virus  into  the  FP  10  days  after 
surgical  denervation.  Recovery  of  virus  from  the  peripheral  regions  may  be  due  either  to 
reactivation  of  virus  latent  within  nervous  tissue  which  subsequently  travels  via  a  nerve  to  the 
peripheral  site,  or  to  the  presence  of  virus  over  a  long  period  at  peripheral  sites,  although  these 
two  possibilities  are  not  mutually  exclusive.  We  think  it  most  unlikely  that  the  input  virus  could 
persist  either  as  such  or  in  a  slowly  replicating  form  during  the  3  months  or  more  elapsing 
between  inoculation  and  dissection.  We  suggest  that  the  virus  is  capable  of  establishing  a  latent 
infection  in  the  FP  and,  as  neural  cell  bodies  have  never  been  described  as  located  in  the  mouse 
FP,  it  follows  that  the  latency  is  established  in  cells  other  than  neurones.  The  observed 
difference  in  timing  of  reactivation  from  the  FP  and  DRG  may  be  a  result  of  this.  At  present,  we 
cannot  exclude  the  possibility  of  mechanical  trapping  after  reactivation  but  before  release  of 
virus  from  the  FP,  contributing  to  the  observed  difference  in  timing  of  virus  release.  We  feel  this 
alone  is  unlikely  to  lead  to  such  a  large  and  consistent  difference  as  is  observed.  We  are  presently 
extending  the  study  using  immunofluorescence  and  in  situ  hybridization. 
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